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SUMMARY
Glucocorticoids have been widely used in reducing the 
oedema associated with brain tumours and post-operative pain. In 
vitro, they have been shown to inhibit growth of several different 
cell types, for example lung tumours and gliomas. Glucocorticoids 
have also been found to encourage immature malignant glioma cells 
to differentiate. This was measured by a reduction in immature 
properties, such as plasminogen activator activity, and the 
appearance of differentiated characteristics, such as glutamine 
synthetase activity.
Malignant cells have been proposed to arise from a 
breakdown in cell communication between the cell and the 
environment. As the cell's surface is the first point of contact 
between the cell and the environment, it has been postulated that 
an alteration in the composition of the plasma membrane may lead 
to a breakdown in cell communication. Carbohydrates are of 
particular interest as they are mainly situated on the outside of 
the membrane, and in spite of their relatively small proportion by 
weight they can cover the entire surface of the cell. Alterations 
in both glycoproteins and proteoglycans have been reported to 
differ between normal and malignant cells. Thus this alteration 
in surface carbohydrates may be important in explaining the 
malignant cells' abnormal behaviour.
In the present investigation dexamethasone and 
methylprednisolone were shown to reduce the saturation densities 
and labelling indices in a number of early passage and continuous 
cell lines. It was shown that the glucocorticoids exert this 
effect through a cytostatic rather than a cytotoxic process. This 
was shown by a clonogenic assay where no decrease in the number of 
colonies was observed in the cells which had been pretreated with 
either dexamethasone or methylprednisolone. The glucocorticoids 
were observed to have a biphasic response: at low cell 
concentrations they enhanced growth while at high cell densities 
they inhibited growth. In the absence of serum both steroids at
II
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2.5x10 M increased the saturation density to the level reached in 
serum.
The exact mechanisms by which the glucocorticoids exert 
these effects have not yet been fully elucidated. A breakdown in 
cellular communication has been suggested by the abnormal 
behaviour of malignant cells. Normal cells continue proliferating 
until cell-cell continuity is established, whereas malignant cells 
are seen to continue proliferating and possess the ability to grow 
on top of one another. This implies that interactions at the cell 
surface are important in normal growth control. In vitro the 
cell's environment has been shown to influence cell shape, 
proliferation and differentiation, which suggests that the 
cytoskeleton may play an important role in these processes. An 
intricate matrix of microfilaments has been shown to exist between 
the interior of the cell, the cell membrane and the extracellular 
matrix. Proteoglycans and glycoproteins have been shown to be 
associated with this matrix in normal cells. Thus, an alteration 
in the proteoglycan and glycoprotein composition may lead to a 
breakdown in cell communication. Proteoglycan and glycoprotein 
composition has been reported to differ between malignant and 
normal cells.
It was asked in the present investigation whether the
glucocorticoids exerted their cytostatic effect through altering
the molecular composition of the cell surface. Examination of the
iodinated glycoproteins of the cell by gel electrophoresis did not
reveal any consistent change, however gel exclusion chromatography
of protease digests of the cell surface showed that the presence
3
of glucocorticoids increased the incorporation of H glucosamine. 
Ion exchange chromatography showed that the presence of 
glucocorticoids increased the proportion of material associated 
with the cell relative to the released fraction and decreased the 
proportion of hyaluronic acid compared to the sulphated 
glycosaminoglycans.
It was concluded that the glucocorticoids were modifying 
the surface of malignant cells to resemble that of their normal 
counterparts in terms of proteoglycans. This alteration in
III
proteoglycan composition might account for the alteration in the 
cell's physiological activity.
IV
CHAPTER 1
GENERAL INTRODUCTION
The aim of this report is to gain a deeper understanding of
how glucocorticoids exert their cytostatic effect at the cellular
level in malignant glioma cell lines. Glucocorticoids have been
widely used for many years to reduce intracerebral pressure
associated with conditions such as brain tumours (Selker et al,
1979). In addition to symptomatic improvements, it has recently
been shown that these agents may directly reduce the size of the
tumour itself. In vitro, glucocorticoids have been shown to
inhibit growth of several different cell types, for example lung 
ctumours (M Lean et al, 1986) and gliomas (Freshney et al, 1980a). 
However, the exact cellular mechanisms through which these effects 
are exerted are still elusive.
The composition of the extracellular matrix and the plasma 
membrane have been found to have profound effects on cell 
behaviour. It was initally asked whether the malignant cells' 
behaviour was due to an alteration in the composition of these 
structures. If so, do the glucocorticoids exert their cytostatic 
effect by altering the composition of the plasma membrane and the 
extracellular matrix to resemble that of normal cells?
An attempt was made in this report to investigate these 
questions by examining the effect of glucocorticoids on the 
composition of glycoproteins and proteoglycans associated with the 
plasma membrane and the extracellular matrix. Before these 
questions can be addressed, the mechanisms involved in normal cell 
growth need to be understood.
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Characteristics of growth control
1. Normal cellular behaviour
1.1. Growth Control In Normal Tissues
The organs of the body all grow to a certain size and then 
cease to grow. Some, however, have the capacity to regenerate in 
response to injury. Such a response has allowed normal growth 
regulatory mechanisms to be probed.
Removal of cells from a confluent monolayer in vitro, as 
happens when a wound is produced, results in the cells at the 
periphery of the site undergoing a burst of proliferation and 
migrating into the "denuded area" until cell-cell continuity is 
re-established (Martz and Steinberg, 1971). The tissue continues 
proliferating until the cells attain their original thickness and 
density, which may involve a temporary overshoot in cell number.
An increase in DNA synthesis in this system is detectable within a 
couple of hours after injury, while mitotic activity reaches a 
peak within a couple of days. These experiments suggest that 
cell-cell interactions are extremely important in controlling 
normal cell growth.
1.2. What are the factors involved in such a process?
The size of mature tissues is maintained by the number of 
cells undergoing mitosis exactly equalling those lost through 
either cell death or cell migration. The majority of cells - with 
the exception of haematopoietic cells in the bone marrow, basal 
cells in the epidermis of the skin and the lining of the GI tract 
- are not cycling. However, these non-cycling cells can be 
encouraged to start dividing, when an organ such as the liver is 
damaged (Goss, 1978b).
Surgical removal of part of the liver triggers a wave of 
mitotic activity in the remaining piece until the organ attains 
its original size. However, the rate of mitosis differs among the 
different cell types found in the liver. The peak mitotic rate is
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reached by parenchymal cells at around 24 hours, Kupffer cells a 
day later, and endothelial lining cells 3-5 days after the 
parenchymal cells. Such observations pose two questions which are 
relevant to theories of growth control. What factor(s) stimulates 
the liver cells to divide and controls the extent to which 
regeneration occurs, and what are the signals which inhibit 
further proliferation once the correct organ size has been 
attained? The above system provided some of the first evidence 
for the existence of growth factors in the circulation.
Bucher (1963) was able to demonstrate, using an elegant 
experiment, that one of the many factors responsible for the 
induction of mitosis is present in the blood, by using a pair of 
rats which had their circulations surgically connected. If 
two-thirds of one of the livers was excised, then mitosis 
increased in both the damaged and unaffected livers. Fisher et al 
in 1971 carried out experiments using a series-arrangement of 
transplanted and host liver remnant tissues, in which they 
diverted portal blood through a partial liver transplant in a 
partially hepatectomised rat. The transplant receiving the portal 
blood responded in the same way as the liver remnant in the 
non-transplanted host. However, the response in the host liver 
remnant, which was in series with the transplant, was considerably 
reduced. Therefore, it was concluded that the transplant used up 
most of the mitogenic factors present in the portal blood, leaving 
little available to stimulate the host's liver. This led to the 
view that the promotion of mitogenic activity in the liver was not 
the result of decreased concentrations in a negative feedback 
system such as is found in the skin (Goss, 1978a).
Further evidence of a positive, rather than a negative 
control system, came from in vitro experiments carried out by Paul 
et al (1972) using foetal rat liver cells. He found that these
cells responded to serum from partially hepatectomised rats by
3 3increasing the uptake of [ H] thymidine and [ H] leucine, whereas
serum from normal rats caused no such response. It seems unlikely
that a negative control system, such as a chalone, would result in
this increased uptake of nucleic acid and protein precursors. In
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experiments carried out by Czeizel et al (1962) the effects of 
radiation and bone marrow injections on rat liver regeneration was 
studied. Injection of unirradiated syngeneic bone marrow into 
irradiated animals restored liver regenerated growth to normal, 
while an excess of bone marrow given by injection produced 
excessive regeneration, ie. the bone marrow appeared to over-ride 
the normal homoeostatic controls. This implies that the hormonal 
factors responsible for liver regeneration are not produced by the 
liver itself, but probably by some "central" machinery which 
controls tissue proliferation and organ size within the body.
1.3. Characteristics of growth in vitro
Tissue culture provides one of the few models where the 
various components described in the previous section can be 
investigated individually, as it allows the environmental 
conditions to be closely controlled. This method has the 
potential for comparing growth characteristics in normal and 
malignant cells of similar lineage, and at similar growth rates.
Growth of most mammalian cells in vitro requires 
supplementation of a chemically defined medium with serum. The 
complex nature of the serum has made the elucidation of the 
various components, which promote and inhibit cell proliferation, 
a difficult and time consuming occupation. Under conditions of 
serum restriction, the cells become arrested in the G0/G1 phase, 
(see Figure 1), of their growth cycle and DNA synthesis is 
reduced, (Lindgren and Westermark, 1977). However, these cells 
can be encouraged to continue proliferating in the presence of 
fresh serum, which results in higher final saturation densities. 
For many cell types, saturation densities have been found to be 
directly proportional to the concentration of serum in the culture 
medium. This implies that cellular proliferation is regulated by 
the availability of mitogenic factors present in the growth 
medium. Growth factors such as EGF (lpg/ml) can stimulate cells 
to proliferate in the absence of serum.
EGF is a potent polypeptide mitogen for epidermal cells in 
vivo and for a variety of cultured cells in vitro, whose mitogenic
epidermal growth factor
-4-
Differentiation
Figure 1
A diagrammatic representation of the mammalian cell 
cycle taken from Plumb and Wright, 1985. Mitosis (M) is 
normally completed Within 1 hour and is the final phase 
of the cell cycle. Upon completing mitosis the cells 
can either remain in the proliferative compartment (Gl) 
or can leave the cell cycle and start to differentiate. 
The length of the Gl phase is variable, 3 hours in rat 
small intestine and 95 hours in mouse epidermis. Some, 
cells enter a resting phase (Go) from which they can 
return when circumstances are appropriate. The synthetic 
phase (S) is normally about 8-12 hours for most 
mammalian tissues, it is this phase where DNA doubles.
effect is mediated through a specific receptor (Jakobovits, 1988). 
The initial identification of EGF was by its ability to induce 
premature eyelid opening in newborn mice, along with observations 
that it was involved in the development of embryonic lung in 
rabbits (Catterton et al, 1979).
A cell will interact with adjacent cells and with the 
structural components of the extracellular matrix, via the 
external surface of its plasma membrane (Nicolson, 1976). This 
membrane is the barrier between the cell and the extracellular 
environment. It contains the cell's antigenic and chemical 
determinants along with receptors for signal molecules whose 
information must be transduced through the lipid bilayer. The 
exact mechanisms through which these cellular interactions take 
place have not yet been fully elucidated. However, it has been 
established that cell development requires the surface membrane 
being able to receive and transmit regulatory signals from its 
environment (Bissel et al, 1982). This suggests that any 
alteration in the composition of the plasma membrane may result in 
a breakdown in the normal cell's development and result in the 
appearance of large quantities of immature cells.
1.4. Influence of the extracellular matrix on cell shape, 
proliferation and differentiation.
In vivo, it is the extracellular matrix (ECM) which is 
important for maintaining order throughout the tissue. The 
composition of this matrix varies between different regions of the 
body (Hay, 1984). The differences in the biochemical composition 
of the extracellular matrix from various sources has been 
correlated to its various functions. For example, in cartilage 
the extracellular matrix combines the tensile strength of type II 
collagen fibres with compressive resilience, provided by the water 
holding properties of hyaluronic acid and proteoglycans with long 
side chains, whereas in bone, the tensile strength contributed by 
type I collagen is combined with rigidity through deposition of 
calcium phosphate crystals in the extracellular matrix.
Connective tissue cells, such as chondrocytes and dermal
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fibroblasts are completely surrounded by their extracellular 
matrix. Some cells are separated from adjacent connective tissue 
by a specialised sheet of extracellular matrix, known as the 
basement membrane or basal lamina. A basement membrane may 
completely surround individual cells, as in the muscle, or make 
contact with only one cell surface, as in the epidermis. Some 
extracellular matrix constituents are widely distributed: type I 
collagen is found in skin, tendon, cornea, ligaments, bone and 
internal organs. Other constituents have a more restricted 
distribution: type X collagen is specific to hypertrophic 
cartilage and laminin is only found in basement membranes.
The substrate on which the cells are grown can profoundly 
influence cell morphology and behaviour as shown by the following 
example. Corneal epithelial cells plated onto a plastic substrate 
adopt a flat, monolayer appearance whereas on collagen gels they 
become stratified with cells in the basal layer adopting a 
cuboidal shape (Gospodarowicz et al, 1978). The latter cellular 
appearance is similar to that found in vivo, emphasising the 
importance of the substrate in relation to the cell's shape.
Such alterations in cell shape can profoundly influence both 
cell proliferation and differentiation. In order to control the 
degree of cell spreading, cells were plated onto substrata coated 
with different concentrations of poly 2-hydroxy-ethyl methacrylate 
(polyHEMA) (Folkman and Moscona, 1978). As the polyHEMA 
concentration is increased, cell spreading and proliferation are 
progressively inhibited. This reduction in cell proliferation is 
accompanied by a decrease in DNA synthesis. Precise control of 
cell shape in the absence of intracellular contacts is achieved by 
plating individual cells onto adhesive islands of various sizes 
(O'Neill et al, 1986). On the largest island, cell spreading is 
maximal but becomes progressively restricted as the island size is 
reduced, this is accompanied by a reduction in the amount of DNA 
being synthesised by the cell. The latter concept is reinforced 
by the increase in DNA synthesis upon mechanically stretching 
epithelial cells (Brunette, 1984). By plotting the proportion of 
cells synthesising DNA against the degree of spreading, a classic
dose response curve was obtained (O'Neill et al, 1986), suggesting 
that a direct relationship between DNA synthesis and the degree of 
spreading exists.
Cell polarity can also be influenced by an alteration in cell 
shape. Upon plating fibroblasts and epithelial cells onto a Type 
I collagen gel, the fibroblasts were seen to become highly 
elongated and enter the gel, whereas the epithelial cells remained 
on top of the gel and became polarised both morphologically and 
functionally (Hay, 1984; Schor, 1980).
Cell shape, in addition to cell polarity and proliferation, 
can influence cell differentiation. This is illustrated in the 
following examples. Friend cell-fibroblast hybrids when grown in 
suspension are spherical in shape and could be induced to express 
haemoglobin, whereas adherent clones which possess a flatter 
morphology could not express haemoglobin (Allan and Harrison,
1980). Benya and Shaffer (1982) demonstrated that chondrocytes in 
tissue culture can produce collagen type II, a specific 
differentiated characteristic, when grown in a suspension culture 
but not when grown as a monolayer.
Changes in cell shape can in turn lead to an alteration in 
the cell's biological activity as illustrated by the following 
experiment carried out by Gospodarowicz et al (1978). Corneal 
epithelial cells grown on plastic are sensitive to fibroblast 
growth factor (FGF), whereas, on collagen-coated dishes they 
respond to EGF rather than FGF. The latter response is similar to 
that found in vivo. It is therefore quite clear from these 
experiments that the substrate is important in vitro for 
maintaining cell shape and hence its biological activity.
1.5. Growth control at the molecular level
The fact that the cell's environment can alter its shape, 
which in turn can influence cell proliferation and 
differentiation, suggests that the cytoskeleton may play an 
important role in these processes. Singer (1979) was among the 
first investigators to illustrate a continuity between the 
interior of the cell, the cell membrane and the extracellular
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matrix. Immunofluorescence microscopy using antisera against 
actin, tubulin and other cytoskeletal proteins has revealed a 
complex organisation of cytoskeletal fibres inside the cell, many 
of which seem to be associated with the plasma membrane (Bissell 
et al, 1982).
The microfilaments extend the contact point through the 
cytoplasm to the nucleus. There is also a mesh of fine filaments 
termed micotrabeculae (Wolosewick and Porter, 1976) from the 
nucleus to the plasma membrane with distinct connections to each. 
While many filaments are associated with the nucleus, the best 
example is seen with intermediate filaments (Lazarides, 1980). In 
fibroblasts treated with colcemid, vimentin filaments, visualised 
by immunofluorescence, collapse to form a perinuclear cap, which 
suggests a connection with both the nucleus and the microtubules. 
Modulation of actin assembly results in changes in cell shape and 
hence in the synthesis, assembly and organisation of other 
cytoskeletal proteins (Ben-Ze'ev, 1985).
The relationship between cell spreading and the cytoskeleton 
is illustrated elegantly in the following experiment. When 
suspended cells are plated in the presence of high concentrations 
of lectin which cross links cell surface carbohydrates and 
immobilises the cells, or alkaloids which disrupt the microtubular 
or microfilamental cytoskeletal systems, cell spreading is 
effectively inhibited but the cells are still able to attach to 
the substrate. Under these conditions the rate of protein 
synthesis recovers in the control monolayer level in about 6-8 
hours and this is not markedly affected by the limited degree of 
cell spreading. This suggests that protein synthesis recovery is 
triggered by establishing only a few contact points between the 
cell and the substrate and that extensive cell spreading is not a 
prerequisite.
A close association has been shown between fibronectin and 
either collagen fibres on the exterior of the cell or 
intracellular proteoglycans such as heparan sulphate (Woods et al, 
1984) on the interior. This results in an interaction between the 
extracellular fibrous network and the cytoskeleton through
- 8 -
mediation of fibronectin and its cell membrane receptor. This in 
turn influences cell-cell and cell-matrix interactions. However, 
the reverse situation also exists where an alteration in the 
cell-cell or cell-matrix interactions may influence changes in the 
cytoskeleton.
Thus, the above results suggest the existence of an intricate 
feedback system where cell shape and the extracellular matrix can 
play an important role in controlling cell proliferation and 
differentiation (Figure 2). It also illustrates a possible 
pathway, at the cellular level, through which information can be 
sent either between the cell and the extracellular matrix, or, 
from cell to cell within a tissue. Such a feedback system will be 
mentioned again in relation to proteoglycan and glycoprotein 
composition (Chapters 3 and 4).
1.6. How do alterations in the cytoskeleton lead to alterations in 
gene expression?
Although a change in cell shape may be a consequence 
rather than a cause of changes in differentiated gene expression 
(Horton and Hassel, 1986), evidence does exist which suggests that 
an alteration in the cytoskeleton does lead to alterations in gene 
expression. Polyribosomes and elements of the Golgi and rough 
endoplasmic reticulum are specifically associated with the 
cytoskeleton, therefore alterations in the cytoskeletal structure 
could influence mRNA translation and protein transport. Lenk et 
al (1977) showed that polysomes were associated with the 
cytoskeletal framework extracted in detergent. Fulton et al 
(1980) and Cervera et al (1981) have provided valuable evidence 
for a significant functional role for this structural association. 
They have demonstrated that the translation of mRNA coding for 
tubulin and polio virus takes place on polysomes attached to the 
cytoskeleton. Furthermore, the state of polymerisation of the 
cytoskeletal components influences the rate of translation. mRNA 
appears to be bound to the cytoskeleton while being translated but 
afterwards is released from the framework to become soluble. An 
increase in free tubulin or actin through microtubule or
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Figure 2
A schematic diagram illustrating the 
inter-relationship between the extracellular matrix, 
cell shape, cell proliferation and differentation.
microfilament disassembly can also trigger changes in gene 
expression.
The actual relationship between cell shape and attachment to 
the nature of the expressed gene products is illustrated in 
experiments carried out by Penman et al 1982 (refs, within Bissel 
et al, 1982). Upon passaging the anchorage dependent 3T6 cells in 
suspension culture, mRNA synthesis and turnover were found to 
decrease rapidly. Thus, the net result is the maintenance of a 
constant level of mRNA. Despite this, protein synthesis gradually 
decreased indicating withdrawal of mRNA molecules to an 
"non-translatable" pool. These cells were then grown in a 
monolayer culture where protein synthesis was found to rapidly 
increase, even when new mRNA synthesis was inhibited with 
Actinomycin D. Inhibitors of cell spreading were used in an 
attempt to elucidate the contributing effects of either attachment 
and/or spreading in the terms of translational and transcriptional 
processes. The results indicate that attachment of cells to their 
substratum was sufficient to reactivate protein synthesis, but 
spreading was necessary for reactivation of mRNA synthesis. These 
results thus indicate two distinct ways by which contact with 
substratum (or shape) can influence gene expression: cell 
attachment appeared to be sufficient for translational control 
while, spreading was necessary for transcriptional control.
Therefore, the cytoskeletal framework, in addition to its 
role in maintaining cell morphology might have a major regulatory 
role in gene expression by virtue of its close association with 
major macromolecular processes.
2. Malignant cell behaviour
With the exception of cells infected by oncogenic viruses, 
neoplastic cells produce no molecules which are not found in 
either normal adult or embryonic cells. For a malignant cell to 
survive and prosper, it must acquire products and functions which 
enable it to grow and divide rapidly, invade surrounding host 
tissues and in many cases migrate to various sites of the body via 
the blood and lymphatic systems. None of these processes are, in
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themselves, biologically abnormal. Rapid cell growth is observed 
in the process of tissue regeneration in response to partial 
removal of or injury to the liver (1.2). "Invasion" and migration 
of many types of cells occurs during embryogenesis and in adults. 
Leukocytes are one example of cells which invade tissues in order 
to carry out their physiological role (Goss, 1978c). Cell 
migration is a prominent feature in wound healing (1.1). It may 
therefore be suggested that in malignant tissues, the mechanisms 
occurring are not abnormal as they are found either in foetal or 
adult tissues, but what is abnormal is that they are being 
exhibited at an abnormal time and seem to be uncontrolled and 
progressive.
Tumours are thought to arise from a breakdown in one of the 
mechanisms correlating cell renewal with cell loss. A good 
example of such a process is seen in psoriasis and excema (Goss, 
1978a). Instead of cell division becoming inhibited when the 
epidermis has attained the correct size, the cells continue 
proliferating and appear as epidermal scales. The life span of 
normal human epidermal cells is approximately four weeks and only 
one cell divides at any one time in the basal monolayer. In 
psoriasis, the average cell divides, differentiates and is 
sloughed off in less than a week. The germative layer in this 
disease instead of being a monolayer is three cells deep and more 
than one cell, at any one time, is undergoing mitosis. It has 
been proposed that such a disease arises from a breakdown in the 
relationship between cell loss at the epidermal surface and cell 
renewal at the basal layer.
Hence, the above results suggest that malignant cells may 
arise from a breakdown in the controlling mechanisms between cell 
loss and cell renewal.
2.1. Characteristics of malignant cells
Malignant cells, in general, do not possess material which is 
not found at some stage in the normal cell's development, 
therefore, they may be abnormal in the respect that they display 
material which is not normally seen at that particular period in
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time. Malignant cells are seen to possess characteristics of 
foetal cells, as illustrated by the re-expression of foetal 
antigens. Tumours derived from gut epithelium have been found to 
produce in some instances, large quantities of carcinoembryonic 
antigen (CEA), while tumour cells derived from liver or yolk sac 
tissue may produce alpha-fetoprotein (AFP) (Sugarbaker et al, 
1982). Both of these substances are normally expressed in foetal 
tissues and are absent in the corresponding mature tissues. This 
relationship between malignant and foetal cells has been found to 
exist in terms of both functional activity and morphology, and is 
most prominent in the more aggressive tumours.
Malignant cells are able to escape the normal constraints
imposed on them by their environment, and this is observed in vivo
by the appearance of growths (Martz and Steinberg, 1971 and
Lindgren and Westermark, 1977). Malignant cells can grow more
efficientlv at i s e r u m  concentrations in vitro than normal
Tucker et al (1981) --------
cells .A There is a tendency with time for tumour cell populations
to increase their growth rate and to show further evidence of
escape from local control mechanisms. Usually this appears not to
reflect a shortening of the cell cycle time, but rather an
increase in the "growth fraction" i.e. an increase in the number
of cells within the neoplastic population actively proliferating
(Westermark, 1973). This leads to a decrease in the number of
cells undergoing differentiation. In some circumstances this
further escape from growth regulation may be related to an altered
response to circulating hormones, through either loss of specific
receptors or an increase sensitivity to growth factors (Gross et
al, 1983).
2.2. How do malignant cells arise?
Malignancy has been found to be reversible in a number of 
tumour types, as illustrated in neuroblastomas (Prasad, 1983), 
squamous carcinomas (Pierce and Wallace, 1971) and leukemias 
(Gootwine et al, 1982). Thus, it may arise from specific genes 
being activated at the wrong time. Malignant cells may 
theoretically arise from either:-
(i) A block occurring in the natural maturation pathway. This 
pathway may be regarded as a series of steps through which the 
cell gains more and more differentiated characteristics, until it 
becomes fully differentiated (Sartorelli, 1985). If the body 
regulates tissue size through a negative feedback system, a 
reduction in the number of fully differentiated cells present will 
result in an increase in the number of immature cells entering the 
maturation pathway. A block occurring in this pathway by whatever 
means, would prevent the immature cells from progressing through 
to their fully differentiated state. As the body is unable to 
detect these partially differentiated cells this would result in 
more and more cells entering the maturation pathway, which results 
in an increase in the number of partially differentiated cells 
present. As this block may occur at any point along the 
maturation pathway, this may explain the large heterogeneity found 
amongst tumour cells of similar lineage (Yates and Stephens, 1987)
OR
(ii) The oncogenic stimulus may act on fully differentiated normal 
cells in such a way as to change their properties to that of 
malignant cells. As these cells continue to proliferate, they 
might gradually lose some of their differentiated characteristics. 
This concept is illustrated by an elegant experiment carried out 
by Rabes et al (1970), where rats were treated with 
diethylnitrosamine, a carcinogen which induces liver tumours, and 
the rate of mitosis in the livers were investigated. Initially, 
when the mitotic index in the parenchymal cells remained at the 
control level, the response to hepatectomy was normal. However, 
as the mitotic index in the parenchyme cells of the 
carcinogen-treated animals began to increase due to neoplasia, the 
response to partial hepatectomy was correspondingly reduced.
Thus, as malignant cells proliferate there may be a corresponding 
loss of normal growth control.
-13-
2.3. What changes at the molecular level would bring about these
abnormal properties?
Two areas have been proposed where such changes can occur:-
(1) Alteration in the composition of the plasma membrane 
(Nicolson, 1976). As the plasma membrane is the first point of 
contact between the cell and its environment, it is important in 
passing information into and out of the cell.
OR
(2) Alteration in the composition of the extracellular matrix. 
Experimental evidence has suggested three areas where such a 
breakdown may occur :-
(i) Reduction in the quantity of fibronectin present. The 
concentration of fibronectin in malignant cells is less than that 
in normal cells (Hynes, 1981).
(ii) Increase in the quantity of high molecular weight 
fucose-glycopeptides (Van Beek et al, 1978) and degree of 
sialation (Warren et al, 1972). Differences are found in the 
linkage region between the polypeptide and carbohydrate and also 
in the number of side chains attached to the mannose cores (see 
Chapter 3). Considerable evidence exists suggesting a possible 
correlation between the degree of glycopeptide sialation and 
malignancy.
Glycoproteins comprise 80% of all cell carbohydrates and are 
mainly situated on the outside of the cell's membrane. In spite 
of their relatively small proportion by weight, the surface 
carbohydrates can cover the entire surface of the cell and thus 
form the first point of interaction with other cells and the 
extracellular matrix. Due to their large structural variability, 
glycopeptides can theoretically carry large quantities of 
information (Kornfelt and Kornfelt, 1980). Van Beek et al, 1978 
found that glycoproteins from malignant glia cells were more 
highly sialated than their normal counterparts. Such changes in 
the degree of sialation in the plasma membrane may influence 
cell-cell and cell-matrix interactions through alterations in 
surface charge, this may lead to a breakdown in the continuity 
between the interior of the cell and the plasma membrane.
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(iii) Proteoglycan production; Proteoglycans differ from the 
glycoproteins described above in the following way. Proteoglycans 
are much larger and usually consist of 90-95% carbohydrates by 
weight, in the form of many long unbranched glycosaminoglycan 
chains whereas glycoproteins contain a lower proportion of 
carbohydrate, (1-60% by weight) in the form of numerous, 
relatively short (>15 sugar residues), branched oligosaccharide 
chains which often contain terminal sialic acid residues. They 
are highly charged molecules due to the presence of carboxyl, 
sulphate and hydroxyl groups on the glycosaminoglycan molecules 
(Smets and Van Beek, 1984). High concentrations of hyaluronic 
acid have been associated with a variety of malignant tissues 
(Satoh et al, 1973).
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3. BRAIN TUMOURS
3.1. Why study brain tumours?
Gliomas and primitive neuro-ectodermal tumours account for 
the majority of childhood neural tumours, occur in young adults 
rather than the elderly and are almost invariable fatal within two 
years of diagnosis. One of the major problems with this disease 
is that although the lesion may be microscopic, the neurological 
effects produced by both the tumour and conventional therapies can 
be significant (Kornblith et al, 1982). Therefore, an alternative 
treatment with fewer side effects would be advantageous. It is 
hoped in this report that by studying the differences between 
malignant and normal cells, a new site for chemotherapy may 
emerge.
3.2. Current treatment of brain tumours
A variety of methods are commonly used in treating brain 
tumours (Kornblith et al, 1982).
(i) Surgery to remove as much of the tumour as possible.
(ii) Radiotherapy to destroy the remaining tumour fragments.
(iii) Chemotherapy to prevent further replication of the remaining 
neoplastic cells.
Unfortunately, the effectiveness of each of these treatments is 
not often complete. Surgery may be virtually impossible without 
destroying vital areas of the brain, due to the invasive capacity 
of the tumour. The dose of radiation required to destroy all the 
glioma cells will often cause severe neurological disability 
through destroying normal cell function. Chemotherapeutic drugs 
are generally cytotoxic to both normal and malignant cells 
(Sartorelli, 1985). An ideal therapeutic method would consist of 
drugs which are able to differentiate between normal and malignant 
cells, without affecting normal cell function. Cytostatic drugs, 
such as glucocorticoids, are thought to be advantageous in this 
respect as they reduce the growth rate of malignant cells without 
affecting that of normal cells as the latter cells already exhibit 
density dependency.
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Glucocorticoids have been widely used in relieving the 
symptoms of brain tumours, but the exact cellular mechanism(s) 
through which this is achieved are still elusive. Glucocorticoids 
have been shown to exert a cytostatic rather than a cytotoxic 
effect on the growth of malignant glial cells in vitro (Guner et 
al, 1977) and to induce the immature cells to differentiate 
(Almazan et al, 1986). However, recent in vivo evidence with lung 
cells suggests that these drugs may directly reduce the size of 
the tumour in vivo (M Lean et al, 1986). Glucocorticoids are 
thought to exert their effects at the nuclear level by combining 
with cytoplasmic receptors as depicted by Figure 3 (Alexis,1987). 
Braunschweiger et al (1978) suggested that this reduction in cell 
proliferation with methylprednisolone was due to a block occurring 
in the G1 phase of the cell's growth cycle. The cells already in 
the growth cycle are committed to complete the entire cycle before 
they can be affected.The latter effect is reversible, upon 
removing the glucocorticoid the cells are seen to synchronously 
progress through the growth cycle.
3.3. Concept under investigation
The concept under investigation in the present study is to 
find whether the cytostatic effect of glucocorticoids is exerted, 
at the cellular level, through altering the carbohydrate 
composition of malignant cells. Malignant cells have not been 
found to possess material which is not normally found at some 
stage in the normal cell's life cycle. This suggests that 
production of these materials themselves are not abnormal but it 
is the mechanisms regulating their production which are at fault. 
Since carbohydrates occupy a strategic position on the cell's 
surface, and their composition differs between normal and 
malignant cells, it was decided to investigate the carbohydrate 
composition of glioma cells in the presence and absence of 
glucocorticoids.
Malignant cells have been reported to possess larger 
molecular weight fucose-glycoproteins, which are more highly 
sialated than their normal counterparts. This relationship has
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Mechanisms of steroid/receptor interaction
The steroid interacts with cytoplasmic receptors and the 
resultant conformational changes result in the complex having 
an increased affinity for the high-affinity acceptor sites on 
the chromatin, and translocation occurs. The presence of the 
complex in the nucleus activates the transciption of mRNA. 
Taken from Alexis, 1984.
been correlated by Poste and Nicolson (1980) to metastasis. 
Glimelius et al (1979) found that gliomas differed from glia in 
terms of their proteoglycan composition; malignant cells generally 
possess a higher proportion of hyaluronic acid compared to 
sulphated proteoglycans. Work carried out in this laboratory 
(Freshney et al, 1980a) showed that increased sialation of 
glycoproteins in gliomas could be reduced with dexamethasone. 
Previously, this difference between normal and malignant cells 
could be diminished by treating the malignant cells with 
neuraminidase (Warren et al, 1972; Van Beek et al, 1978). 
Therefore, it was asked whether the glucocorticoids were exerting 
their effect through altering the glycoprotein and proteoglycan 
composition of the malignant cells.
In this laboratory, McLean et al (1986) have previously shown 
that glucocorticoids exert their effect through inducing malignant 
cells to become more differentiated, both morphologically and 
functionally. Dexamethasone was observed to encourage glioma 
cells to become more differentiated in function, as illustrated by 
the increase in differentiated characteristics such as, y-amino 
butyric acid (GABA) uptake and reduced plasminogen activator 
activity. Thus, it may be asked whether the glucocorticoids were 
exerting their cytostatic effect by inducing the malignant cells 
to become more differentiated through altering the carbohydrate 
composition at the cellular level.
This question was looked at in this report in the following way:-
(i) The second chapter looks at the cytostatic effect of 
dexamethasone and methylprednisolone on saturation densities and 
labelling indices. The cell's differentiated appearance was 
monitored in relation to its plasminogen activator activity. A 
decrease in plasminogen activator activity was found to accompany 
the re-expression of density inhibition in malignant glioma 
cultures.
(ii) Chapters 3 and 4 deal with the glucocorticoid's effect at the 
cellular level. Chapter 3 deals with the effect of 
glucocorticoids on glycoprotein composition. Glucocorticoids were 
found to reduce the high molecular weight glycoproteins
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characteristic of malignant cells. Chapter 4 deals with the 
effect of glucocorticoid on proteoglycan composition. Glimelius 
et al (1979) have investigated the proteoglycan composition 
between malignant and normal glia cells, and found that malignant 
cells generally contained higher quantities of hyaluronic acid 
compared to their normal counterparts. A similar result was 
obtained by Satoh et al (1973) using hamster embryo fibroblasts 
transformed with either Herpes Simplex Type-2 or Simian Virus-40,
(iii) Chapter 5 discusses how the cytostatic effect of 
glucocorticoids may be related to an alteration in either 
glycoprotein or proteoglycan composition in either the plasma 
membrane or the extracellular matrix. If the altered carbohydrate 
composition at the cellular level can account for the abnormal 
physiological properties of the malignant cells, then this type of 
investigation may reveal a new target site for chemotherapy.
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CHAPTER 2 
INTRODUCTION
INVESTIGATING THE CYTOSTATIC EFFECT OF GLUCOCORTICOIDS
In this chapter the cytostatic effect of glucocorticoids will 
be investigated in relation to saturation densities and labelling 
indices.
1. Growth characteristics of normal glia and malignant glioma 
cultures in vitro
Normal glial cells derived from adult brain have slow initial 
growth rates in culture and a finite in vitro life span of about 
40-60 generations (Yates and Stephens, 1987). These cells are 
stable in culture and do not undergo spontaneous transformations 
into continuous or morphologically altered cell lines. Foetal 
glial cells adapt much more rapidly than normal glial to growth in 
vitro although their life span is short, about 6-8 generations in 
the majority of cases. Normal glia cells show density dependent 
growth inhibition in monolayer cultures where the majority of the 
cells were retained in the G0/G1 phase (see Figure 1) of the 
cell's growth cycle even in the presence of fresh serum. The 
mitotic rate of these cells is low (1-5%) (Martz and Steinberg, 
1971; Lindgren and Westermark, 1977). This plateau phase can be 
maintained for months with a high percentage of viable cells 
provided the medium is renewed weekly.
Malignant cells can be grown in tissue culture with relative 
ease and a small percentage (20-40%) of the early passage lines 
derived from biopsy material may become permanent cultures, that 
is, appear capable of indefinite proliferation (Yates and 
Stephens, 1987). Gliomas are comprised of a heterogeneous cell 
population ranging from highly differentiated to undifferentiated 
cells. They attain higher saturation densities than normal glia, 
and only a small percentage of these malignant cells at confluence 
are retained in the G0/G1 phase of the growth cycle, i.e.
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inhibition is not complete (Westermark, 1973 and Lindgren and 
Westermark, 1977). This accounts for both the higher saturation 
densities and labelling indices. However, a pseudo-plateau phase 
may be reached by these malignant cells in vitro where the rate of 
cell division exactly equals the rate at which the cells are being 
sloughed off into the medium. These malignant cells were found to 
be more susceptible than their normal counterparts to chromosome 
breakage, non-disjunction and ploidy changes (Nowell, 1986).
In general, malignant cells are generally defined by the 
pattern of molecular gene activation and "silencing". It is 
therefore necessary to consider the differences between these 
cells and their normal counterparts in terms of the deletion 
"switching off" of specific genes and the inappropriate expression 
of others (Nowell, 1986; Sartorelli, 1985). The observed effect 
is the loss of some differentiated characteristics, such as 
glutamine synthetase activity, and the appearance of less mature 
ones such as plasminogen activator activity (Frame et al, 1984). 
However, different tumours vary considerably in relation to the 
period of time and sequence in which these various aspects of 
tumour progression become apparent. In some instances, properties 
of far advanced malignancy may be established before the neoplasm 
reaches macroscopic size, while well differentiated slow growing 
tumours may persist for many years before undergoing a transition 
to a more aggressive form.
2. Proliferative control of normal glia and malignant gliomas.
The regulation of proliferation in both human glia and glioma 
cells has been studied in vitro (Freshney et al, 1980a and b). 
Westermark et al (1973) have shown that astrocyte-like cells, 
derived from an adult human brain, are subject to stringent 
control mechanisms in vitro. At confluence, only 1% of normal 
glia were found to synthesise DNA at any one time, while the 
addition of fresh serum resulted in only a transitory increase in 
DNA synthesis (Lindgren and Westermark, 1977). In contrast,
10-20% of either glioma or virus transformed glia-like cells, were 
still synthesising DNA upon reaching confluence. This reflects
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the higher saturation densities reached by these malignant cells.
Plating normal glia onto a confluent monolayer of either 
glia, foetal human intestinal epithelium or fibroblasts, showed 
that proliferation was only inhibited by the glial substrata 
(MacDonald et al, 1985). Thus, proliferation was only decreased 
by plating these normal cells onto a confluent monolayer of a 
similar lineage. This suggests that there must be some type of 
communication between cells of similar type. Malignant glioma 
cells under similar conditions continued proliferating, thereby 
suggesting that they were able to escape, to a certain extent, 
from the constraints imposed on them by their environment. As 
previously mentioned in the general introduction, this increase in 
proliferation did not appear to reflect a shortening of the cell 
cycle time, but rather an increase in the "growth fraction" (Ford 
and Maizel, 1986). In some circumstances, this type of reaction 
may be due to an altered response of the cell to circulating 
hormones through loss of specific receptors, for example Gross et 
al, (1983) have shown a correlation between the down regulation of 
EGF receptors and the increase in plasminogen activator activity. 
The proliferative index, as shown by the labelling index, is a 
useful diagnostic tool in assessing the aggressiveness of brain 
tumours. Hoshino (1981) found that patients with brain tumours 
which had a labelling index of greater than 5% generally had less 
than a year to live, while those with labelling indices of less 
than IX had a chance of more prolonged survival. This suggests 
that a drug which reduces the proliferative activity of malignant 
tissues may be a useful therapeutic tool in enhancing the life 
span of these patients.
3. The relationship between cell proliferation and differentiation
Experimental data from transformed cell lines shows that a 
loss of differentiated characteristics is accompanied by an 
increase in cell proliferation (Sartorelli, 1985). Thus, it may 
be proposed that by encouraging the malignant cells to become more 
differentiated this may decrease the abnormal behaviour of these 
cells. This concept has been previously studied in this
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laboratory by looking at the maturation of glioma cell lines in 
relation to astroglial differentiation markers such as high 
affinity amino acid transport and glutamine synthetase activity
(Frame et al, 1984; McLean et al. 1986}.
Kato et al (1981)
Glia maturation factor (GMF)',/yisolate'd from cow's brain, was
found to stimulate cell proliferation and maturation of normal
glia but prevented overgrowth once the cells had reached
confluence (Lim et al, 1981). GMF has been chemically
characterised as consisting of a group of acidic proteins existing
in multiple molecular sizes, the smallest of which is 23,000
daltons. These results suggest that GMF has the ability to
restore contact inhibition, possibly through encouraging the cells
to become more differentiated.
4. Plasminogen Activator
Plasminogen activators (PAs) are a specific group of serine 
proteolytic enzymes that specifically convert plasminogen to the 
active proteinase plasmin (Saksela, 1985; Dano et al, 1985). 
Plasmin has a broad substrate specificity and can break down a 
variety of tissue proteins. The best characterised substrate for 
plasmin in vivo is fibrin. There are two major types of PA, they 
differ from each other with respect to tissue distribution, 
molecular and immunological properties: a tissue type PA (t-PA) 
and a urokinase-like PA (u-PA). The u-PA is a 54 kDa enzyme 
composed of two disulphide-linked 30 and 24 kDa subunits (Dano et 
al, 1985). The native t-PA in contrast is a single 70 kDa 
polypeptide chain (Rijken and Collen, 1982; Edlund et al, 1983). 
Both the u-PA and t-PA are synthesised as proenzymes (Saksela, 
1985; Dano et al 1985). Exactly how the pro-PAs are converted to 
active forms is not clear. The majority of cell lines cultured in 
vitro secrete the u-PA.
U-PA is thought to be responsible for the activation of 
plasminogen present in the extracellular tissues. In addition to 
u-PA being fibrinolytic, plasmin can degrade the non-collagenous 
matrix components such as laminin and fibronectin (Liotta et al,
1981). This will be mentioned again in Chapter 3. Both foetal
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cells and malignant cells possess a high u-PA activity (Roblin and 
Young, 1980). The increased levels of u-PA has been associated 
with their ability to degrade the extracellular matrix in vitro 
(Liotta et al, 1981).
Dexamethasone has been shown by McLean et al, (1986) to
inhibit u-PA activity. The glucocorticoid was found by Seifert
and Gelehrter, (1978) to exert its activity by inducing the
production of an inhibitor. This is clearly illustrated in the
following experiment. PA activity was measured in Triton-X-100 
125cell extracts on I fibrin-coated plates. When extracts of 
dexamethasone treated cells were mixed with extracts of control 
cells, u-PA activity was drastically reduced. Whereas, variant 
cells of rat hepatoma cells were fully resistant to inhibition of 
u-PA activity by dexamethasone. These variants were found to have 
no demonstrable inhibitor activity, as u-PA production in these 
cells was still sensitive to inhibitors produced from wild-type 
cells.
Gross et al, (1983) have shown an inverse relationship 
between EGF activity and PA activity. They found using Human A431 
epidermoid carcinoma cells that an enhanced rate of EGF receptor 
inactivation is closely correlated with an increase in cellular PA 
activity. Blocking PA synthesis or activity by cycloheximide or 
dexamethasone prevented down-regulation of the EGF receptor. The 
removal of EGF from previously down-regulated cells resulted in 
the recovery of total cellular EGF binding activity with a 
concurrent loss of cellular PA activity. Thus, the effect of 
dexamethasone may be inversely related to the mitogenic effect of 
growth factors such as EGF.
The above results suggest that glucocorticoids may be 
exerting their cytostatic effect through encouraging the cells to 
become more differentiated. This is accompanied by a reduction in 
the rate of proliferation, however, the reverse situation may also 
exist i.e. by inhibiting proliferation, differentiation becomes 
reduced. In this chapter, the cytostatic effect of dexamethasone, 
methylprednisolone and 11-a-epihydrocortisone were investigated in 
terms of saturation density and labelling index. The structure of
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these drugs are shown in Figure 4.
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Figure4
CH
A schematic representation of the structure of a) 
methylprednisolone, b) dexamethasone and c)
11-a-epihydrocortisone. Taken from Healey et al, 1971.
MATERIALS AND METHODS
TISSUE CULTURE
1. Cell lines
The cell lines used in this investigation were:-
Cell line 
G-UVW
G-IJKt
G-CCM
G-ELL
BG-14
BG-28
BG-30
BG-35
BG-84
BG-103
EWLU
Passage level 
continuous
10
Pathology
Anaplastic
Astrocytoma
Origin
Institute of 
Neurological 
Sciences 
Glasgow
Ependymoma
Parieto- W.G.H.
occipital lobe Edinburgh
Astrocytoma Inst.
Neurological
Sciences
Glasgow
Recurrent 
malignant glioma
normal human 
foetal lung 
fibroblast.
Southern 
General 
Hospital, 
Glasgow
The passage number of the early passage cell lines is denoted by 
by the number after the cell name. All materials, unless 
otherwise stated, came from BDH and were of ANALAR grade. The 
growth medium unless otherwise stated, was a 1:1 mixture of Ham's
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F10 (Flow Labs, ltd) and Dulbecco's modification of Eagle's Basal 
Medium (Gibco), i.e. F10/DMEM.
Solutions:-
Holding medium:-
Growth medium 500ml
Penicillin 125,000 units (Glaxo)
Streptomycin 125mg (Gibco)
Gentamycin 25mg (Gibco)
2+ 2-f-
PBS:- Phosphate buffered saline without Ca and Mg (Dulbecco 
'A'), (Oxoid).
Dissection PBS:- PBS containing penicillin, streptomycin and 
gentamycin at the above concentrations.
Phenol red free medium:-
HBSS-Phr 95ml
Vitamins 1ml
MEM AA 2ml
NE AA 1ml
Glutamine(200mM) 1ml
Glucose 1ml
HC03 1.1ml
NaOH to pH7.2
2. Making primary cultures from biopsy material
Biopsies were aseptically collected into holding medium. The
tissue was finely chopped, washed three times in dissection PBS
and the pieces were transferred into culture flasks, about 20-30 
2
pieces per 25cm flask, containing holding medium with 10% serum 
and 0.5ml of crude collagenase (2000 units/ml; to give a final 
concentration of 200 units/ml ;Sigma) and incubated at 37^C. 
Eighteen hours later the medium was removed, the sample was spun 
at 150g for five minutes and the material was reseeded in fresh
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medium. The cells were then grown in growth medium, supplemented 
with 10% foetal bovine serum (Flow Labs. Ltd), and with a gas 
phase of 2% (X^ in equilibrium with 8mM NaHCO^ for approximately 
two weeks. After this period of time the cells were fed with 
medium containing no antibiotics in order to prevent the 
appearance of resistant organisms.
3. Maintenance of cell lines (monolayers)
Cells were trypsinised using 2ml of 0.25% trypsin (PBS)
(Sigma) for 60 seconds. The trypsin solution was discarded. The
cells were then incubated at 37^C for 5-15 minutes, until they
became rounded in appearance. The cells were resuspended and 
4
reseeded at 2x10 cells/ml in a new culture flask (Nunc), which 
was gassed with 2% CO 2 and fed with fresh growth medium every 2-3 
days. Early passage lines were used up to the 10th passage. A 
cell line whose passage exceeded 50 was assumed to be continuous. 
The cells were used from frozen stocks within 3 months of thawing.
4. Electronic cell counting
A homogeneous single cell suspension for cell counting was 
obtained by trypsin isolation. A sample of the cell suspension 
was then diluted 1:50 in 20ml of counting fluid using a 25ml 
disposable counting cup. The counting sample was mixed thoroughly 
and read on a Coulter counter ZB.
5. Cell freezing
Frozen stocks of all cell lines were maintained in liquid
6 7
nitrogen. Cell suspensions of approximately 5x10 -2x10 cells/ml 
in culture medium containing serum and 10% dimethyl sulphoxide 
(DMS0) were frozen with an approximate cooling rate of l^C/minute 
for approximately 18 hours, and were then transferred to liquid 
nitrogen.
-28-
6. Thawing
Frozen ampoules were thawed out in water at 37 C. The sample 
was suspended in fresh culture medium. The medium was changed 
after 18 hours in order to remove the DMSO.
7 Mycoplasma staining
Cultures fixed with 25% acetic acid in methanol, were checked 
for mycoplasma by treating with fluorescent DNA stain, Hoechst 
33258 (Hoechst) at 0.05yg/ml for 15 minutes at room temperature. 
Surplus stain was then removed with two washes of distilled water. 
The slides were stored in the dark as the stain is sensitive to 
light. The detection of extra nuclear DNA by fluorescence 
microscopy indicated the presence of mycoplasma.
8. Clonogenic assay
2Subconfluent cells were grown in flasks (75cm ) in the 
presence of ei ther dexamethasone (Merck, Sharp1 and Dobme Ltd) or 
methylprednisolone (Upjohn Ltd) for five days. Dexamethasone was 
used in the form of dexamethasone phosphate (Decadron) which is 
rapidly hydrolysed in the culture medium to dexamethasone 
(Rohdewald et al, 1987), therefore Decadron will be referred to as 
dexamethasone throughout this report. Cells were trypsinized 
(0.25%), then resuspended in 5ml of medium (F10/DMEM) and 
centrifuged at 1500g for 5 minutes. The pellet was then 
re-suspended in 5ml of fresh medium and spun once more. The cell 
pellet was then resuspended in 10ml of medium, 200 cells/ml were 
plated into 50mm petri dishes and the medium was made up to 5ml. 
The cells were grown for 10 days, with the medium being changed 
every three days. The colonies were then fixed with acetic 
methanol and stained with Giemsa, as described in section 10. The 
number of colonies per dish were recorded.
9. Saturation densities
5
Cells were seeded at a concentration 1x10 cells on 15mm 
Thermanox coverslips in 24-well plates (Nunc.), where they were
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either:-
(i) Grown to confluence in the 24-well plates, supplemented with 
10% foetal bovine serum (Flow Labs. Ltd.) and with a gas phase of 
2% CO^ in equilibrium with 8mM NaHCO^. In an attempt to prevent 
the medium from becoming exhausted the medium was changed every 3 
days at low cell densities and daily at high cell densities.
(ii) The coverslips were transferred into 50mm petri dishes 
containing 4ml of growth medium two days latOr and grown in a 
humidified incubator. The cells were fed every 2-3 days.
Upon reaching confluence, saturation density was investigated by 
trypsinising and counting the cells as described in section (4). 
The saturation density was defined as the maximum cell density 
attainable past confluence on three consecutive days under 
non-limiting conditions.
10. Fixing and staining cells
Cell monolayers on either coverslips or petri dishes were 
fixed in the following way. In order to prevent the cells from 
rolling up and detaching from the substrata, the cells were 
exposed to increasing concentrations of acetic methanol (1:3) in 
PBS (50:50) each for 3 minutes, until the cells were exposed, for 
5 minutes, to the pure fixative. The cell monolayer was then 
dried using an industrial blower. The coverslips were then 
mounted on glass slides using D.P.X. and were left to dry 
overnight. The cells were then stained by immersing either the 
slides or petri dishes in neat Giemsa for 2 minutes, which was 
then diluted in 10 volumes of water. After five minutes the 
slides were rinsed under running tap water until the cells could 
be clearly seen under the light microscope.
11. Labelling index experiments
The cells were grown to confluence on 15mm Thermanox 
coverslips in 50mm petri dishes in the presence of F10/DMEM 
containing 10% serum. They were then exposed to 1% serum 
containing the drug or compound being tested for one week, during 
which the medium was changed every 3 days. The cells were then
-30-
3
transferred to medium containing 1% serum and 5-Me-[ H] thymidine 
4pCi/ml (40yCi/mol, Amersham) for 24 hours. The cells were then 
thoroughly washed in order to get rid of the excess radioactivity. 
The slides were then immersed in 1) two separate solutions of 10% 
ice cold T.C.A.(trichloroacetic acid), each for 5 minutes, 2) 
distilled water for 5 minutes and 3) methanol for 5 minutes. The 
slides were then dried using an industrial blower.
The following procedures were carried out in the dark room 
using a red safe light. The slides were coated with radiographic 
emulsion (K12, Kodak) diluted 1:1 with distilled water. The 
slides were then drained vertically for 5 seconds to remove any 
excess emulsion and dried horizontally, and were then placed in a 
light-tight box containing silica gel and left at 4^C for 7 days 
to expose. The cells were then processed, under a red safe light, 
by immersing them sequentially into, developer (D19, Kodak) for 5 
minutes, distilled water containing 1% acetic acid for 30 seconds, 
fixative for 5 minutes (Ilfofix, Ilford), hypoclearing agent 
(Kodak) for 3 minutes and then finally washed thoroughly for 5 
minutes in distilled water. The slides were then dried and 
stained with Giemsa according to the method in section 10.
The labelling index was determined as the percentage of 
nuclei labelled in relation to the total number of nuclei in that 
field. A cell was determined labelled if the grain count exceeded 
100 grains per cell.
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12. Investigating both the cell-associated and released
plasminogen activator activities in glioma cell lines in the 
presence of glucocorticoids (Whur et al, 1980).
The assay is based on the following set of reactions:-
Monolayer -------------  plasminogen
cells activator
plasminogen ---1—  plasmin
chromogenic — I------ peptide
substrate +
p.nitroanaline
The p.nitroanaline produces the yellow colour the absorbance of 
which can be measured at 405nm and relates to the amount of 
plasminogen activator released by the cells.
The P.A. activity associated with both the cell monolayer and 
that released into the medium were both measured, using the 
following methods:-
12.1. Cell associated P.A. activity:-
The cells were grown to confluence in 24-well plates (Nunc) 
with F10:DMEM (1:1) containing 10% foetal calf serum as the growth 
medium in either the presence or absence of glucocorticoids. The 
cells were then incubated in serum free phenol red medium for 24 
hours and they were then thoroughly washed with PE. 500pl of the 
reaction mixture, which contained lOOpl of plasminogen (5Cu/ml) 
(Flow Labs. Ltd), lOOpl of S-2251 (Flow Labs. Ltd) (5mM), 50pl 
poly-D-lysine (1.5mg/ml) and 250pl of Hanks balanced salt solution 
(HBSS) without phenol red, was added to the cell monolayer. The 
cells were then incubated with the latter medium for 2 hours at 
37^C. A 500pl aliquot was then removed and the reaction was
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terminated by the addition (500pl) of 5% acetic acid. The 
absorbance was then read at 405nm, and the reading was corrected 
for both cell number and the presence of endogenous plasmin 
present in the sample as a result of either impurities or 
autocatalytic degradation. The proteolytic enzyme urokinase, 
which also activates plasminogen, was used as a standard in these 
experiments. In order to express P.A. activity in Plough units 
per 10 cells, an individual cell count was made using a duplicate 
plate and the result expressed as cells/well.
12.2. P.A. activity released by the cells into the medium
The cells were grown to confluence in the presence or absence 
of either dexamethasone or methylprednisone as described in 
section 8. The cells were then washed with PBS containing ImM 
EDTA and then incubated in serum and phenol red free medium for 48 
hours. 250pl of the latter supernatant was then incubated for 2 
hours at 37°C with 500pl of the reaction mixture as described in 
section 12.1. above. The reaction was then terminated and the 
results were then expressed in Plough units per ml as previously 
described.
13. Extraction of glia maturation factor (Lim and O'Connell,
1982)
Fresh bovine brains were obtained from the Vet School 
slaughter house (Glasgow University) within 45 minutes after 
killing, and were transported in ice to the laboratory. The 
brains were cleaned of meninges and blood clots and cut up into 
small pieces. The brain tissue, in 150g portions, was homogenised 
with 3 volumes of Tris-buffer saline (0.02M Tris HC1, 0.15M NaCl, 
pH7.45) and homogenised for lmin in a Waring blender at 23,000rpm. 
The supernatant fraction after spinning the above homogenate at 
23,000g for 16 hours in the ultracentrifuge was designated as the 
crude extract. The volume was then reduced from 350ml to 30ml 
using an Amicon PM10 membrane filtration unit. This material was 
then stored at -80^C.
In an attempt to purify the above extract, the following
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protocol was followed. The supernatant was fractionated by 
ammonium sulphate precipitation, first at 45% then at 70% 
saturation. At each stage the suspension was stirred for 20 
minutes and centrifuged for 30 minutes to collect the precipitate. 
The precipitate between 45 and 70% saturation was taken up with 
Tris-buffered saline at a ratio of 25ml buffer per brain (283g). 
The samples were then dialyzed against two changes of water for a 
total of 18 hours using dialysis tubing with a molecular cut-off 
point of 6000-8000Kda. The solution was then adjusted to contain
0.15M NaCl and 0.02M Tris at pH7.45 and applied to a G75 column, 
5X93 cm in size and eluted with Tris-buffered saline at 50ml/hour. 
Fractions of 13.4ml were collected and tubes no. 65 to 95 were 
pooled. The volume was then reduced using an Amicon PM10 membrane 
filtration unit. Various dilutions (1:4, 1:8, 1:40, 1:80) were 
then added to sub-confluent cells and differentiated 
characteristics such as shape and fall in PA activity were noted.
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RESULTS
1. Investigating the cytotoxicity of dexamethasone and 
methylprednisolone by clonogenic assays
A clonogenic assay was used in order to investigate whether
the glucocorticoids exerted a cytotoxic effect on the cell lines
under investigation. These experiments were carried out as
described in the methods section. Figure 5 illustrates the effect
of various concentrations of both methylprednislone and
dexamethasone respectively on colony formation. The majority of
—5 —6concentrations tested (2.5x10 M and 2.5x10 M) were not found to
be cytotoxic to the cell lines under investigation, as suggested
by the fact that the number of colonies formed in the presence of
the steroid was never less than that of the control. However,
-4dexamethasone and methylprednisolone at 2.5x10 M were found to be 
cytotoxic to the early passage cell line BG84/5. This 
concentration was much higher than would be pharmacologically 
attainable in vivo. The lower doses of glucocorticoids were found 
in general to augment survival, as seen by the increase in the 
number of colonies formed, and in their size as illustrated in the 
photographs in Figure 6.
2. Effect of glucocorticoid on saturation density
Malignant glioma cell lines characteristically reach higher 
saturation densities than normal glia. The photographs shown in 
Figure 7 are representive of how glioma cell lines "pile" up on 
top of one another, the extent of which varies among the different
_5
cell lines. Dexamethasone and methylprednisolone (2.5x10 M) were 
found to reduce this "piling up" effect. The following set of 
experiments demonstrates the cytostatic effect of these 
glucocorticoids in terms of saturation densities and labelling 
indices. Saturation densities were considered as being achieved 
when three similar readings were obtained on three separate days 
of post confluent growth.
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Effect of glucocorticoids in a clonogenic assay.
Cells were grown to confluence in the presence and
absence of either dexamethasone or methylprednisolone at
2.5x10 M^, 2.5x10 and 2.5x10 M^. They were then
trypsinized and cloned by dilution in the presence of
glucocorticoids. Colonies were fixed in methanol, 
stained in Giemsa and counted.
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_5
The photographs illustrate the effect of (a) 2.5x10 M
_5
dexamethasone and (b) 2.5x10 M methylprednisolone on a 
clonogenic assay using cell lines G-CCM. Culture G-CCM was 
cloned by dilution in the presence or absence of 
glucocorticoids. After 3 weeks the colonies were fixed in 
methanol and stained in Giemsa. The colonies produced in the 
presence of glucocorticoids were much larger in size and 
number than the controls.
Figure7
Cell line BG84/9
a) IN THE PRESENCE OF DEXAMETHASONE.
IN THE ABSENCE OF DEXAMETHASONE.
0-1mm
Figure7
_5
The photographs illustrate the effect of 2.5x10 M of 
dexamethasone on the saturation density of (a) BG84/9 and (b) 
BG105/5. Cells were seeded at 10^ cells ml-'*' (5660cm- )^ on 
15 mm Thermanox coverslips in 24 well plates in the presence 
and absence of dexamethasone at the concentrations indicated 
and then transferred to 50 mm petri dishes and grown for a 
further 5 days. The cells were then fixed with methanol. In 
each case the "piling-up" effect was reduced by the presence 
of steroid.
Figure7 continued
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3. Experiments carried out in 24-well plates
The effect of dexamethasone and methylprednisolone at
_5
2.5x10 M on saturation densities was initially investigated using 
24-well plates as described in section 9. At high cell densities 
the medium was found to be the rate limiting factor in terms of 
cell proliferation, as indicated by the colour of the medium even 
when it was changed daily. It was therefore decided that this 
method was unsatisfactory to determine saturation densities, as 
the results reflected both the effect due to the steroid and the 
cytotoxic effect produced by the low pH of the medium.
4. Density experiments using 50mm petri dishes
In order to overcome the previous difficulties, these 
experiments were repeated using 15 mm Thermanox coverslips in 50mm 
non-tissue culture petri dishes, according to the protocol in the 
methods section. Using this method, the medium was no longer the 
rate limiting factor in cell proliferation, as the quantity of 
medium present was always in excess of that required by the cells.
In order to test whether the presence of endogenous mitogenic 
inhibitors and activators in serum influenced the glucocorticoids' 
effect, experiments were initially carried out in both the 
presence and absence of serum using cell line G-IJKt (Figure 8).
In the absence of serum the cells reached a lower saturation 
density than those in the presence of serum. Both dexamethasone 
and methylprednisolone were found to inhibit cell proliferation in 
a dose dependent way in the presence and absence of serum.
-9However, low concentrations of glucocorticoids, eg. 2.5x10 M, in 
the absence of serum were found to augment proliferation to a 
value, which was equivalent to that reached by the cells in the 
presence of serum. Thus, glucocorticoids seem to possess a 
biphasic response; at low concentrations in the absence of serum 
they augment growth while at high concentrations in the presence 
or absence of serum they inhibit it.
The general effect of dexamethasone and methylprednisolone on 
both early passage and continuous cell lines is illustrated in
-36-
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Table! Effect of glucocorticoids on saturation density in both early 
passage and continuous cells.
Cell line Saturation densities 
cells len-r
Control nexamethasonc (M) ____ MelhvJntcdn LsoIonelMl.
2-5 xlO-9 2-5x10~7 2-5X10"5 2-5xl0"9 2-5X10'7 2-5x10-5
G-UVW 1-99X10° 
10*05
1-70 X105 
±0-05
1-69X105
±0-07
1-.G7x105
±0-05
2-37x10° 
+ 0-11
1-77x10° 
± 0-07
1-50x10°
±0-05
G-!JKt 2-50 x106 1-40x10° 1-00x10° 8-S0<104 2-50x10° 4-60x10° 1-50x10°
G-CCM 21-0 0x104 
±4-90
13-0 0x104 
±2-40
5-4 Ox 104 
±0-05
BG35/6 1-20 x105 0-36x104 6-50 *104
BG30/4 G-10x10° 5-50x104 1-03x10° 7-05x104 G.05X104 4-60x104 6-31x104
BG20/4 7-36x104 5-00 x104 3-70X104 5*90x104 6-50X104 4170X104
BG105/5 4-20 *104 ±0-30
3-60X104
±0<10
3-29*ld* 
+ 0-14
BG103/10 2-00x104
L 0-20
1-61x104 
+ 0-07
I-64X104
±0-02
Effect of glucocorticoids on saturation density in both early
passage and continuous cell lines. Cells were seeded at 10^ per 
_2
ml (5660 cm ) on 15mm Thermanox coverslips in 24 veil plates in
the presence and absence of either dexamethasone. They were then
transferred to 50mm petri dishes and grown till confluent. The
cells were fed every three days in order that the medium did not 
become the rate limiting factor of growth.
Table 1. A concentration of steroid as low as 2.5xlO-^M was found 
to reduce the saturation density. In the majority of cell lines, 
methylprednisolone was seen to have a slightly greater effect than 
dexamethasone. However, larger numbers of samples are required in 
order that this observation can either be statistically confirmed 
or disproved. Both glucocorticoids were observed, in the present 
investigation, to reduce the saturation density, in a dose 
dependent manner, to approximately the same value each time within 
a single cell line, while the actual values differed among the 
various cell lines. The largest reduction in saturation density 
was observed in the cell lines which reached the highest 
saturation densities, eg 96% reduction in saturation density was 
observed with cell line G-IJKt.
It was postulated in the general introduction that the longer 
a cell grows in culture the higher the probability of that cell 
line transforming. In order to see whether the cell's response to 
dexamethasone and methylprednisolone changed under 
tissue culture conditions, experiments were repeated with the same 
cell line at two different passage levels. The results are shown 
in Table 2; there does not seem to be any difference in the 
results between the two passage levels.
Glucocorticoids have been reported to exert many of their 
effects through modulating the cell response to various hormones 
such as EGF (Baker et al, 1978). This hypothesis was investigated 
in terms of saturation density. Epidermal growth factor (EGF) at 
lng/ml was seen to have a mitogenic effect (Figure 9). 
Concentrations of dexamethasone as low as 2.5xlO-^M were generally 
found to reduce the mitogenic effect of EGF.
Thus, both dexamethasone and methylprednisolone were found to 
reduce, in a dose dependent manner, the saturation densities of 
both early passage and continuous glioma cell lines, even in the 
presence of a mitogenic factor. The glucocorticoids were seen to 
exert the largest effect on those cell lines which reached the 
highest saturation densities.
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Table2
The reduction in saturation densities 
at different passage levels.
Cell line Passage no. % reduction in 
saturation density
DX MP
BG103 3 - 30
BG103 10 40 41
BG105 5 14 11
BG105 10 14 11
The reduction in saturation density by 
dexamethasone (Dx) and methylprednisolone (MP) were 
investigated in early passage cell lines of different 
passage levels.
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5. The effect of glucocorticoids on labelling index
The labelling index provides a quick, efficient method for
determining the proportion of cells undergoing proliferation at
any one time (Maurer, 1981). The following experiments were
carried out, as described in the methods section, in order to
investigate whether the glucocorticoids' cytostatic effect,
observed in terms of saturation densities, could also be observed
in terms of the labelling index. If in the presence of
3
glucocorticoid, the uptake of [ H] thymidine by the cell was not 
altered, then the results obtained using the labelling index 
should reflect those obtained in the previous section using 
saturation densities. It was found in the labelling index 
experiments that the concentration of serum could be reduced at 
confluence to 1% without any obvious deterioration of the culture.
As the labelling index of sub-confluent and confluent 
cultures are drastically different, the cells were grown to 
confluence in the presence of 10% serum in order to reduce any 
differences which may arise from differences in cell numbers.
They were then transferred to 1% serum containing the drug under 
investigation for 5 days, an appropriate control was carried out 
in the absence of drug, then the labelling index experiment was 
carried out. Unfortunately, the labelling indices had to be 
carried out within a week of reaching confluence, as some of the 
monolayers started to roll up and detach from the coverslips.
The labelling index of various early passage and continuous
_5 _7
cell lines were investigated in the presence of 2.5x10 M, 2.5x10 M and
_9
2.5x10 M of either dexamethasone or methylprednisolone. The 
results are shown in Table 3. In general, both dexamethasone and 
methylprednisolone, at concentrations as low as 2.5xlO- M^, were 
seen to reduce the labelling index in both the continuous and 
early passage cell lines. Thus similar results were produced in 
terms of saturation densities and labelling indices in the 
presence of glucocorticoids as seen from Table 4, however the 
actual magnitude of the reduction may differ. For example, 
dexamethasone was found to have a more profound effect in terms of 
saturation density and labelling index on cell line G-IJKt than
-38-
Table-3
The effect of glucocorticoids on labelling index.
Cell
line
contro! % labelling index in serum
Dexamethasone
2.5X
Me thylprednisolone 
2.5X
10~9M H* O 1 S
4
10“SM io-9m 10 “7M 10“5M
BG84/7 17.5 13 14 14 9.5 12 8.0
±1.0 ±0.7 ±1.5 ±0.2 ±1.5 ±1.0 ±0.2
G-IJICt 21.2 3.0 1.0 2.5 2.6 6.5 6.0
±3.6 ±0.6 ±0.4 ±0.5 ±0.4 ±0.4 ±6.7
G-CCM 12.95 - 9.0 10.3 10.8 - 8.4
±0.9 - ±0.5 -
BG30/4 13.4 5.19 6.09 5.25 8.3 - 3.79
±0.3 ±0.2- ±2.0 ±0.5 ±0.2 - ±0.4
BG105/5 6.8 6.2 3.0 2.4 - 3.2 3.05
±1.0 ±1.0 ±0.1 0.7 - ±0.5 ±0.15
Illustrates the reduction in the labelling index in
both early passage and continuous cell lines by either
dexamethasone or methylprednisolone. The cells were
grown to confluence and were then exposed to
-13
glucocorticoids for 5 days. 4]iCiml.“ . H-thymidine was 
added for 18 hours and autoradiographs were prepared as 
described in the methods section.
.Tablb'4
Cytostatic effect of glucocorticoids in a variety of 
early passage and continuous cell lines.
Cell line ^Decrease in labelling index
Dexamethasone Methylprednisolone
2.5x 2.5x 2.5x 2.5x 2.5x 2.5x
10-9M 10-7M 10-5M 10-9M 10-7M 10-5M
G-IJICt 85 95 88 88 69 72
G-CCM - 30 20 17 - 35
BG30/5 61 54 61 38 - 72
BG105/5 9 ‘ J 55 64 - , 52 55
Cell line % Decrease in saturation densities
Dexamethasone Methyl prednisolone
2.5x 2.5x 2.5x 2.5x
10-7M 10-5M 10-9M 10-7M
G-IJKt 96 96 81 94
G-CCM - 38 - 74
BG30/5 70 88 92 89
BG105/5 - 14 - 22
Comparison of the percentage decrease in labelling index and 
saturation densities of dexamethasone and methylprednisolone in a 
variety of early passage and continuous cell lines. The results 
are a summary of the results in Tables 1 and 3.
methylprednisolone. The glucocorticoids were clearly seen to 
exert their cytostatic effect in a dose dependent manner in terms 
of saturation densities, but this effect was not as prominent in 
the labelling index experiments. Further experimentation is 
required to clarify this point.
In an attempt to see whether the cytostatic effect is 
associated with glucocorticoid activity, the labelling index 
experiments were repeated with 11-a-epihydrocortisone, an analogue 
of hydrocortisone. The glucocorticoid activity is associated with 
the 11-3 orientation (Mealey et al, 1971), thus molecules with the 
ll-<x orientation are devoid of glucocorticoid activity. This 
analogue of hydrocortisone was found to possess no cytostatic 
effect but the results (Table 5) suggested that it may have had a 
mitogenic effect as the labelling indices were increased in the 
presence of glucocorticoids.
Experiments were carried out to investigate whether the 
mitogenic effect of EGF (lng/ml, lOng/ml), seen in section 4 
could be visualised in terms of the labelling index, and whether 
the presence of glucocorticoid could abolish this effect. For the 
exact method see section 11 in the methods section. The results 
are shown in Figure 10. The mitogenic effect of EGF at lng/ml and 
lOng/ml was prominent and this was significantly reduced by 
concentrations of either dexamethasone or methylprednisolone as 
low as 2.5xlO- M^.
Thus, the glucocorticoid's cytostatic effect was similar in
terms of saturation densities and labelling indices. This
suggests that the labelling index in the present set of
experiments is representive of cellular proliferation. Taken
together the results suggest that the glucocorticoids are only
reducing the proportion of cells proliferating at any one time and
3
are not altering the uptake of [ H] thymidine into the cells. In 
both sets of experiments methylprednisolone was generally observed 
to exert a greater effect than dexamethasone.
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FigurelO
Illustrates the effect of epidermal growth factor 
(EGF), dexamethasone (Dx) and methylprednisolone (MP) at 
various concentrations on the labelling index of cell 
line G-CCM. The various concentrations are read from 
the left to the right. Thus, unless stated, everything 
to the right of a specified concentration was carried 
out using that concentration.
6. Determining the number of glucocorticoid cytoplasmic receptors
present in the various glioma cell lines
The question was asked as to whether the reduction in 
saturation densities and labelling indices were proportional to 
the number of glucocorticoid receptors present in the various cell 
lines. This concept was investigated with the help of Shelia 
Colven, from the Biochemistry Department at Glasgow University, 
using one continuous and two early passage cell lines. All the 
cell lines tested were shown to contain steroid receptors (Table
6). Cell line G-CCM was observed to possess ten times the number 
of receptors found in the other cell lines, but did not respond to 
the same extent in terms of the reduction in saturation density 
and labelling index, suggesting that no correlation exists between 
receptor number and response in the present experiments.
7. Plasminogen activator activity
Previous work carried out in this laboratory by Frame et al, 
(1984) using anaplastic astrocytomas and rat glioma cells, 
reported an inverse relationship between plasminogen activator 
activity and the cell's differentiated state. Plasminogen 
activator can thus be regarded as a monitor of the differentiated 
state of the cell. It was used for this purpose in the present 
study. Plasminogen activator activity was measured by the method 
described by Whur et al, (1980) and is described in the section 12 
in the method section.
_5
2.5x10 M of either dexamethasone or methylprednisolone was 
found to abolish plasminogen activator activity (Table 7), even in 
the presence of either epidermal growth factor or platelet derived 
growth factor. Thus, the glucocorticoids must be inducing the 
undifferentiated malignant cells to differentiate, as Frame et al 
(1984) associated loss of PA activity with cell differentiation. 
Glial maturation factor (GMF) has been previously shown by McLean 
et al (1986) to induce glioma cells to differentiate. However, in 
this study the crude brain extract (CBE) was found to elevate 
rather than reduce the plasminogen activator activity. The 
significance of this is not quite clear.
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DISCUSSION
The glucocorticoids were seen to exert a cytostatic rather
than a cytotoxic effect on the various glioma cell lines under
investigation, which confirms the results reported by Guner et al
(1977). Glucocorticoids were found to reduce the saturation
density in a dose dependent manner, but this effect was most
prominent in terms of saturation densities. This posed the
question as to whether the technique investigating saturation
densities was more sensitive than that used in measuring the
labelling indices. Further experimentation is required in order
to answer this question. In the absence of serum, the lower
-9concentrations of glucocorticoid (2.5x10 M) were found to augment 
cell proliferation, while higher drug concentrations were found to 
inhibit it. This suggests that glucocorticoids exert a biphasic 
effect, at low concentrations in the absence of serum they augment 
cell growth while at higher concentrations they inhibit growth. 
There was a corresponding loss in plasminogen activator activity, 
which suggests that the glucocorticoids had induced the immature 
malignant cells to differentiate.
In an attempt to observe if the cytostatic effect is 
associated with the glucocorticoid activity, the labelling index 
experiment was carried out using 11-a-epihydrocortisone. This 
analogue was not found to have any cytostatic effect on cell line 
G-CCM. On the contrary, the preliminary experiments suggested 
that the latter compound may be mitogenic. Thus, the present 
results suggest that the cytostatic ' property of the steroids 
resides in the same part of the molecule as glucocorticoid 
activity (Mealey et al, 1971).
The clonogenic assay illustrates that the glucocorticoids 
were not exerting their reduction in saturation density through a 
cytotoxic effect, as the number of colonies formed in the presence 
of glucocorticoids, for the majority of cell lines, were always 
greater than that of the controls. Malignant glioma cells were 
seen to attain higher saturation densities than normal glia, by 
growing on top of one another, as illustrated in the photographs
-41-
in Figure 7. Normal monolayer cells remain roughly at the same 
cell density upon reaching confluence, providing that they are fed 
regularly, whereas malignant cells continue proliferating, though 
at a slower rate than that of sub-confluent cultures (Westermark 
et al, 1973).
Dexamethasone and methylprednisolone were both observed to 
reduce the saturation density in a dose dependent manner. In the
_9
absence of serum, a low steroid concentration (2.5x10 M) was seen
to augment rather than inhibit growth. This biphasic response has
been previously reported in lung carcinoma and glioma cultures 
c(M Lean et al, 1986). Throughout this investigation the 
glucocorticoids were found to reduce each cell line by 
approximately the same value each time, however the exact values 
differed from one cell line to another. It could be asked whether 
the latter values are representative of the densities achieved by 
their normal counterparts. This concept is very hard to 
investigate unless malignant and normal cells of a similar lineage 
are available. In the presence of either dexamethasone or
4
methylprednisolone, BG30/4 plateaued consistently at about 4-6x10
2 5 2cells/cm , while G-IJKt plateaued around 9-13x10 cells/cm . The
most pronounced reduction in saturation density was observed in
those lines which reached the highest saturation densities, for
example G-IJKt. These results may be explained by the following
hypothesis. If glucocorticoids exerted their effect through the
re-expression of density inhibition, the largest effect would be
expected to occur in those cell lines which were able to overcome
this factor to the greatest extent. The results obtained in the
present investigation favours such a concept as the cells which
respond the least to density inhibition would be expected to
attain the highest saturation densities, and it was on these cell
lines which glucocorticoids had their greatest effect.
The labelling index is a quick and efficient method by which
the cell's proliferative activity can be measured. The principle
of this technique involves the dividing cells taking up exogenous
3
[ H]thymidine (Maurer, 1981; Fukuyama, 1985). The cells were only 
exposed to the radioactivity for approximately 18 hours, this time
-42-
is less than the cells doubling time, which is approximately 30
hours, in order to minimise the quantity of radioactivity taken up
by quiescent cells where it is used to repair DNA. Otherwise the
results would suggest that a much higher rate of cell
proliferation was occurring. The labelling index can be
influenced by the ratio of exogenous to endogenous thymidine
present. Endogenous thymidine is incorporated from a pool of
nucleotides which are largely fed by the thymidylate synthetase
reaction, while exogenous thymidine is incorporated exclusively
through the salvage pathway (Figure 11). Fluctuations in the
intracellular precursor pools can markedly stimulate or reduce the
rate of incorporation of exogenous thymidine, without
corresponding changes in the actual rate of DNA synthesis. It
was hoped to eliminate this factor by measuring the labelling
3
index and not the total [ H] thymidine incorporated. Thus, the 
percentage of labelled nuclei should reflect the general 
proliferative activity of the cells under investigation.
In the present experiments, dexamethasone and 
methylprednisolone were seen to reduce the labelling index in both 
the early passage and continuous cell lines. This cytostatic 
effect of glucocorticoids was previously reported by Freshney et 
al, (1980a). This may account for the re-expression of saturation 
density, but without normal cells of the same type this is a hard 
concept to investigate. For future work it would be desirable to 
repeat the above experiments using a larger cell population in 
order that the results could be statistically analysised.
As glucocorticoids are thought to exert their major effect 
through cytoplasmic receptors (Alexis, 1987) it was decided to 
investigate whether the degree by which the glucocorticoids 
reduced the saturation densities, corresponded to the number of 
cytoplasmic receptors present in the various cell lines. In the 
present experiments, the results suggest that there may be no 
correlation between the number of receptors present and the 
reduction in saturation density. This conclusion was reached from 
the following argument:-
Cell line G-CCM was found to possess ten times the number of
dUMP
\|/
De novo pathway
dTMP--->cITDP— f>dTTP----£>DNA
Salvage \// 
pathway YL
TdR
T >^DHT g > fi-UIBA— -^>g-AIBA
5 o  7
Figure'll
Metabolic pathway of thymidine (TdR). Substrates: dUMP, 
deoxyuridinemonophosphate, dTMP, dTDP, dTTP, deoxythymidinemono, di , 
triphosphate; T, thymidine; DfIT, dihydro thymidine; (3-UIBA, p-ureidoi- 
sobutyric acid, {3-AIBA, |3-aminobutyric acid.
Enzymes:1, thymidine kinase2, thymidine phosphorylase; 3, thymidine 
synthetase;•4, thymidine Hydrolase; 5, thymidine dehydrogenase;
6,DIIT hydrolase;7, decarbamylase. Taken from Maurer, 1981.
receptors than the other cell lines tested (Table 6), however it 
did not produce a corresponding decrease in saturation density.
If anything it produced a similar reduction to that of the early 
passage cell lines. Thus, the present results show no correlation 
between receptor number and saturation densities. If a 
correlation did exist between receptor number and saturation 
densities, a larger reduction in saturation density would have 
been expected in cell line G-CCM.
It must be stressed that the above conclusion may not 
necessarily be true if the number of receptors actually present in 
each cell line was in excess of that required to produce the 
maximum reduction in saturation density. This can be explained as 
follows, if 100% occupancy is required to produce the maximum 
reduction in saturation density, then by plotting drug 
concentration against saturation density a dose-response curve 
would be obtained. Whereas, if only a small proportion of the 
receptors in all the cell lines were required to be occupied in 
order to produce the maximum reduction in saturation density, the 
dose-response curve would be masked if the concentration of 
dexamethasone added was in excess of that required to produce the 
response. This hypothesis could be tested by repeating the above 
experiments in the presence of various concentrations of an 
irreversible antagonist for the dexamethasone receptors, by making 
the excess receptors present unavailable to the glucocorticoid 
then any relationship between receptor number and reduction in 
saturation density would be obvious.
It could also be postulated that the glucocorticoids may 
exert their cytostatic effect through inducing the immature glioma 
cells to become more differentiated. Such a mechanism has been 
discussed by Sartorelli (1985). This would result if the 
following hypothesis is correct. Malignant cells resemble foetal 
cells in both morphology and biological properties (see general 
introduction). The transition from foetal to mature cells is 
gradual, thus if a block occurs in this pathway this would result 
in the production of immature cells (Sartorelli, 1985). If the 
"body” regulates cell number by only monitoring the number of
-44-
fully differentiated cells present, the latter situation would 
result in the "body" being unable to detect the partially 
differentiated cells present, thus it would encourage the passage 
of more and more cells into the maturation pathway. Thus, 
dexamethasone and methylprednisolone could be exerting there 
cytostatic effect through encouraging the cells to pass this 
"block" and progress through the cycle. The glucocorticoids were 
seen in the present investigation to reduce the PA activity of the 
malignant cells which emphasises that the glucocorticoids are 
encouraging the malignant cells to express more differentiated 
characteristics. This agrees with work carried out in this 
laboratory by McLean et al, (1986). They found that glial 
maturation factor also encouraged the immature malignant cells to 
differentiate. However, in the present study we did not find this 
to be the case. It is not clear why this inconsistency exists.
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CHAPTER 3
INTRODUCTION
SURFACE CARBOHYDRATES OF TUMOUR CELLS
In this chapter the effect of glucocorticoids will be 
investigated in relation to the glycoprotein composition. 
Malignancy has been correlated with an increase in the proportion 
of high molecular weight fucosylated peptides, in particular with 
an over-sialation (Smets et al, 1984; Berthier-Vergnes et al, 
1985). Freshney et al (1980b) demonstrated that this difference 
could be diminished by dexamethasone, which suggests that the 
glucocorticoid is altering the abnormal glycoprotein composition 
of malignant cells to resemble closer that of glia-like cells 
derived from normal brain. Therefore, it may be asked whether the 
glucocorticoids are exerting their cytostatic effect observed in 
Chapter 1 through altering the glycoprotein composition of 
malignant cells.
1. General structure of glycoproteins
Glycoproteins vary greatly in size, type and degree of 
glycosylation (Smets, 1984). This diversity in their structure 
may reflect their large range of biological functions. The 
carbohydrate residues are situated asymmetrically on the outer 
surface of the plasma membrane. The monosaccharides predominantly 
occurring in membrane glycoconjugates consist essentially of :-
(1) neutral sugars : mannose, galactose, fucose
(2) amino sugars : glucosamine, galactosamine
(3) acetylated derivatives : N-acetyl glucosamine
N-acetyl galactosamine
(4) sialic acids : collection of nine-carbon sugars
with different substitutions on the 
amino and hydroxyl groups.
-46-
Membrane glycoproteins can be subdivided into three groups 
according to the type of linkage present between the sugar and 
protein:-
(i) 'N-linked sequences', in which an N-acetylglucosamine residue 
is linked to the side chain amino group of asparagine (Figure 
12a). This group can be further subdivided into the so-called 
"complex-type" and "simple-type" sugars. Both groups contain a 
common core region. The "complex-type" contain several branches, 
with different monosaccharides associated with the protein core, 
whilst the "simple type" contain simple mannose residues. These 
glycopeptides are assembled on a lipid carrier, dolichol 
phosphate, as a branched dolichol oligomannose. This compound 
contains two N-acetyl glucosamine residues in the linkage region, 
with dolichol and three glucose units in the periphery of one of 
the branches. The high-mannose oligosaccharides are then 
transferred to the apoprotein in the rough endoplasmic reticulum. 
Before protein synthesis is complete, the glycan is transferred to 
the peptide where the carbohydrate chain can either remain 
unchanged, or may lose its outer mannose branches and gain new 
branches containing either N-acetyl glucosamine, galactose or 
sialic acid residues, through a complex interplay of glycosidases 
and glycosyltransferases (Hunt, 1979) forming the complex N-linked 
oligosaccharide moieties. Phosphorylation can then take place on 
some of the mannose residues present in these molecules. This 
type of linkage is commonly found in membrane and serum 
glycoproteins.
(ii) 'O-linked' sequences, in which N-acetyl galactosamine is 
linked to the side chain hydroxyl group of serine (Figure 12b). 
This type of linkage is found in secretory mucus.
(iii) 'O-linked' sequences, in which a xylose residue is bound to 
serine, (Figure 12c) are found in proteoglycans (Chapter 4).
Lipid intermediates are not involved in the biosynthesis of these 
structures. The sugars are added directly to the protein by 
sequential transfer from sugar nucleotide precursors (Hook, 1984).
Glycoproteins possess the potential of carrying large
Figure12
Protein core
Asn-
GlcNAc— Fuc
GlcNAc
Man
Man Man
‘V ^ L 7  - " w 7
GlcNAc (Man)n
Gal
"simple" type 
chain
Sialic acid 
"Complex" type
b) CH,OH
vH—CO— CM,— CH
NHAc
c) CH,OH SERINE (R— H);t h r e o n i n e (r^ c h 3;
n- H-
-— CH — CH
NHAc
Figure 12
(a) A schematic representation of N-glycosidically-linked 
oligosaccharide complex in secreted glycoproteins. The core 
protein either contains mannose residues (i.e "simple-type") 
or a "complex -type" which contains several branches 
containing different monosaccharides, which may carry 
terminal sialic or fucose units. A single glycoprotein may 
have both types of chain elongation and up to four chains can 
branch off from the mannose units of the core. Taken from 
Smets, 1984.
Abbreviations are:-
GlcNac., N-acetyl glucosamine; Gal., galactose; Man.,
Mannose; Fuc., fucose; Asn., asparagine
(b)"N-linked sequences"
Glycopeptide bond involving an N-glycosidic linkage 
between asparagine and N-acetylglucosamine. Taken from Smets, 
1984.
(c) "0-linked sequences"
Glycopeptide bond involving an O-glycosidic linkage 
between serine or threonine and N-acetyl galactosamine. 
Taken from Smets, 1984.
quantities of information due to their high degree of 
heterogeneity which arises mainly from:-
(i) the degree of branching
(ii) the fact that the monosaccharides can be joined to each 
other through any of the several hydroxyl groups present
(iii) that the C-l linkage can have either an a- or 0- 
configuration.
2. Laminin and fibronectin
Laminin and fibronectin are two major glycoproteins which are
thought to play an important role in cell adhesion (McCarthy et
al, 1985). Fibronectin is ahnnt 9?0kDa and forms a class of 
Hynes et al (1978) 
multifunctional glycoproteins/V It is widely distributed in
tissues throughout the body in an insoluble tissue form and a
soluble plasma form. Most of its functions are assigned to
domains of the polypeptide chains of the molecule (Yamada, 1981).
Fibronectin promotes spreading of a variety of cell types:
fibroblasts, chondrocytes and adipocytes (Spiegelman and Ginty,
1983; West et al, 1979). Addition of fibronectin to
pre-adipocytes prevents the cells from rounding up during
differentiation and the cell subsequently fails to express
lipogenic enzymes. Laminin is about 900kDa, comprised of three
disulphide-linked polypeptide chains termed A (405kDa),
(225kDa) and (205kDa) (Von der Mark and Kuhl, 1985) and is
localised in basement membrane structures (M°Carthy et al, 1985).
Laminin appears very early in development being detected in the
morula stage of the mouse embryo. Laminin like fibronectin has
multiple binding activity to other matrix components including
basement membrane collagen and proteoglycans as well as the
surface of many cells. Laminin promotes attachment of cells that
synthesise laminin in vivo, but the shape adopted depends on the
origin of the cell: Sertoli cells on laminin have a columnar
morphology, while Schwann cells are elongated (Kleinman et al,
1984). Both glycoproteins have been found to promote adhesion of
cells to collagen.
It could be postulated that if glucocorticoids influence the
binding affinity of malignant cells then they may exert their 
effect through modulating the quantity of either fibronectin or 
laminin being synthesised by the cell. This hypothesis was 
investigated in the present investigation using antibodies which 
recognise laminin and fibronectin respectively.
3. Glycoprotein distribution in vivo
Membrane glycoproteins occur commonly in vivo as dimers or 
oligomers in which the subunits may be linked either by disulphide 
bonds or by non-covalent interactions. The transferrin receptor 
is comprised of four very similar glycoprotein subunits bound by 
disulphide bonds, while, the HLA-DR antigens, 
(HLA-histocompatibility antigens), consist of two dissimilar 
non-covalently linked glycoproteins. Transmembrane glycoproteins 
are usually orientated with the amino terminus on the outside of 
the cell and the carboxyl terminus on the inside (Figure 13). 
However, the reverse orientation has also been found, for example 
band 3 glycoproteins of erthyrocytes, may have the reverse 
orientation, that is the carboxyl on the outside and the amino 
terminus on the inside (Smets et al, 1984; Lennarz W.J, 1980).
4. Glycopeptides in relation to differentiation and proliferation
Cellular proliferation has been found to alter both the 
quantity and type of glycopeptides produced by the cell. 
Proliferating hamster cells contain a greater quantity of higher 
molecular weight glycopeptides compared to quiescent cultures 
(Buck et al, 1971). In addition to this alteration in the 
glycopeptide size, the actual quantity of glycopeptides being 
produced is also affected. Confluent non-growing cells produced a 
larger proportion of the "complex-type" rather than the 
"simple-type" glycopeptides which are normally produced during 
active proliferation (Sasak et al, 1985). Differentiation can 
also decrease the quantity of the higher molecular weight 
glycopeptides present (Freshney et al, 1980b). A good example of 
this is seen with human myeloid leukaemia HL60 cells (Smets and 
Van Beek, 1984).
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Figure13
Transmembrane glycoproteins are usually orientated with 
the amino (NI^) terminus on the outside of the cell and 
the carboxyl terminus on the inside. Glycoproteins 
normally span the bilayer once only but Band 3 
glycoprotein of erythrocyte membranes traverses the 
bilayer several times with the carboxyl and amino ends 
of the polypeptide in reverse orientation to most other 
membrane glycoproteins interacts with a specific 
membrane receptor. Sugar residues are shown as f . 
Pronase cleaves glycopeptides on the external surface of 
the plasma membrane at the point illustrated in the 
diagram. Adapted from Lennarz, 1980.
5. Surface carbohydrates in malignant cells
Cancer tissues have been found to be comprised of higher 
molecular weight glycoproteins than their corresponding normal 
tissues (Van Beek et al, 1978; Smets et al, 1984). Such 
alterations have been reported to have no effect on the adhesive 
properties of these molecules. This difference in terms of 
glycoprotein composition can be reduced by pretreating the 
malignant cells with neuraminidase. This suggests that the above 
difference between malignant and normal cells was due to an 
increase in sialic acid concentration, which may arise from an 
increase in sialyltranferase activity. Warren et al (1972) were 
the first to report an increase in sialytransferase activity, 
suggesting a correlation between sialytransferase activity and 
proliferation in both transformed and normal proliferating cells. 
However, Grimes et al (1971) found decreased levels of 
sialyltransferase activity in 3T3 cells transformed by the SV40 
virus. This correlates with the absence of the more highly 
sialated membrane glycoproteins in these cells.
Along with the size of the glycoproteins changing, 
Berthier-Vergnes (1985) found that the distribution of these 
glycoproteins differed between cell lines of differing 
tumourigenicity: 87% of the total sialic acid residues produced by 
highly metastatic lines were associated with the cell's surface, 
compared to only 53-55% in low tumourigenic lines. This suggests 
that highly tumourigenic lines may not necessarily possess a 
greater quantity of sialic acid residues than corresponding 
"normal" cells, but it is their cellular distribution which 
differs. Sialic acid residues were found to be cell-associated in 
the highly tumourigenic cells, whereas, in the lower tumourigenic 
cells they were generally released into the extracellular matrix. 
This increase in the degree of sialation has been associated with 
the cell's inability to respond to its external environment.
Fusion of genetically transformed mouse L-cells, where the genetic 
deficiency is in the fucosylation of surface glycopeptides and 
normal mouse cells (Smets et al, 1984), results in only the
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hybrids possessing the normal cell's surface carbohydrate 
composition being able to communicate normally. Poste and 
Nicolson (1980) correlated the above increase in sialic acid 
residues with metastasis. Thus, malignancy may be correlated to 
an increase in the proportion of cell-associated sialic acid 
residues, but not necessarily with an increase in total 
glycoprotein production. Thus, by altering the glycopeptide 
composition of the external plasma membrane, the cell's biological 
properties may be dramatically altered.
The loss of surface fibronectin has generally been correlated 
with acquisition of tumourigenic potential in chemically and 
virally transformed cells, although some exceptions have been 
reported (Hynes, 1981). It may be asked whether this reduction in 
fibronectin is due to a decrease in the rate of synthesis of 
fibronectin or an increase in the rate at which this glycoprotein 
is excreted from the cell. Biosynthesis of fibronectin by 
transformed cells is lower than that by normal cells, but in 
general this reduction in synthesis is not sufficient* to account 
for the reduction in surface levels of this glycoprotein.
Increased turnover rates and the decreased ability of transformed 
cells to bind fibronectin may also contribute to the reduced 
surface levels of fibronectin in malignant cells.
6. How can these alterations affect cell behaviour?
As discussed in the general introduction, the cytoskeleton 
may be important in terms of cell proliferation and 
differentiation. It was asked whether these alterations could 
account for the malignant cell's abnormal behaviour. Transformed 
cells generally have less ordered arrays of microfilaments. In 
particular, they usually lack, or have reduced levels of, 
microfilament bundles or "stress fibres" characteristic of many in 
vitro cells (Allred and Porterk, 1975). When fibronectin is
m  / U  «  *• *• M t r r t  ^  f  m  •£ v» -P *1 "1 #■% m  ♦* n  v* v* r n r* /s 4* r*4 4- V*» o  f*a u u c u  y cu. i.ay  o u i  i i ih m Iu i ix a m c u  10 j .c ~ a p p c a i.  9 o u g g ^ o io  u n a t
these cells are unable to synthesise sufficient quantities of 
fibronectin. This type of experiment suggests some form of 
transmembrane effect of the extracellular fibronectin on the
intracellular microfilaments. Such an effect may be postulated to 
produce no noticeable effect until the tumour is of significant 
size. This arises because the tumour is initially surrounded by 
normal cells, so a reduction in the production of fibronectin by 
the few tumour cells is insignificant. However, fibronectin 
production becomes important when the tumour mass is of 
significant size. In contrast, a reduction in the ability of 
these malignant cells to bind fibronectin could be important at 
the early stages of tumour formation.
Along with the quantity of fibronectin changing, Wagner et al 
(1981) found that the actual structure of fibronectin altered. 
Transformed cells, compared to their normal counterparts, 
contained a larger number of branches per core protein along with 
a higher degree of sialation, however they showed that this 
alteration in structure had no effect on the glycoproteins' 
adhesive properties.
7. Alterations in the composition of carbohydrate can affect gene 
expression.
As cancer is caused, at the molecular level, by changes in 
DNA, the alterations in carbohydrate composition mentioned in the 
previous section may be related to a direct effect on gene 
transcription and cell behaviour. Transformation by oncogenic 
viruses usually appears as a single step process, probably by the 
en bloc transfer of the relevant transforming genes (Smets et al, 
1984). Several studies with temperature-sensitive mutants of 
transforming viruses have revealed that the expression of the 
viral genome is required for the emergence of tumour associated 
carbohydrate changes (Warren et al, 1972). The entire viral gene 
is not always required for transformation. De Leij et al (1982) 
studied carbohydrate changes following transfection of rat kidney 
cells with restriction enzyme fragments of Adenovirus 12 DNA. 
Transfection of a small left hand fragment (0-7.2%) resulted in 
immortalised and morphologically transformed non-tumourigenic 
cells, whereas, the entire El region (0-11.5%) was required for 
the manifestation of the tumourigenic phenotype and for expression
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of the characteristic changes in glycopeptides.
Several oncogenes have been identified which are implicated 
in malignancy. Altered glycosylation has been demonstrated in NIH 
3T3 cells transformed by transfection with DNA from human 
neuroblastoma and bladder carcinoma cell lines. The oncogenes 
responsible have been identified as N-ras and C-Hras-I 
respectively (Santer et al, 1984).
8. The effect of glucocorticoids on glycopeptide composition
Freshney et al (1980b) have previously shown that pretreating 
glioma cell lines with dexamethasone resulted in these cells 
acquiring a glycopeptide composition similar to that of their 
corresponding normal cells. This effect was similar to that found 
by Van Beek et al (1978) using neuraminidase, which suggests that 
the glucocorticoid produces its effect by reducing the quantity of 
sialic acid on surface glycoproteins. McLean et al (1986) 
suggested that the glucocorticoids may be exerting their effect 
through inducing the immature malignant cells to become more 
differentiated, which may be expressed by an alteration in the 
composition of the glycoconjugates. Alternatively, the 
glucocorticoids could directly reduce the sialytransferase 
activity.
9. Aim of Chapter
The aim of this Chapter was to investigate the effect of 
dexamethasone and methylprednisolone on glycopeptide composition. 
This was investigated in two different ways. Initially the 
composition of glycopeptides was investigated by Gillian Hunt 
(Royal Victoria Hospital, Newcastle) using gel electrophoresis.
As the composition of the extracellular glycopeptides may be 
important in determining the biological behaviour of the cell, the 
composition of these glycopeptides was specifically looked at 
using gel exclusion chromatography.
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Materials and Methods
Dexamethasone and methylprednisolone were used at a
_5
concentration of 2.5x10 M throughout this chapter, as this 
concentration was observed in Chapter 2 to produce the maximum 
decrease in saturation density. At this concentration any effect 
the glucocorticoids have on the glycopeptide composition should be 
clearly seen. The glucocorticoids were seen in Chapter 2 to have 
a similar effect on both the continuous and early passage cell 
lines, the continuous cell lines G-CCM and G-IJKt were arbitrarily 
chosen for the following investigation. As the following methods 
do not differentiate between glycoproteins and proteoglycans the 
mixture will be referred to as glycoconjugates throughout this 
chapter.
1. Radioiodination of monolayer cultures
This method was carried out by Gillian Hunt (Royal Victoria
Hospital, Newcastle). The cell layer was pre-incubated in
phosphate-buffered saline (PBS), pH 7.2 for 15 minutes at 37^C,
followed by a final PBS rinse to remove adherent serum proteins.
3ml of 5mM glucose in PBS was then added to each flask, followed
125by lmCi of carrier free Na I, 2.5yg of glucose oxidase and IV 
lacto-peroxidase. These solutions were mixed gently and were left 
for 10 minutes at room temperature. The reaction was terminated 
with 5ml of phosphate-buffered iodine (PBI), containing 0.137M Nal 
and 2 mM phenyl-methyl-sulphonyl-fluoride (PMSF) a protease 
inhibitor. The monolayer was then rinsed 3 times in PBI-PMSF.
The cells were scraped off in a small quantity of PBI-PMSF and 
centrifuged to obtain a cell pellet. The pellet was then 
solublised by boiling in 0.3ml of 0.01M sodium phosphate buffer, 
pH7, containing 1% (w/v)SDS, IX (w/v) mercaptoethanol and 2mM PMSF 
for 10 minutes. Sucrose was added to give a 30% w/v final 
solution. The extract was stored at -20^C.
30pl aliquots of extracts of the above solution were run on 
6% w/v cylindrical polyacrylamide gels (6mmxl40mm). The running
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buffer contained 200mM sodium phosphate buffer pH 7.2, 0.2% (w/v) 
SDS and 0.05% (w/v) bromophenol blue as a tracking dye. 1mm 
slices of the gel were then cut and counted for radioactivity.
The counts per slice were expressed as a percentage of the total 
radioactivity recovered per gel. The molecular weights of the 
labelled proteins were determined by comparison with molecular 
weight markers on the gel.
2. Gel exclusion chromatography
2Cells were grown in 23.8cm (5.5cm) petri dishes to 70%
confluence. They were then incubated in either dexamethasone or
-5methylprednisolone (2.5x10 M) in the presence or absence of 
lng/ml EGF for 5 days. The cells were then treated in the 
following way:-
3
(i) Cells were exposed to 5 yCi/ml [ H] glucosamine (NEN; 
29Ci/mmol) for 16 hours.
(ii) Medium was removed and stored at -80 C. The cells were then
incubated with 1ml of lmg/ml of pronase (Sigma) on day 1, followed
by 0.2ml of lOmg/ml pronase solution on days 2, 3 and 4. The
pronase extract was then centrifuged for 5 minutes to remove the
precipitated material. This extract was stored at -80^C.
3
(iii) In order to separate the unincorporated [ H] glucosamine 
from that incorporated into glycoproteins, the above solutions 
were passed through a C^g cartridge (Whatman Co.). The cartridge 
was activated by passing 2ml of methanol (HPLC grade) through it, 
then rinsed with 5ml of distilled water. The sample was passed 
through the cartridge followed by some distilled water and the red 
colour of the medium was seen to be retained at the top of the 
cartridge. The sample was then washed out with 3ml of a solution 
containing 0.1% TCA and 50% acetonitrol (HPLC grade), and 0.5ml of 
this exudate was then counted in 10ml of Ecoscint in the 
scintillation counter (Packard). The remaining solution was then 
lyophilised and stored at -80^C.
(iv) The glycoproteins were separated using a TSK-G3000SW column 
at 4^C. A lOOpl sample of each of the above solutions was then 
run through the column and 0.5ml fractions were collected. These
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samples were then added to Ecoscint, thoroughly mixed and counted 
on the scintillation counter. The results were standardised by 
multiplying up by the dilution factor and expressed as counts per 
10^  cells.
Note: In all the above results 90% of all the radioactivity put on 
the column was recovered. The missing 10% was probably dispersed 
throughout the column exudate, appearing as background.
Therefore, the area under the curves should represent the quantity 
of radioactivity taken up by the cells.
3. Detecting the quantity of either laminin or fibronectin in the
presence or absence of glucocorticoids
In order to detect whether dexamethasone or
methylprednisolone affected the quantity of either fibronectin or
laminin present, the following protocol was followed.
The protocol is based on the principle that a 1° antibody is
added which detects the appropriate glycoprotein. The staining is
q Which; o
amplified by using a 2 antibodyAbiiids to the 1 antibody and '
peroxidase anti-peroxidase (PAP) molecules then bind to the 2°
antibody. The PAP molecules are then visualised via a
substrate-chromagen reaction with diaminobenzidine (DAB; Sigma)
(Figure 14). All the antibodies were obtained from Dakopatts.
4
Cells were seeded at approximately 2X10 cells in either Lab 
Tek slides (0.4ml) or in 50mm petri dishes (4ml). These cells
_5
were then grown in the presence or absence of either 2.5X10 M 
dexamethasone or methylprednisolone. The cell monolayer was then 
fixed using cold methanol as described in section 9. The 
antibodies used in this section were obtained from Dakopatts:-
1) For fibronectin, the 1° antibody was mouse anti-fibronectin,
the 2° antibody was anti-mouse attached to peroxidase.
o o2) For laminin the 1 antibody was rabbit anti-laminin, the 2
anti-rabbit linked to peroxidase.
The fixed monolayer was incubated at 37^C with the 1^ antibody for 
20 minutes, washed thoroughly with PBS, incubated for 20 minutes 
with the 2° antibody, washed thoroughly with the PBS then 
incubated with peroxidase anti-peroxidase for 20 minutes then
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A schematic diagram of the technique used 
the presence of both laminin and fibronectin. 
peroxidase enzyme is visualised via a 
substrate-chromagen reaction.
:°ANTlBODY 
—1° ANTIBODY
to detect 
The
finally washed thoroughly with PBS. The cells were then exposed 
to 0.5mg/ml of DAB in PBS until the brown stain could be seen, 
they were then washed thoroughly with PBS before being mounted. 
The quantitation of laminin and fibronectin was arbitrary.
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RESULTS
1. Investigating the effect of glucocorticoids on the molecular 
weight distribution of glycoconjugates
In collaboration with Gillian Hunt (Royal Victoria Hospital, 
Newcastle), cell surface carbohydrates were examined in the 
presence of methylprednisolone using polyacryalmide gel 
electrophoresis. Confluent cultures of G-CCM and G-IJKt, were
_5
grown in the presence or absence of 2.5x10 M methylprednisolone, 
iodinated by the lactoperoxidase technique and separated using gel 
filtration chromatography as described in the methods section.
The results obtained are shown in Figure 15. In cell line 
G-CCM, glucococorticoid reduced the quantity of glycoconjugates of 
molecular weight 225kDa (possibly fibronectin) and 20kDa, while 
increasing the 63kDa component. There was a slight decrease in 
the 87KDa species, but this was not statistically significant. In 
cell line G-IJKt the drug reduced the quantity of 148kDa, 63kDa, 
48kDa and 32kDa glycoconjugates while increasing the proportion of 
the 130kDa and 87kDa species. Thus, there is no evidence for a 
consistent change in the membrane glycoproteins in these two cell 
lines.
2. Separating glycoconjugates by molecular weight gel exclusion 
chromatography.
In the previous section, intact glycoconjugates were 
examined. This section deals with the glycoconjugates on the 
surface of the cell which are accessible to pronase digestion 
(Figure 13). Prelabelled glycoconjugates were separated using a 
T.S.K. column, as described in the methods section, which is is a 
quick and efficient method for separating proteins according to 
their molecular weight (Kato et al, 1980). Two fractions were 
investigated, the medium which contained the material secreted 
from the cell and the pronase digest which contained the cell 
associated material.
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Data obtained from radioiodination of surface
glycoproteins by Gillian Hunt (Newcastle). Illustrating the 
-5effect of 2,5x10 M of methylprednisolone (MP) on cell line
a) G-IJKt and b) G-CCM. Each cell line was grown to
2
confluence in a 75cm flaslc, exposed to methylprednisolone 
for 5 days post confluence and the iodinated as described in 
the methods section. In (a) n=5 for the control group and 4 
for the glucocorticoid group, while in (b) for the control 
group and 5 for the test group. The means were statistically 
compared by a two sample t-test where 0 p<0.05 and Slp<0.01.
2.1 Cell line G-CCM:
In cell line G-CCM dexamethasone was found to increase the 
quantity of glycoconjugates present in both the medium and pronase 
fractions (Figures 16 and 17). Methylprednisolone produced a 
similar effect on the pronase fraction, but had the opposite 
effect on the medium extract. Dexamethasone increased the range 
of glycopeptides eluting in both fractions, as depicted by the 
broadening of the elution peak, and the increased area under the 
curve as shown in Table 8. Methylprednisolone was seen to produce 
a similar effect on the pronase fraction, however it reduced the 
quantity of glycoconjugates eluting in the medium extract as seen 
from the narrower width of the elution peak. EGF was seen in the 
medium fraction of both cell lines to effectively shift the peak 
to the left, which indicates the presence of higher molecular 
weight glycoconjugates. This shift by EGF was diminished in cell 
line G-CCM in the presence of methylprednisolone, but was 
augmented by dexamethasone.
2.2 Cell line G-IJKt
Both dexamethasone and methylprednisolone were seen to 
increase the quantity of material present in the medium extract, 
as seen by the broadening of the peak and the increase in the area 
under the curve (Figures 18, 19 and Table 8). However, 
dexamethasone was seen to possess a greater effect than 
methylprednisolone. Dexamethasone was seen to increase the 
quantity of the glycoconjugates in the pronase fraction, which was 
similar to its effect on the medium fraction, however 
methylprednisolone showed no effect. In the pronase fraction, the 
peak was seen to shift to the left in the presence of 
glucocorticoids, indicating the presence of higher molecular 
weight species. Whereas, in the medium extract the 
glucocorticoids increased the quantity of the lower molecular 
weight species eluting from the column, as seen from the 
broadening of the peak to the right. EGF was seen in this cell 
line to increase the quantity and size of the glycoconjugates
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The effect of glucocorticoids on the glycoconjugates
profile. The effect of (a) methylprednisolone (HP) and (b)
dexamethasone (Dx) on the elution profile of glycoconjugates
in the medium fraction of cell line G-CCM from a TSK-G3000SW
gel column. The cells were grown to 70% confluence, then
were exposed to glucocorticoid for 5 days, then they were
-1 3exposed to 5 pCi ml of II-glucosamine as described in the 
methods section.
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Figure 17
The effect of glucocorticoids on the glycoconjugates
profile. The effect of (a) methylprednisolone (MP) and (b)
dexamethasone (Dx) on the elution profile of glycoconjugates
in the pronase fraction of cell line G-CCM from a TSK-G3000SW 
gel column. The cells were grown to 70% confluence, then
were exposed to glucocorticoid for 5 days, then they were
-1 3exposed to 5 pCi ml of H-glucosamine as described in the 
methods section.
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The effect of glucocorticoids on the glycoconjugates
profile. The effect of (a) methylprednisolone (HP) and (b) 
dexamethasone (Dx) on the elution profile of glycoconjugates
in the medium fraction of cell line G-IJKt from a TSK-G3000SW
gel column. The cells were grown to 70% confluence, then
were exposed to glucocorticoid for 5 days, then they were
-1 3
exposed to 5 pCi ml of H-glucosamine as described in the 
methods section.
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The effect of glucocorticoids on the glycoconjugates
profile. The effect of (a) methylprednisolone (MP) and (b)
dexamethasone (Dx) on the elution profile of glycoconjugates
in the pronase fraction of cell line G-IJKt from a
TSK-G3000SW gel column. The cells were grown to 70%
confluence, then were exposed to glucocorticoid for 5 days,
-1 3then they were exposed to 5 pCi ml of H-glucosamine as 
described in the methods section.
Table. Q
The effect of glucocorticoids on the quantity of 
glycoconjugates elluting from the TSK-G3000SW column.
Cell line
G-CCM
G-CCM
G-IJKt
G-IJKt
Fraction Drug Area under curve
medium control 13,7-51
Dx+EGF 16,395
MP+EGF 19,009
MP 10.707
Dx 10,209
EGF 0,154
Pronase control 14,521
Dx 10,964
MP 21,453
EGF+DX 15,175
EGF 10,749
MP+EGF 17,976
medium control 6,696
Dx 17,103
EGF 10,459
MP+EGF 10,495
MP 13,445
pronase control 5,174
EGF+Dx 12,006
EGF 32,239
Dx 10,617
MP 5,425
EGF+MP 14,100
Illustrates numerically the area under the 
glycoconjugate peaks elluted from the TSK-G3000GW 
column. This was worked out by adding up all the counts 
within that peak. (Dx) dexamethasone, 2.5x10 M; (MP)
_5
methylprednisolone, 2.5x10 M and (EGF) epidermal growth 
factor, lng/ml.
present in both the medium and pronase fractions. In the presence 
of dexamethasone, the shift in terms of molecular weight by EGF 
was reduced.
3. Investigating the effect of glucocorticoids in relation to the 
quantity of either fibronectin or laminin produced by the cell 
An example of fibronectin positive cells is shown in Figure 
20 with cell line BG84/5. Quantification of the results 
presented some difficulties since they depended on assessing the 
intensity of the staining, which is very subjective. Thus, it 
proved extremely difficult to try to ascertain whether the 
presence of either lOyg/ml or lyg/ml of dexamethasone or 
methylprednisolone altered the intensity of the staining. The 
staining was not found to be uniform throughout the slides: it 
increased towards the edges of the coverslips. The results 
obtained suggested that dexamethasone may have reduced the 
quantity of laminin present in the glioma cell lines, while in 
terms of fibronectin the results were inconclusive.
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The photograph illustrates staining for fibronectin in cell line
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DISCUSSION
Malignancy has been correlated with an oversialation of the 
glycopeptides (Van Beek et al, 1978; Warren et al, 1972). It was 
therefore asked whether alteration of the glycopeptide composition 
of malignant cells would diminish the abnormal behaviour of 
malignant cells. Freshney et al (1980b) showed that an 
oversialation in malignant cells could be reduced by treating the 
cells with dexamethasone. Thus, it was hoped to observe in this 
chapter an alteration from high molecular glycoconjugates to lower 
molecular weight species in the presence of either dexamethasone 
or methylprednisolone.
The results obtained by Gillian Hunt, looking at the 
composition of intact glycoconjugates, illustrated that both 
methylprednisolone and dexamethasone did induce alterations in the 
composition of glycoconjugates produced by the cell. However, 
both cell lines differed in terms of their actual response. Thus, 
these experiments would have to be repeated using a variety of 
different cell lines before any conclusive decisions can be made.
The composition of the surface glycoconjugates was 
investigated using a TSK-G3000SW gel exclusion column, as 
described in the methods section. Upon separating the 
glycopeptides in the pronase digest using a TSK-G3000SW gel 
exclusion column changes in both the size and quantity of the 
glycoproteins were detected in the presence of either 
dexamethasone or methylprednisolone. With respect to the medium 
extract, both dexamethasone and methylprednisolone were seen to 
produce changes. Dexamethasone was found to increase the total 
quantity of glycoconjugates present in the medium fraction of both 
cell lines, whereas methylprednisolone had the opposite effect on 
cell line G-CCM. However, dexamethasone was seen to have a more 
pronounced effect than methylprednisolone on cell line G-IJKt, 
which corresponds with the results obtained in the last section 
with respect to cell proliferation. In the pronase extracts, the 
glucocorticoids were seen to increase the quantity of 
glycoconjugates present, this effect was more prominent in cell
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line G-IJKt. It is very hard to interpret the effect of epidermal 
growth factor in the present experiments.
Thus, dexamethasone and methylprednisolone were observed to 
alter the quantity of glycopeptides on the surface of the 
malignant cells. However, no consistency in the alterations were 
observed between the two cell lines tested. These experiments 
need to be repeated with a larger number of different cell lines 
before any conclusions can be drawn. The sensitivity of this 
technique was insufficient to detect small changes in molecular 
weight. It was therefore concluded that a more sensitive method 
was required. As glycopeptides comprise a vast range of different 
species, it was decided that it may be easier to investigate the 
above relationship by looking specifically at one particular group 
of molecules. It was therefore decided to investigate the 
composition of proteoglycans as these molecules have been shown to 
have profound effects on normal cell behaviour.
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CHAPTER 4 
INTRODUCTION
PROTEOGLYCAN AND GLYCOSAMINOGLYCAN PROFILES IN RELATION TO 
MALIGNANCY
The aim of this chapter is to investigate the effect of 
glucocorticoids on proteoglycan composition and whether such an 
effect could account for the cytostatic effect of the 
glucocorticoids observed in Chapter 2.
1. STRUCTURE OF PROTEOGLYCANS
Proteoglycans are comprised of glycosaminoglycan (GAG) chains 
bound to a protein core via a linkage region (Figure 21). The GAG 
chains consist of repeated disaccharide sequences containing 
either glucuronic acid or iduronic acid residues and an amino 
sugar, which can either be N-acetyl glucosamine or N-acetyl 
galactosamine (Hook, 1984; Kraemer, 1975; Lindahl and Hook, 1978). 
There are no formal criteria for identifying proteoglycans, 
however seven different glycosaminoglycans families have been 
identified according to their sugar residues:- hyaluronic acid, 
chondroitin-4-sulphate, chondroitin-6-sulphate, dermatan sulphate, 
heparan sulphate, heparin and keratan sulphate (Lindahl and Hook, 
1978; Hook, 1984; Poole, 1986). They are comprised of linear 
polymers of alternating A and B monosaccharide units (Figure 22)
1.1 Hyaluronic acid proteoglycan
Hyaluronic acid is the largest GAG molecule of all the seven 
groups, (molecular weight exceeds 10 daltons in normal tissues), 
and exists as a linear structure. It is the only GAG group which 
is not found sulphated or bound to a protein core. Under 
physiological conditions the carboxyl group dissociates to form 
hyaluronate. The literature on hyaluronic acid however does not 
differentiate between the acid and salt forms, therefore both will 
be referred to as hyaluronic acid throughout this report. Turley
H-O-CHj-O— XYLOSE— Gal— Gal-jA-B^
■ 1_____________ I 1___ I
Link trisaccharide 
core protein
Figure 2-1
Schematic drawing of the linkage between a 
glycosaminoglycan chain (GAG) and the protein core. A 
specific linkage sequence at the end of the GAG chain is 
bonded to a serine of the protein core.
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A schematic drawing of the molecular structure of the 
seven different glycosaminoglycan groups. The abbreviations 
are: GlclIA, glucuronic acid; IdUA, iduronic acid; GlcN, 
galactosamine; Gal, galactose.
and Roth (1979) proposed that hyaluronic acid may be synthesised 
at the cell's surface, while Prehm (1983(a), 1983(b)) using 
teratocarcinoma cells, suggested a stepwise addition of 
UDP-N-acetyl glucosamine and UDP-glucuronic acid alternatively to 
the reducing end of the polysaccharide at the plasma membrane.
The UDP unit is released as the subsequent sugar nucleotide is 
added. Initiation of synthesis is thought to be independent of a 
protein core, resembling the mechanism for assembling bacterial 
polysaccharides (Hook, 1984).
1.2 Dermatan sulphate /Chondroitin sulphate proteoglycan
Dermatan sulphate is formed from chondroitin sulphate through 
the conversion, at the polymer level, of some or all of the 
glucuronic acid residues by epimerization into iduronic acid 
residues. The content of D-glucuronic acid residues in dermatan 
sulphate may range from negligible amounts to more than 90% of the 
total uronic acid residues. This variation in the D-glucuronic 
acid content introduces a considerable degree of heterogeneity: 
some sources of dermatan sulphate consist solely of 
iduronosyl-N-acetyl galactosamyl-4-sulphate disaccharide units, 
while the more complex form contains an extensively hybridised
polysaccharide backbone where both the 4- and 6-0 galactosamine
and Hook
residues are sulphated (Lindahl,^19/8)* The degree of sulphation 
can vary considerably within this molecule and may occur at the 4 
and/or 6 position of N-acetyl galactosamine or at the 2-0 position 
of iduronic acid residues. Sulphation is carried out by 
sulphotransferases which utilise 3'phosphoadenylsulphate (PAPs) as 
the sulphate donor and catalyse the formation of ester sulphate 
(0-sulphate) groups at positions and of N-acetyl 
galactosamine residues (Hook, 1984; Kraemer, 1975; Dorfman, 1981).
1.3 Heparan sulphate and Heparin proteoglycan
Heparan sulphate has beenTthe most widely, investigated
:Hook et al 1 974 '
proteoglycan (Gallagher et al, 1986yyHook, 1984). It is thought 
to contain the largest degree of structural variability of all the 
different GAG groups, which may reflect its broad range of
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biological functions (see discussion section). Despite heparin 
and heparan sulphate containing identical residues, Gallagher and 
Walker (1985) have suggested that they are actually two separate 
families of N-sulphated GAGs. Heparan sulphate is produced by 
most mammalian cells. Within this molecule, N-sulphated 
galactosamine comprises of about 50% of the total hexosamine 
content, while the quantity of 0-sulphated groups present varies 
between different tissues. Heparin, on the other hand, is 
produced mainly by mast cells. The majority of these residues are 
N-sulphated, (>80% of the glucuronic acid residues), and there is 
always a molar excess of 0-sulphates over N-sulphates. Compared 
to heparan sulphate, heparin in general contains fewer N- and 
0-sulphated groups and reduced numbers of tri-sulphated 
disaccharides. They concluded that in heparan sulphate, both the 
iduronate and 0-sulphate groups were largely confined to regions 
of high N-sulphated glucosamine content, while the O-sulphates 
were never found to be separated from the N-sulphates by more than 
one monosaccharide. The N-acetylated glucuronic acid groups were 
correlated to the regions containing low sulphated and enriched 
glucuronic acid residues. It is reasonable to suggest that the 
above structural rules may also apply to the other GAG groups. 
Heparan sulphate is synthesised according to a series of 
polymerisations shown in Figure 23. These reactions do not always 
go to completion, hence a mixture of the various intermediates are 
found in vivo (Lindahl and Hook, 1978).
1.4 Polymer formation for sulphated GAGs
Polysaccharide formation is initiated by the transfer of 
xylose units from UDP-xylose to serine residues in the protein 
core. The xylosated protein core then acts as an acceptor for 
successive transfer of two galactose units from their 
corresponding UDP sugars (Hook, 1984; Kraemer, 1975). The neutral 
trisaccharide xylosylgalactosylgalactose acts as a primer for 
growth of the polysaccharide chain. In the case of chondroitin 
sulphates, polymer formation involves an alternating transfer of 
glucuronic acid and N-acetyl galactosamine units to the non-
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A schematic representation of polymerisation of 
heparan sulphate. Herparan sulphate is synthesised 
initially as a non-sulphated polymer of repeat sequences 
of N-acetylglucosamine (GlcNAc) and glucuronic acid 
(GlcUA). The extensive postpolymerisation modifications 
that occur can convert the non-sulphated disaccharides 
(1) into disaccharides containing 3 sulphate groups with 
the original GLcllA residue converted into iduronic acid 
(IdUA) (6). The modifications do not go to completion 
so (3 and 4) are found in vivo. Adapted from Lindahl et 
al, 1978.
reducing end of the growing polysaccharide chain, forming a chain 
of repeating disaccharides.
The length of the polysaccharide chains appears to be 
controlled by the ratio of available primers and UDP- sugar 
precursors present. This is clearly shown by the following 
example. Upon increasing the concentration of @-Xylosides, the 
number of primers available for chain elongation are increased and 
the length of the synthesised chains are reduced (Schwartz, 1979). 
In contrast, if protein synthesis is inhibited by cyclohexamide, 
the number of growing chains are reduced while the length of the 
polysaccharide chains are increased (Kimura et al, 1981).
1.5. Protein cores of proteoglycans
Compared to the polysaccharide GAG chains, there is 
relatively less information available concerning the molecular 
structure of the protein cores, mainly due to the denaturing 
conditions necessary in the purification procedures. Recent 
evidence suggests that protein cores are not unique entities but 
exist either as unsubstituted proteins or as proteoglycans. A 
240kDa protein from the surface of melanoma cells, was found to 
exist on its own or in association with chondroitin sulphate 
groups (Hassel et al, 1986). Fransson (1987) found that protein 
cores differed in terms of their molecular weight and biological 
properties. Recent evidence suggests a relationship between the 
protein core structure and the cellular distribution of 
proteoglycans. Antibodies to protein core determinants have shown 
cross reactivity between a range of basement membrane 
proteoglycans, for example yolk-sac carcinoma,
Engelbreth-Holmswarm (EHS) sarcoma, kidney, liver, skin and cornea 
basement membranes. Whereas antibodies against the rat liver 
membrane proteoglycans cross reacted with the cell surface but not 
with the basement membrane proteoglycans from either EHS sarcoma 
or parietal endoderm cells (Oohira et al, 1982; Fenger et al,
1984; Dziadek et al, 1985). This suggests that there may be two 
structurally dissimilar proteoglycan protein cores being 
synthesised in tissues with different distributions in vivo.
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1.6. Proteoglycan synthesis and degradation
Proteoglycans are synthesised either through altering 
existing proteoglycans or by synthesising totally new molecular 
species. New protein cores are synthesised in the rough 
endoplasmic reticulum, from where they are transported into the 
Golgi apparatus, for the addition of new GAG chains (Hassel et al, 
1986; Gallagher et al, 1986; Lindahl et al, 1986; Farquhar, 1985). 
The vast majority of post-translational modifications occur when 
the precursor protein is processed in the Golgi apparatus. These 
include one or more of the following:-
i) Addition of O-linked oligosaccharides onto appropriate serine 
and threonine residues.
ii) Addition of GAG chains onto serine and threonine residues.
iii) Conversion of high mannose N-linked oligosaccharides to 
complex forms.
iv) Possible processing of the protein by removal of portions of 
the polypeptide.
The newly synthesised proteoglycan can have a large variety of 
fates depending upon the cell type and function of the 
macromolecule. It may enter a storage granule for example, as 
heparin proteoglycan does in mast cells (Metcalf et al, 1980) or 
it may enter secretory vesicles where it may either be deposited 
on the cell surface as an intercalated, integral membrane 
component, as for heparan sulphate on rat liver plasma membranes 
(Kjellen et al, 1981), or, it may be secreted into the 
extracellular matrix as a structural component, for example 
heparan sulphate proteoglycan in glomerular basement membranes 
(Kanwar et al, 1981).
Surface proteoglycans can either be removed by being secreted 
into the matrix or by being endocytosed (Bienkowski and Conrad, 
1984). Two different endocytotic pathways have been elucidated, 
one with a half life of approximately 30 minutes, while the other 
has a half life of approximately 4 hours (Yanagishita and Hascal, 
1984). Only a small fraction of the cell's total surface 
proteoglycans are reported to be endocytosed, where they are
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either partially degraded in the endosome and then transferred to 
the Golgi apparatus or are totally degraded to monosaccharides, 
sulphate and amino acid moieties. Enzymatic degradation 
(Piepkorn et al, 1988) of proteoglycans requires the presence of 
glycosidases to cleave the GAG side chains and proteinases to 
degrade the core and link proteins.
2. Distribution of proteoglycans in vivo
Proteoglycans are either found in the extracellular matrix or 
associated with the plasma membrane where they are either 
intercalated into the membrane or bound to it as illustrated in 
Figure 24. 85% of cell associated proteoglycans are situated on
the external surface of the plasma membrane (Piepkorn et al,
1988).
2.1. Proteoglycans in the extracellular matrix
The extracellular matrix consists of a dense lattice of 
collagen and elastin containing proteoglycans and glycoproteins 
(Kramer and Vogel, 1981; Bosman et al, 1985). Heparan sulphate, 
heparin and a highly sulphated dextran sulphate have been 
implicated in playing a role in matrix stabilisation. Some in 
vitro data suggests that the binding of heparan sulphate to 
fibronectin is too weak to constitute a stable association in 
vivo. However, certain protease generated fragments of 
fibronectin were found to bind heparan sulphate more strongly than 
the intact molecule, implying that cryptic binding sites may exist 
which are only accessible after certain conformational changes in 
the fibronectin molecule. This conformational change may be 
induced by composition of the extracellular matrix.
2.2. Proteoglycan associated with the plasma membrane
(I) Proteoglycans intercalated with the plasma membrane
Recent evidence implies the existence of intercalated 
proteoglycans. A hydrophobic segment has been identified in the 
protein core associated with proteoglycans, which possesses the
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Taken from Fransson, 1987. Illustrates how
proteoglycans are attached to the plasma membrane. They 
are either found
(a) Intercalated: The proteoglycans may be an integral 
plasma membrane component anchored via a hydrophobic 
peptide segment.
(b) Bound to the plasma membrane either via:-
(i) The core protein.
(ii) Non-covalent bonds to a receptor in the 
plasma membrane.
(iii) The glycosaminoglycan side chains.
ability to span the plasma membrane, while the GAG groups are 
situated on the outside of the membrane (Rapraeger and Bernfield, 
1983; Norling et al, 1981; Kjellen et al, 1981). The existence of 
such a molecule has been ascertained from the following set of 
experiments:-
(i) Exogenous proteoglycans can be incorporated into artificial 
membrane vesicles illustrating the presence of a hydrophobic 
region.
(ii) Proteoglycans contain hydrophobic regions in the protein 
core, as seen from their adhesion to hydrophobic gel matrices.
(iii) Proteoglycans can be extracted from cells using 4M guanidine 
hydrochloride. Large aggregates can then be dissolved upon 
addition of detergents, thereby implying the presence of a 
hydrophobic region.
These protein cores are not unique to proteoglycans but are also 
found as free entities in the body. The above experiments provide 
indirect evidence for the presence of a hydrophobic region in the 
protein core. Direct evidence could be obtained upon identifying 
an intradomain region containing a lipophilic amino acid sequence. 
This type of proteoglycan was found to be resistant to trypsin 
digestion.
The intracellular proteoglycan concentration is thought to 
influence the physiological behaviour of the cell by acting 
indirectly via the nucleus. Unusually high concentrations of 
heparan sulphate fragments, rather than sulphated proteoglycans, 
were found to accumulate in the nucleus of hepatocytes at 
confluence. If the entry of heparan sulphate into the nucleus was 
inhibited, this resulted in the cell being unable to respond to 
contact inhibition (Ishihara et al, 1987). However recent 
evidence suggests that the proportion of GAGs endocytosed, 
compared to the net quantity produced by the cell, is very small 
(Fransson et al, 1987) and thus, the significance of nuclear 
localisation may be open to question.
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(II) Proteoglycans found bound to the plasma membrane
Proteoglycans are found bound to the plasma membrane (Figure 
24) through either:-
(a) Covalent links to an inositol-containing phospholipid in the 
plasma membrane. This type of binding was found, using 
endothelial cells, Chinese hamster cells and brain cells, to be 
reversible, and dependent on time, pH, ionic strength and 
temperature (Kjellen et al,1980; Oldenberg et al, 1979; Robinson 
and Gospodarowicz, 1984).
(b) The core protein or the glycosaminoglycan side chains.
Proteoglycan receptors have been identified on the plasma 
membrane by displacement studies, where endogenous GAGs are 
displaced by an alternative molecule, for example heparan sulphate 
proteoglycan can be displaced from its receptors by the addition 
of heparin (Kjellen et al, 1980). Heparin, heparan sulphate and 
iduronic-acid rich chondroitin sulphate were found to compete for 
the same receptor, while glucuronic-acid rich chondroitin sulphate 
and hyaluronic acid competed for a different receptor. These 
results suggest the presence of at least two distinct receptors 
for proteoglycans on the cells surface. However, it must be 
stressed that these experiments only suggest that these various 
compounds compete for the same receptor, but does not actually 
prove it. A good example where this suggestion was proved wrong, 
was seen when highly sulphated polysaccharides were thought to 
compete with low-density lipoproteins in cultured fibroblasts. 
However, upon analysis the LDL receptors were found to differ 
significantly from the GAG receptors (Goldstein and Brown, 1977). 
Such a result could be explained if a conformational change could 
occur, when a ligand binds to its receptor and results in the 
dissociation of a completely distinct ligand. Thus, care must be 
taken in analysing such data. From the proteoglycans position on 
the extracellular matrix and on the plasma membrane they are 
thought to influence cell adhesion, proliferation and migration. 
The ability of proteoglycans to bind to either the plasma membrane 
or the extracellular matrix is influenced by:-
(i) Electrostatic forces at physiological pH and ionic strength
-70-
(Underhill and Toole, 1980). With the exception of hyaluronic 
acid and keratan sulphate (which lack sulphate and carboxyl groups 
respectively), binding was found to increase with the degree of 
sulphation.
(ii) Molecular weight. Using hyaluronic acid moieties of 
different molecular weights, Underhill and Toole (1980) found that 
the larger molecular weight species bound more strongly to the 
surface of 3T3 cells than the lower molecular weight species.
They explained the higher affinity for large polymers in terms of 
multiple-site attachment, the larger the number of receptors 
interacting with the polymer then the stronger the attachment 
(Figure 25). However, Laurent et al (1986) carrying out a similar 
investigation denied that the above relationship was due to 
multiple binding sites. They explained the results in terms of 
multiple exclusion: the increased binding of the higher molecular 
weight species was due to a larger number of sequences being 
recognised along the oligosaccharide by the receptor.
(iii) The degree of ionisation of the side chains, that is the 
partition coefficient (Underhill and Toole, 1980; Lindahl and 
Hook, 1978).
(iv) Composition of proteoglycans. L-iduronic acid residues (for 
example, dermatan sulphate and heparan sulphate), were found in 
general to bind proteins to a greater extent than residues only 
containing D-glucuronic acid as the only uronic acid component 
(for example, chondroitin sulphate).
Each of these factors were found to influence binding, 
however the intact proteoglycan molecule was found to interact 
with proteins to a greater extent than their corresponding 
polysaccharide chains. This suggests that the three dimensional 
structure may be important in terms of their biological 
properties.
3. Biological activity of proteoglycans
The biological properties of proteoglycans are thought to be 
primarily due to the glycosaminoglycan residues attached to the 
protein core. There are on average 50-100 disaccharide repeat
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Figure 2 5
A schematic model of the multiple receptor 
occupancy model. The larger the size (and hence 
molecular weight) of the GAGs then the greater the 
number of receptors they interact with. Taken from 
Underhill .et al, 1900.
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Figure 2 6
A schematic drawing of a large proteoglycan aggregate in 
cartilage of about 100 proteoglycans (taken from Stryer, 
1901).
units in each GAG chain. Glycosaminoglycans, with the exception 
of hyaluronic acid, are not found to exist in the native form as 
free entities but are found bound to proteins as proteoglycans. 
These molecules exist in vivo as aggregates which can either be 
made up of one GAG group, or a combination of different groups 
(Figure 26). Heterogeneity is introduced into the proteoglycan 
molecule, as the GAG chains themselves differ in terms of 
molecular weight, charge and in both the quantity and spatial 
arrangement of the hydroxyl, sulphate and carboxyl chains (Table 
9). The situation is even more complicated as GAG chains have 
been found to contain more than one GAG group. Sequences for both 
chondroitin sulphate and dermatan sulphate have been found to 
exist on the same GAG chain in mouse mammary epithelial 
proteoglycans (Rapraeger et al, 1985).
Before the profile of proteoglycans in malignant tissues can 
be analysed in terms of abnormal behaviour, the GAG profile of 
normal cells needs to be investigated in relation to the following 
criteria:-
(i) The degree of cellular maturation,
(ii) Differences between the logarithmic and stationary phases of 
the growth cycle.
(iii) The relationship between the composition of the 
extracellular matrix, cell shape and proteoglycan production.
(iv) The relationship between cell adhesion and the proteoglycan 
profile.
3.1. Proteoglycan profile in relation to cell maturation
Upon correlating proteoglycan production with malignancy, 
many investigators have omitted to take into consideration the 
stage of tissue maturation and age of the tissue, resulting in an 
unjustified over-generalization of results. Giant et al (1986) 
reported that normal cartilage showed age-related differences in 
terms of proteoglycan composition. Roughly and White (1980) 
reported that the change from foetal to the mature adult state 
occurred through a gradual transition rather than a sharp 
alteration. As cartilage tissue becomes more mature the following
Table 9
Piffcrences_in_r.c.lation to charge and molecular 
yvcight of proteoglycans
Polysaccharide 1 Mol. wgt. 
Range xIO^
Charge/
Disaccharide
unit
Site of 
occurancc
Hyaluronic
acid
4000-0000 1
synovial
fluid,
vitreous humor
Chondroitin-6-
sulphatc
5-50 1-2-2-3 Cartilage,
bone
Chondroitin-4-
sulphate
5-50 1-1-2-0 Cartilage,
bone
Dermatan
sulphate
15-40 2-0-2-2 Skin, heart 
valves
Heparan
sulphate
50 1-1-2-0 Lung, liver
Heparin j 4-16 3-4 Lung, liver
Illustrating the range in molecular weight and 
charge of proteoglycans, along with an example of where 
each proteoglycan is found in the body. The variation 
in "charge density" essentially resides in the sulphate 
content. Taken from Compel* et al, 1978.
changes are prominent:-
i) Proteoglycan content of the cartilage decreases.
ii) Size of the proteoglycan subunits decreases.
iii) The proportion of keratan sulphate relative to chondroitin 
sulphate proteoglycans increases.
iv) 6-sulphation relative to 4-sulphation along the chondroitin 
sulphate chains increases.
v) The relative proportion of protein present relative to GAG 
chains increases.
These results stress that when comparing proteoglycan composition 
in tissues, it is important to take the maturation state and age 
of the tissue into account when reporting results. Unfortunately, 
determining the degree of maturation of the cells under 
investigation in vitro is not always possible as the parent cell 
lineage is seldom known. Some investigators have overcome this 
problem by either using chemically (Rabes et al, 1970) or virally 
transformed cell lines (Roblin et al, 1975), thereby producing 
both normal and transformed cells of similar age in terms of 
tissue maturation. However, it is questionable to what extent 
such transformants actually resemble the cells present in 
spontaneous tumour formation.
3.2. The relationship between cell proliferation and proteoglycan 
profile
Conflicting evidence exists about whether proliferation can 
influence proteoglycan production independently of cell shape. 
Extensive cell proliferation in vivo often takes place within a 
hyaluronic acid enriched environment (Toole, 1981). Greater 
quantities of cell-associated hyaluronic acid and lower quantities 
of sulphated proteoglycans have been found to be produced from 
both proliferating normal and transformed cells, compared to their 
corresponding resting cells (Glimelius et al, 1979). However, 
some investigators (e.g. Cohn et al, 1976) have not found this 
difference. Along with proliferation influencing the quantity of 
proteoglycans being produced, alterations in the actual structure 
of these molecules has also been noted. Heparan sulphate produced
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by cells during the log phase, generally consists of simple, 
unbranched molecules while the same GAG produced during the 
stationary phase comprises a longer, more highly branched 
structure.
Heparan sulphate has been implicated in inhibiting cell 
proliferation as illustrated in the following example. 
Proliferation was drastically decreased when normal fibroblasts 
were plated onto confluent, glutaraldehyde fixed fibroblasts. 
Pretreating the latter substrata with heparitinase enabled the 
fibroblasts to continue proliferating (Culp et al, 1978). Kraemer 
and Tobey (1972) showed that a specific shedding of cell-surface 
associated heparan sulphate occurred immediately before Chinese 
hamster ovary cells divided thus implying that the heparan 
sulphate proteoglycan is associated with inhibition of cell 
proliferation. However it is not clear whether a change in cell 
shape was evident in the latter experiment.
Therefore, in order to compare proteoglycan production in any 
tissue, consideration must be given to the substrata involved, the 
cell's shape, state of maturation and whether the cells are in 
logarithmic or stationary phase of their growth cycle. These 
factors are important in normal tissues and need to be taken into 
consideration when making any correlation between proteoglycans 
and malignancy.
3,3. Proteoglycan production and cell shape.
A complicated relationship exists between cell shape and 
proteoglycan production (Folkman and Moscona, 1978). The cells 
synthesise and release the proteoglycans which are structural 
components of the extracellular matrix. Plating normal 
chondrocytes onto a substratum coated with increasing 
concentrations of poly-2-hydroxylethyl methacrylate (polyHEMA) 
caused cell spreading to be progressively restricted, while 
proteoglycan production was enhanced (Glowachi et al, 1983).
Hence, upon inhibiting cell spreading the quantity of 
proteoglycans being synthesised was increased. Along with the 
substrata influencing the quantity of proteoglycans being
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synthesised, the composition of these proteoglycans can also be 
affected, as shown by the following example. Human skin 
fibroblasts cultured on collagen gels produced two species of 
dermatan sulphate, one enriched in iduronic acid residues which 
binds specifically to collagenous fibres of the gel and the other 
enriched in glucuronic acid which is excreted from the cell in 
vitro. Both types of proteoglycans were also produced by cells 
grown on plastic, however in this environment they were both 
released into the growth medium. Net synthesis of dermatan 
sulphate was three fold higher on collagen gels than on plastic.
In contrast, heparan sulphate synthesis was not influenced by the 
nature of the culture surface (Gallagher et al, 1983).
This relationship between cell shape and proteoglycan 
production is more complicated than depicted above as the 
proteoglycan composition of the extracellular matrix can have a 
profound effect on cell shape. In the presence of high 
concentrations of extracellular hyaluronic acid, the cells have a 
more rounded appearance, while in the presence of heparan sulphate 
proteoglycan they take on a more flattened appearance. Thus, an 
intricate system is set up where cell shape can influence 
proteoglycan production, which in turn can influence the 
composition of the extracellular matrix, which may affect cell 
shape etc. Hence, the relationship between cell shape, 
proteoglycan production and the composition of the extracellular 
matrix is complex.
3.4. The relationship between proteoglycan profile and cellular 
adhesion
Cellular adhesion has been found in vivo to be favoured by 
the presence of either heparan sulphate or low concentrations of 
hyaluronic acid and inhibited by high concentrations of hyaluronic 
acid. Biochemical analysis of cellular adhesive sites to the 
substrata showed that its proteoglycan composition altered in 
relation to age (Lark and Culp, 1984). High concentrations of 
heparan sulphate were found in the relatively newer sites, 
implying a relationship between the concentration of heparan
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sulphate and the binding force of the cell. Cellular migration 
may therefore be favoured by the weaker binding forces present at 
the older adhesion sites due to lower heparan sulphate 
concentrations.
The above results may be explained in the following way. 
Hyaluronic acid possesses an unique ability among GAGs, to form 
aggregates due to the presence of multiple binding sites.
Underhill and Toole (1980) found that these aggregates could be 
inhibited by either hyaluronidase (total inhibition was obtained 
in the absence of divalent cations such as Mg^+,Ca^+) or high 
concentrations of hyaluronic acid. In addition to hyaluronic 
acid, chondroitin, (desulphated chondroitin-6-sulphate) and to a 
smaller extent dermatan (desulphated dermatan sulphate), also 
inhibited cellular aggregation. However, chondroitin-4-sulphate, 
chondroitin-6-sulphate, heparin and heparan sulphate had little or 
no effect on cellular aggregation (Underhill and Dorfman, 1978). 
The cell's binding affinity in vivo has been postulated as being 
much weaker in the presence of high concentrations of hyaluronic 
acid. Such conditions in foetal tissues have been found to be 
essential for cell migration (Toole, 1981). Hence, it may be that 
when the cell binds to the substrate through the hyaluronic acid 
receptors, by occupying these sites the tissues may be more prone 
to migrate due to the lack of adhesive forces to the substratum.
3.5. How can these alterations in proteoglycan composition affect 
growth control?
Proteoglycans are found to interact with the cytoskeleton, 
which, as discussed in the sections 1.3. and 1.4. in the 
introduction, can affect cell shape and gene transcription. 
Proteoglycans have been found to bind directly to collagen fibres 
and actin stress filaments within the cell, indicating a direct 
means of communication between structural elements of the stromal 
and cytoplasmic matrices. They may also act indirectly via other 
components such as cartilage link proteins, which have an affinity 
for collagen, laminin and fibronectin. The latter glycoprotein, 
as mentioned in section 6 in the introduction, can interact
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directly with actin stress filaments. Thus there is a complex 
series of interactions where intercalated proteoglycans may 
interact with intracellular actin, or extracellular proteoglycans 
may interact with structural glycoproteins such as fibronectin, 
which in turn can interact with actin filaments (Hook, 1984; Woods 
et al, 1984). This results in an intricate system involving 
proteoglycans by which information can be sent from the 
extracellular matrix into the cell and vice versa (Figure 27).
4. THE RELATIONSHIP BETWEEN PROTEOGLYCAN PRODUCTION AND MALIGNANCY
4.1. Proteoglycan production in malignant tissues
Malignant glioma lines in comparison to their normal 
counterparts were found to produce greater quantities of 
hyaluronic acid and lower quantities of sulphated proteoglycans.
In general higher concentrations of hyaluronic acid compared to 
sulphated glycosaminoglycans are associated with malignant 
tissues, hamster embryo fibroblasts and for most oncogenic lines 
derived by virus transformation by the Herpes Simplex Type-2 or 
Simian Virus-40. In comparison Chandrasekaran and Davidson (1979) 
found that the opposite relationship existed with breast tissue.
By modifying the mode of proteoglycan extraction, Glimelius et al 
(1978) compartmentalised the differences between glioma and normal 
glia cell lines as illustrated in Table 10. Glimelius et al 
(1978, 1979) found that the majority of proteoglycans produced by 
normal brain cells in vitro were cell-associated, while in 
malignant cells a larger proportion of this proteoglycan was 
released into the surrounding medium. Proteoglycan production in 
terms of quantity and distribution, for both normal and malignant 
tissues, may be influenced by the way in which the cells are 
handled, but are neverless tissue specific. Various investigators 
have found that the net production and distribution of 
proteoglycans in vitro were relatively similar among normal cell 
lines, whereas malignant lines seemed to display more individual 
characteristics (Chandrasekaran and Davidson, 1979). Glioma cell 
lines in vitro produce higher concentrations of hyaluronic acid
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Figure 27
A schematic diagram of how cell associated 
proteoglycans may alter the type of proteoglycans being 
synthesised by the cell. Adapted from Fransson, 1987. 
Abbreviations are:- RER,rough endoplasmic reticulum; 
SER., smooth vesicles; SV., secretory vesicles. The 
proteoglycans which are assembled in the golgi are 
either released by the cell where they can bind to 
membrane receptors or are intercalated into the cell 
membrane. The cell can alter its proteoglycan 
by endocytosing the surface proteoglycans, degrading 
them in the endosome and synthesising the new 
proteoglycans required. The above process may be 
controlled by the interaction of proteoglycans either 
directly or indirectly via the actin filaments which can 
in turn affect the array of nuclear tubules.
Figure27
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Table 10 Distribution of proteoglycans in glia and glioma cell 
lines as reported by Glimelius et al, 1979.
Compartmen t/ 
Enzymes or 
chemicals used
Glia Glioma ,
EDTA resis tent 
material i.e. 
matrix left on 
culture dish.
High conc. 
of Heparan 
sulphate
Reduced amounts 
of heparan sulphate
Medium High conc. 
of dermatan 
sulphate.
'
Higher-conc. of 
hyaluronic acid 
and reduced 
amounts of 
dermatan sulphate.
Trypsin
susceptible
Mainly heparan 
sulphate, minor 
quantities of 
various GAGs.
Hyaluronic acid 
predominant, whereas 
chondroitin sulphate 
rather than heparan 
sulphate was the 
predominant sulphated 
GAG.
EDTA+Trypsin Heparan sulphate 
was the dominant 
sulphated GAG.
Chondroitin sulphate 
rather than heparan 
sulphate was the 
predominant sulphated 
GAG.
and release a larger proportion of proteoglycans into the medium 
compared to normal glia.
4.2. The relationship between malignancy, proteoglycan production 
and cell shape
Cell shape, as seen in section 3.3 can dramatically influence 
the proteoglycan profile in normal cells, which in turn may affect 
the physiological behaviour of the cells. As discussed in the 
general introduction, malignant cells are thought to resemble 
immature foetal cells in terms of both cell shape and 
physiological properties. Therefore, it is reasonable to propose 
that malignant cells are only abnormal in respect that they are 
expressing foetal properties at an abnormal period of time. These 
processes themselves are not unique but appear to be not as 
tightly regulated. Such an effect was seen upon comparing 
proteoglycan composition of malignant and foetal cells. Both cell 
types were found, by a number of investigators, to contain larger 
quantities of hyaluronic acid compared to their normal mature 
counterparts (Satoh et al, 1973). Turley and Tretiak (1985) using 
B-16 melanoma metastatic cell lines found that hyaluronic acid was 
concentrated at the tumour-stromal interface. Hyaluronic acid has 
the ability to absorb large quantities of water, which results in 
the proteoglycans swelling. This may account for the more rounded 
appearance of both foetal and malignant cells, which in turn would 
reduce the quantity of the cell's surface in contact with the 
substrata. This may explain the reported lack of adhesion by both 
neoplastic and foetal cells. In support of this hypothesis is the 
finding that high concentrations of hyaluronic acid are essential 
for migration of immature cells to their site of differentiation 
(Toole, 1981).
High concentrations of hyaluronic acid have also been 
associated with the malignant cell's undifferentiated appearance 
and its ability to invade into surrounding tissues as illustrated 
by the following examples. High concentrations of hyaluronic acid 
were found to inhibit differentiation of chick somite cells as 
seen through the lack of morphological signs of chondrogenesis
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(Toole, 1972). However, differentiation was found to occur if the 
concentration of hyaluronic acid was enzymatically reduced.
Turley and Tretiak (1985), using melanoma cells, found a 
correlation between the cell's invasive potential and an increase 
in the concentration of hyaluronic acid.
Thus, the above hypothesis relating high concentrations of 
hyaluronic acid to the cells malignant behaviour is quite 
attractive, as it explains the tendency of malignant cell's to 
migrate from their site of origin, their more rounded, 
undifferentiated appearance and their ability to invade 
surrounding tissues. However, other investigators have either 
found the reverse to be true (Cohn et al, 1976) or no correlation 
at all (Davidson et al, 1975), but this may be a consequence of 
the type of cells used in their investigations.
4.3. The correlation between the extent of sulphation of 
glycosaminoglycan groups and malignancy
Malignancy has been correlated with either an over or under 
sulphation of proteoglycans (Kraemer, 1979; Hook, 1984). For 
example, the reduced binding affinity of rat hepatoma cells to a 
fibronectin-sepharose column has been correlated with the presence 
of undersulphated heparan sulphate (Robinson and Gospodarowicz, 
1984). Disruption of the extracellular matrix in vitro has been 
associated with the presence of undersulphated proteoglycans as 
illustrated in the following example. Rat cells transformed by a 
temperature sensitive mutant of the Rous Sarcoma Virus were found 
to synthesise all the extracellular matrix components 
(fibronectin, laminin, heparan sulphate and slightly reduced 
quantities of procollagen), but were unable to lay down a matrix 
(Alitalo et al, 1982). Upon investigating the difference between 
normal and virally infected cells, the latter cells were found to 
produce undersulphated heparan sulphate. This proteoglycan has 
been implicated in matrix stabilisation (Gallagher et al, 1986). 
This may be due to multiple co-operative interactions between 
proteoglycans and collagen, fibronectin and laminin molecules. A 
good example of this is seen in rheumatoid arthritis, where
proteoglycan degradation (which is reversible) can lead to 
irreversible cartilage degradation (Handley et al, 1985). Hence, 
any abnormalities in proteoglycan structure may affect the 
structure of the extracellular matrix which can influence the 
physiological behaviour of the cell.
4.4. Correlation between the malignant cell's invasive capacity 
and proteoglycan degradation
A major characteristic of malignant cells compared to their 
benign counterparts, is their ability to invade surrounding 
tissues either through mechanical or enzymatic mechanisms (Barsky 
et al, 1983). This invasive property can be visualised in vitro 
by plating both malignant and normal cells onto a prelabelled 
matrix (Vlodavsky et al, 1983). Degradation of the extracellular 
matrix by the malignant cells, but not by their normal 
counterparts, was visualised by the appearance of radioactive 
material in the growth medium. This disruption of the structure 
of the extracellular matrix is thought to occur by activation of 
degradative enzymes such as plasminogen activators, collagenases 
and proteoglycanases. High levels of plasminogen activator (PA) 
have also been associated with a loss of anchorage regulation in 
primary rat embryo cells transformed by Simian Virus-40 (Pollack 
et al, 1974). Ossowski and Reich (1983) have associated a 
reduction in PA activity with a reduction in metastasis. Thus, 
the high levels of PA activity may be necessary for the cells to 
invade the surrounding tissues. Laug, 1983 and Frame et al, 1984 
have shown that glucocorticoids can inhibit PA production in 
endothelial and glioma cells respectively. Thus, it could be 
postulated that this reduction in PA activity cause a reduction in 
the invasive capacity of malignant cells.
5. Aim of chapter
Interactions of cell associated proteoglycans with their 
microenvironment have been shown to be important for normal cell 
growth and development, and for the maintenance of differentiated 
functions. An intricate balance exists where proteoglycan
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production is influenced by cell shape, state of proliferation and 
the degree of sulphation, which in turn can influence the 
physiological behaviour of the cell. It was asked whether the 
immature characteristics of malignant cells were related to their 
proteoglycan composition. This led to the hypothesis that 
induction of differentiation in malignant cells with drugs such as 
glucocorticoids may alter the proteoglycan composition of the 
malignant cells to resemble that of there mature counterparts, 
this would explain the re-expression of contact inhibition as 
observed in Chapter 2. This hypothesis will be investigated in 
this chapter by looking at the effect of glucocorticoids on 
proteoglycan composition and comparing the results with those of 
normal glia reported by Glimelius et al (1979).
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Materials and Methods
1. Extraction of cell surface and extracellular matrix 
glycosaminoglycans (Gallagher et al, 1983)
2Cultures of human glioma lines were grown in 75cm flasks 
until 70% confluent. The cells were then grown in either the
_5
presence or absence of 2.5x10 M dexamethasone or 
methylprednisolone for 5 days. In order to ensure that the medium 
did not become the rate limiting factor of proliferation, it was 
changed every two days. The cells were then incubated with medium
3
containing 5uCi/ml of [ H] glucosamine (29Ci/mMol; NEN) for 48 
hours. The glycosaminoglycans produced by the cells were 
subdivided according to the following extraction procedure.
(i) Medium extract
The medium was collected along with the two PBS washes of the 
cell monolayer.
(ii) Collagenase fraction
The cell monolayer was then incubated at 37^C for 20 minutes 
with 3 ml of 0.05mg/ml of collagenase solution (grade IV, 
Boehringer) in Eagle's minimal essential medium containing serum 
albumin (O.lmg/ml). The enzyme supernatant was then removed and 
stored with two subsequent PBS washes of the cell monolayer.
(iii) Trypsin extract
The cell monolayer was then incubated with 3ml of 50 yg/ml 
trypsin (Worthington, 3x crystallised) and 2mM EGTA for 15 minutes 
at 37^C and the reaction was terminated by the addition of 
0.25mg/ml of soya bean trypsin inhibitor. The solution was then 
centrifuged and the trypsinate was collected. The cell suspension 
was then washed twice with PBS by centrifugation and these washes 
were then added to the trypsinate fraction.
(iv) Cell pellet
The pelleted cells were re-suspended in PBS and treated with 
papain as described below.
(v) Papain digestion
The medium, collagenase and trypsinate fractions were
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dialyzed exhaustively against distilled water and the volume was 
reduced by using PEG 6000. These extracts were then dialyzed 
against 50mM sodium phosphate buffer pH 6.8 containing ImM NaCl, 5 
mM cysteine and ImM EDTA. The cell pellet fraction was also 
suspended in this buffer, and incubated in the presence of
O.lmg/ml of papain overnight at 60^C, followed by a further 
incubation of 50yg/ml of papain for 4 hours. These various 
extracts were then dialyzed against distilled water and 
concentrated using PEG 6000.
The various GAG groups in the above extracts were separated 
and identified at 4^C using a DE52 column (25cm x 1cm) and the 
various GAG groups were identified according to the NaCl 
concentration at which they eluted. The experimental set-up is 
illustrated in Figure 28. The apparatus consists of two flasks 
with a side arm containing 250ml of 1M NaCl and 0.1M NaCl in 20mM 
sodium phosphate buffer, pH6.8. The side arms of the two flasks 
were connected together with a rubber tube containing a clip to 
initially separate the contents of both flasks. Both solutions 
were stirred continuously with a magnetic stirrer. The sample was 
loaded onto the column in phosphate-buffered saline 
(0.lMNaCl/lOmM sodium phoshhate buffer, pH6.8), equilibrated in 
the same buffer and sufficient volumes of the equilibration buffer 
was passed through to remove the unbound material. The bound 
radioactivity was eluted by the NaCl gradient which was set up by 
opening the clip and pumping the solution, at a rate of 20ml/hour 
from the flask containing the lower NaCl concentration. Elution 
volumes of 2ml were collected using the automatic fraction 
collector. The salt concentration in the elution volumes was 
determined by comparing the conductivity reading with those from a 
NaCl standard curve. A 1ml aliquot of each sample was added to 10 
ml of Ecoscint and read on the scintillation counter. The counts 
per fraction were then plotted against fraction number. The 
quantity of each GAG group present was estimated from the graph by 
adding up the absolute counts in each of the fractions making up 
the peak. The individual GAG groups were identified from the NaCl 
elution concentrations as stated by Glimelius et al 1983.
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2. Identifying individual GAG groups using a cellulose acetate
electrophoretic technique (King, 1985)
In an attempt to identify the different peaks obtained from 
the DE52 column, each peak was collected, lyophilysed and 
resuspended in approximately 500pl of electrophoresis buffer. The 
cellulose acetate sheets (Cellogel), stored in 30% methanol, were 
soaked in electrophoresis buffer (0.05M phosphate buffer pH 7.2) 
for 5 minutes and the excess buffer was removed by blotting. 2yl 
of the sample was applied in 0.5ul aliquots, allowed to soak into 
the gel and then re-applied. These radioactive samples were then 
electrophoresised at 30mA for approximately 1 hour or as long as 
it took the Bromophenol Blue front to reach the other end of the 
gel. The gels were then stained with 1% (w/v) Alcian blue 8GX 
(Sigma) in 1:1 (v/v) ethanol/0.05M acetate pH5.8 for 10-15 
minutes, and destained using 5% acetic acid/10% ethanol. To
2determine the GAG composition, each sample lane was cut into 1 cm 
strips which were placed into counting vials. The strips were 
dissolved overnight using 1ml of 80% (v/v) acetic acid and were 
then counted in 10 ml of Ecoscint in the scintillation counter.
The quantity of hyaluronic acid present in the extract was 
taken to be the proportion of material susceptible to Streptomyces 
hyaluronidase (Sigma). 25pl of extract was treated with 10 units 
of S. hyaluronidase in a buffer consisting of 0.0375M sodium 
acetate/0.0375M NaCl pH5.4 and the incubation volume was lOOpl.
The proportion of heparan sulphate present was taken to be
the proportion of material resistant to treatment with
chondroitinase ABC (Sigma) but susceptible to subsequent treatment
with nitrous acid (HN02)* lOOpl samples of culture fluids were
mixed with lOOpl of 5.7M acetic acid and lOOpl of 0.75M NaN0« and
0left at room temperature (22 C) for 80 minutes. The reaction was 
inhibited by the addition of lOOpl of 0.1M ammonium sulphamate. 
Controls were prepared by adding the test sample only after 
inactivation of the reaction mixture with sulphamate. Chondroitin 
sulphate was identified as the proportion of material resistant to 
HNO2 and chondroitinase AC digestion. 100yl samples of extract 
was mixed with 0.1 unit (where 1 unit is that amount of enzyme
which converts O.lpmol of substrate per minute), of chondroitinase 
AC (Sigma) in 300iil of 0.08M NaCl/0.06M sodium acetate/0.01M Tris 
HC1, pH8.0 containing 170pg of bovine serum albumin* The reaction 
mixture was incubated at 37^C for 6 hours and was stopped by 
heating the mixture to lOO^C for 2 minutes. Finally, dermatan 
sulphate was estimated as the proportion of labelled material 
resistant to treatment with HNO2 and chondroitinase AC (Sigma) but 
susceptible to chondroitinase ABC (Sigma).
3.Investigating the malignant cell's adhesion force to the 
substrata in the presence and absence of glucocorticoids.
Cells were grown to confluence in N25 flasks using growth 
medium, F10:DMEM (1:1), containing 10% foetal calf serum. The 
cells were then grown for a week in growth medium containing 1%
_5
foetal calf serum containing either 2.5x10 M of dexamethasone or 
methylprednisolone. The cell monolayer was then dissociated using 
either EDTA or 0.25% trypsin. The cells were harvested in growth 
medium containing 1% foetal calf serum and this cell extract was 
then transferred into capillary tubes (Camlab) using a Gilson 
pipette. These capillary tubes were incubated in a humidified 
incubator at 37^C, at various times these capillary tubes were 
inverted for 30 minutes and the number of cells adhering to the 
1 top” surface were expressed as a percentage of the total number 
of cells in that field.
4. Investigating the ability of glioma cell lines to digest a 
prelaid extracellular matrix. (Vlodavsky et al, 1983)
The method used to lay down a prelabelled extracellular
matrix is that reported by Vlodavsky et al. (1983). Normal
endothelial cells were grown to confluence in 50mm petri dishes.
Upon reaching confluence, the cells were fed every two days with
3
growth medium containing [ H] glucosamine. This overcame the 
possibility of the medium becoming exhausted of nutrients and 
label. The labelled extracellular matrix was then isolated by the 
following method. The cell monolayer was washed with PBS and then 
exposed to 0.5% Triton X-100 in PBS (v/v) for 30 minutes. The
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latter treatment dissolved the cell layer leaving the underlying 
extracellular matrix intact. The remaining nuclei and 
cytoskeletons were then removed by a 2-3 minute exposure to 0.025M
NH.OH followed by four PBS washes. Malignant cells were then
4 2plated at a concentration of 2x10 cells/ml (320 cells/cm ) onto
the above pre-labelled matrices. Experiments were carried out in
medium containing either 10% and 1% FCS. 1ml samples of the
medium were taken at various time points, added to 10 ml of
Ecoscint and counted in the scintillation counter. The results
were then expressed as the total quantity of label released by the
cells compared to a control plate which only contained the
appropriate growth medium.
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RESULTS
1. Proteoglycan profile in relation to the presence/absence of 
glucocorticoids
Both dexamethasone and methylprednisolone were found in
Chapter 2 to reduce malignancy associated characteristics, i.e.
elevated saturation densities and plasminogen activator activity
in glioma cell lines. In this chapter, the proteoglycan profile
was investigated in the presence or absence of either
dexamethasone or methylprednisolone and related to the cells'
physiological behaviour. The proteoglycans were isolated
according to the method described in the methods section.
Pre-treating the cells with glucosamine resulted in all the
carbohydrate groups of glycosaminoglycans, glycoproteins and
35glycolipids being labelled. If S had been used, this would have 
labelled preferentially all the glycosaminoglycans groups with the 
exception of hyaluronic acid. As the latter glycosaminoglycan 
group is important in the present study, the former method was 
used in labelling the glycosaminoglycan groups and they were 
separated using a DE-52 column.
The glycosaminoglycan groups were found to elute at the
following salt concentrations: hyaluronic acid at 0.26-0.3M NaCl;
heparan sulphate at 0.4M NaCl, while dermatan sulphate eluted at
0.5M NaCl. An initial identification was carried out by
collecting the eluted peaks, concentrating them and then treating
each peak with various enzymes as described in section 2 in the
Methods section. These solutions were then run through the column
again in an attempt to determine whether the various peaks had
been degraded. As this was a time-consuming process, the peaks
were also identified on cellulose acetate gels. Standards were
obtained, dermatan sulphate and chondroitin sulphate were found to
comigrate, and could only be clearly identified by pretreating
them with the enzymes described above. Unfortunately, hyaluronic
acid purchased from Sigma produced a very diffuse band on
: Dr, C.R.C.
cellulose acetate gels. After consultation withAKing, (^ Harrow), 
it was decided to use hyaluronic acid purchased from Life
Sciences, which was of a much purer quality. According to results 
published by King (1985), this glycosaminoglycan group should 
migrate in front of the sulphated glycosaminoglycans, however, 
this product could not be obtained during the duration of these 
experiments.
The proteoglycan composition of the medium, trypsinate,
collagenase and cell pellet fractions of the cell was investigated
in the presence or absence of either dexamethasone or
methylprednisolone. The cells were pretreated with either
dexamethasone or methylprednisolone for 6 days, then labelled with 
3
[ H] glucosamine for 48 hours (for details see methods section). 
Figures 29 to 31 illustrates the data obtained from both the 
medium and trypsinate fractions of cell line G-CCM. The 
collagenase and cell pellet fractions were found to possess very 
low counts. As these counts were not much higher than the 
background of the scintillation counter it was decided that the 
errors involved in these results were too large, thus these 
fractions were not further considered.
2. Radioactivity eluting in the void volume
In each extract (medium and trypsinate) a proportion of the 
labelled material was eluted in the void volume before the 
gradient was applied, this was comprised in some cases of one or 
more peaks (Figures 29 to 31). These elution peaks were found to 
contain protein as determined from a Bradford assay and from its 
absorbance at 280nm. In the presence of dexamethasone or 
methylprednisolone, the quantity of the material eluting in the 
void volume was reduced. This material may consist of either 
glycoproteins or glycolipids as these molecules are also labelled 
with exogenous glucosamine. Alternatively, it may comprise of 
partially degraded proteoglycans or the protein cores of the 
sulphated proteoglycans.
3. Proteoglycan profile of the medium fraction
Figure 32 illustrates quantitatively the data from 
fractionating the medium of the cell lines as described in the
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Figure29
Fractionation of radiolabellecl glycosaminoglycans by 
chromatography on DEAE-cellulose.
The glycosaminoglycans in the medium extract of 
cell line G’-CCM were elluted from a DEAE cellulose 
column with a linear gradient of 0.1-0.8M NaCl in 20mM 
sodium phosphate buffer. pH6.8. Peak II was identified 
as hyaluronic acid, peak III was thought to be heparan 
sulphate while peak IV was either dermatan sulphate or 
chondroitin sulphate.
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Figure 30
Fractionation of radiolabelled glycosaminoglycans by 
chromatography on DEAE-cellulose.
The composition of glycosaminoglycans in the presence and 
absence of either dexamethasone or methylprednisolone in cell line 
BG84/5 was determined using a DE-52 column with a linear gradient 
of 0.1-0.8M NaCl in 20mM sodium phosphate buffer, pH6.8. Peak II 
was identified as hyaluronic acid, peak III was thought to be 
heparan sulphate while peak IV was either dermatan sulphate or 
chondroitin sulphate.
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Fractionation of radiolabelled glycosaminoglycans by 
chromatography on DEAE-cellulose.
The glycosaminoglycans in the medium extract of 
cell line BG105/5 were elluted from a DEAE cellulose 
column with a linear gradient of 0.1-0.8M NaCl in 20mM 
sodium phosphate buffer. pll6.8. Peak II was identified 
as hyaluronic acid, peak III was thought to be heparan 
sulphate while peak IV was either dermatan sulphate or 
chondroitin sulphate.
methods section. Four peaks were isolated (numbered I, II, III 
and IV) as illustrated in Figures 29-31). Peak II was identified 
as hyaluronic acid, peak III heparan sulphate and peak IV dermatan 
sulphate or chondroitin sulphate according to their NaCl elution 
profiles. Peak I which absorbed at 280nm appeared at the 
beginning of the NaCl gradient and was not associated with the 
void volume peaks. As the relative proportion of the different 
glycosaminoglycan groups present was considered to be important in 
relation to cell's physiological activity, the quantity of the 
different glycosaminoglycans groups was expressed as a proportion 
of the total quantity of counts in fractions I-IV.
The data was expressed quantitatively by adding all the 
sample points (cpm/10 cells) within one peak as illustrated on 
Figures 29-35 and expressing the results as a percentage of the 
total counts in that fraction. These results suggest that
_5
dexamethasone and methylprednisolone (at 2.5x10 M) increased the 
quantity of peak I, decreased peak II (hyaluronic acid) and 
increased peaks III and IV. Dexamethasone was seen to have a 
greater effect than methylprednisolone. Thus, both 
methylprednisolone and dexamethasone were found to decrease the 
quantity of hyaluronic acid while increasing the quantity of 
sulphated glycosaminoglycans in the medium extract of cell line 
G-CCM.
In the medium extracts from the early passage cell lines only 
peaks II-IV were dominant after the addition of the NaCl gradient, 
as identified from their elution profiles. Thus the results were 
expressed as a percentage of the total counts in peaks II-IV.
Once again, both dexamethasone and methylprednisolone were found 
to decrease the quantity of hyaluronic acid in the medium while 
increasing the relative quantity of sulphated glycosaminoglycans.
4. Proteoglycan profile of the trypsinate fraction
Figure 36 illustrates quantitatively the proteoglycan profile 
in the trypsinate fraction of both early passage and continuous 
cell lines in the presence and absence of either dexamethasone and 
methylprednisolone. This fraction represents the proportion of
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Figure 32
Illustrates quantitatively the area under the different 
glycosaminoglycan peaks in the medium fraction. The
results were worked out by counting up all the
radioactive counts in each peak and expressing them as a
percentage of the total counts for peaks I-IV.
Peak I is unknown, peak II is hyaluronic acid, peak H I  
is heparan sulphate, peak IV is either dermatan sulphate 
or chondroitin sulphate.
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Figure33
Fractionation of radiolabelled glycosaminoglycans by 
chromatography on DEAE-cellulose.
The composition of glycosaminoglycans in the presence and 
absence of either dexamethasone or methylprednisolone in the 
trypsinate extract of cell line BG-CCM was determined using a 
DE-52 column with a linear gradient of 0.1-0.8M NaCl in 20mM . 
sodium phosphate buffer, pII6.0. Peak II was identified as 
hyaluronic acid, peak III was thought to be heparan sulphate while 
peak IV was either dermatan sulphate or chondroitin sulphate.
The NaCl gradient is switched on at 'f •
Figure34
Fractionation of radiolabelled glycosaminoglycans by 
chromatography on DEAE-cellulose.
The composition of glycosaminoglycans in the presence and 
absence of either dexamethasone or methylprednisolone in the 
trypsinate extract of cell line BG84/5 was determined using a 
DE-52 column with a linear gradient of 0.1-0.8M NaCl in 20mM 
sodium phosphate buffer, pII6.8. Peak II was identified as 
hyaluronic acid, peak III was thought to be heparan sulphate while 
peak IV was either dermatan sulphate or chondroitin sulphate.
The NaCl gradient is switched on at ^
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Figure 35
Fractionation of radiolabelled glycosaminoglycans by 
chromatography on DEAE-cellulose.
The composition of glycosaminoglycans in the presence and 
absence of either dexamethasone or methylprednisolone in the 
trypsinate extract of cell line BG105/5 was determined using a 
DE-52 column with a linear gradient of 0.1-0.8M NaCl in 20mM 
sodium phosphate buffer, pII6.8. Peak II was identified as 
hyaluronic acid, peak III was thought to be heparan sulphate while 
peak IV was either dermatan sulphate or chondroitin sulphate.
The NaCl gradient is switched on at t  .
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Illustrates quantitatively the area under the different 
glycosaminoglycan peaks in the trypsinate fraction. The 
results were worked out by counting up all the 
radioactive counts in each peak and expressing them as a 
percentage of the total counts for peaks I-V. Peak I is 
unknown, peak II is hyaluronic acid, peak III. is heparan 
sulphate and peak four is either chondroitin sulphate or 
dermatan sulphate. Peak V is unknown^
cell-associated material. Compared to the medium fraction, the 
quantity of labelled proteoglycans present in this fraction was 
dramatically lower.
Five peaks were identified by the NaCl gradient in the medium 
extract of the early passage cell line BG105/5, (i.e. there was an 
additional peak at the end of the gradient (i.e. 0.7M) compared to 
the medium results). In this case the results are expressed as a 
percentage of the total counts in peaks I-V. The results suggest 
that in the presence of both dexamethasone and methylprednisolone, 
the absolute quantity of labelled proteoglycans increased in the 
cell lines under investigation. In the continuous cell lines the 
results suggest that dexamethasone increased the quantity of 
material eluting in peaks I and IV, while decreasing the quantity 
in peaks II and III, whereas methylprednisolone increased the 
quantity of material eluting in peaks I and II, while peaks III 
and IV were reduced. Hence, these results suggest that in the 
presence of glucocorticoids, the proportion of the proteoglycans 
bound to the cell surface were dramatically increased, hyaluronic 
acid decreased and heparan sulphate increased.
5. The effect of glucocorticoids on the malignant cell's 
adhesiveness
The question was asked whether the reduction in the 
concentration of hyaluronic acid by glucocorticoids would increase 
the adhesive force of these cells. This was tested according to 
the protocol in the methods section. Cells were grown either in 
the presence or absence of glucocorticoid, the monolayer was 
dispersed and the cells were transferred to capillary tubes. At 
various time points the capillary tubes were turned over for 30 
minutes, then the number of cells adhering to the top surface was 
expressed as a percentage of the total number of cells present in 
that field. Preliminary experiments showed that upon dissociating 
cells with trypsin, compared to EDTA, the former cells took 
longer to adhere to the new surface (Figure 37). This may be 
related to the mechanisms through which EDTA and trypsin exerts 
their respective actions. Trypsin acts by removing surface
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Figure 37
Illustrating the effect of glucocorticoids on cell 
adhesion. The cells were dissociated with either 
trypsin or EDTA and the time was monitored for them to 
adhere to the surface of capillary tubes. The method is 
described in the methods section. Each estimate 
consists of a mean or four readings, each consisting of 
more than a hundred cells.
glycoproteins, which presumably needs to be replaced before these
2++cells can adhere to the substrata, whereas EDTA, a Ca chelator, 
does not cause any structural damage. Cells treated with EDTA 
were seen to recover within 30 minutes, whereas, trypsinised cells 
took a couple of hours.
As the aim of the present report was to investigate the 
relationship between proteoglycans and cell behaviour, it was 
therefore decided to dissociate the cells in the present 
experiment with EDTA. The continuous cell lines were seen to 
recover much more quicker than the early passage cell lines from 
this treatment. This may be related to the ability of these 
malignant cells to adapt more quickly to new environments, a 
property which is required by malignant cells to migrate into 
surrounding tissues. However, the results obtained with the early 
passage cells, as discussed in the general introduction, are 
probably more representive of how tumours in vivo will react to 
glucocorticoids. The results obtained suggested that cell 
adhesion was increased, in the presence of glucocorticoids, most 
significantly in cell line BG84 within the first couple of hours, 
but further confirmation is required, this cell line had the 
greatest increase in heparan sulphate. However, this effect was 
most prominent in the early passage cell lines. The 
glucocorticoid was not found to produce any significant effect in 
the continuous cell line G-CCM.
6. Relationship between addition of exogenous proteoglycans and 
cellular proliferation
Throughout this chapter proteoglycans have been suggested to 
influence cellular behaviour. Therefore, it was proposed that the 
addition of exogenous proteoglycans may influence cellular 
proliferation. The effect of exogenous proteoglycans were 
investigated in terms of both labelling index (Figure 38) and cell 
proliferation (Figure 39). The exogenous GAGs investigated were 
not found to have any effect on cell proliferation. Hyaluronic 
acid (lOyg/ml) and dermatan sulphate (lOpg/ml) produced a slightly 
higher labelling index than that of the control group. This
Figure‘38
The effect of exogenous glycosaminoglycans in relation to 
labelling index in cell line G-CCM. Hyl, hyaluronic acid 
(lOpg/ml, Derm SO^ , dermatan sulphate (lOpg/ml), Dex. SO^ , dextran 
sulphate (10pg/ml), Dx., dexamethasone and HP, methylprednisolone, 
n=4. The experiment was carried out as described in the methods
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Figure 39
The effect of exogenous glycosaminoglycans in relation to 
| cell growth in cell line G-IJKt. Hyaluronic acid (10yg/ml, 
dermatan sulphate (10yg/ml) and chondroitin sulphate (10yg/ml). 
The results are means of four experiments. The experiment was 
carried out as described in the methods section.
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effect could be diminished by 2.5x10 M of either dexamethasone or 
methylprednisolone. However, dextran sulphate in the presence of 
dexamethasone was observed to augment the labelling index. It was 
repeatedly found that the presence of either glucocorticoid 
reduced the labelling index even in the presence of exogenous 
glycosaminoglycans (with the exception of dextran sulphate) where 
the presence of dexamethasone augmented the labelling index. The 
presence of chondroitin sulphate, hyaluronic acid and dextran 
sulphate was found to have no effect on either saturation density 
or labelling index. Future work would involve investigating the 
effect of heparan sulphate on cell proliferation in vitro, as this 
is the most likely glycosaminoglycan to inhibit cell growth. 
Unfortunately we were unable to purchase any of this particular 
glycosaminoglycan.
7. Investigating the invasive properties of gliomas in vitro 
The effect of dexamethasone and methylprednisolone on the 
cells invasive capacity was investigated. Plasminogen activator 
(P.A.) activity has been proposed to be correlated with the 
ability of malignant cells to invade surrounding tissues. It was 
seen in Chapter 2 that the glucocorticoids abolished the PA 
activity of the cell lines under investigation, so it was asked in 
whether this decrease was related to a reduction in the ability of 
the cells to invade an extracellular matrix. The ability of 
gliomas to degrade the extracellular matrix was investigated using 
the procedure described in the methods section. Using both 10% 
and IX foetal calf serum, no detectable release of radioactive 
material was detected above the spontaneous release which occurred 
in the absence of cells. Thus, under these conditions the cell 
lines investigated did not seem to have the capacity to dissolve 
the extracellular matrix even though they possessed a high level 
of plasminogen activator activity.
-92-
DISCUSSION
The concept under investigation in this chapter was the 
effect of glucocorticoids on the composition of proteoglycans in 
malignant astrocytoma cell lines and whether this effect could 
account for the cytostatic activity of the glucocorticoids. The 
precise physiological functions of proteoglycans remain elusive, 
although they have been implicated as being involved in a number 
of different functions:-
(i) Cell-substrata adhesion (Lark and Culp, 1984). Heparan 
sulphate has been associated with promoting cell adhesion and in 
reducing cell proliferation (see section 4.2 of the introduction 
for further details).
(ii) As cell surface receptors (see section 2 of the introduction 
for full details).
(iii) In both inter- and intra-cellular communication as proposed 
from in vitro observations (see introduction for details).
(iv) Cell migration and differentiation. High concentrations of 
hyaluronic acid in foetal tissues have been found to be essential 
for cell migration and inhibit cell differentiation. The 
concentration of hyaluronic acid has to be enzymatically reduced 
before the cells are able to differentiate (see section 4 of the 
introduction.
(v) Selective filtration of blood plasma by the glomerular 
basement membrane of the kidney (Farquhar, 1981). This property 
was lost upon removing heparan sulphate from the basement 
membrane.
(vi) Stabilisation of the extracellular matrix. Undersulphated 
heparan sulphate has been associated with the breakdown of the 
extracellular matrix (section 4.3 of the introduction).
Malignant glia cells have been reported by Glimelius et al (1978 
and 1979) to differ from their normal counterparts with respect to 
their proteoglycan composition. The malignant cells possess 
higher quantities of hyaluronic acid and lower quantities of 
sulphated proteoglycans than their normal counterparts. The 
proteoglycan composition between different normal cell lines was
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quite reproducible, whereas a large variation was observed between 
different malignant cell lines. This latter variability may be 
related to the degree of malignancy, i.e the extent to which the 
various cell lines can escape from the normal mechanisms 
controlling growth and differentiation. This would result in the 
largest differences being between the more aggressive tumour cell 
lines and their normal counterparts.
In addition to the composition of proteoglycans altering in 
malignant tissues, their distribution was also affected.
Malignant cells, compared to their normal counterparts, have been 
reported to retain a larger proportion of proteoglycans on their 
cell surface instead of secreting them into the medium.
It was asked whether the glucocorticoids were exerting their 
cytostatic effect through altering the proteoglycan composition to 
resemble that of normal cells. Many investigators have looked at 
the proteoglycan composition of normal and malignant cells, (Satoh 
et al, 1973; Glimelius et al, 1979). However, there has been 
little work carried out studying the effect of glucocorticoids on 
proteoglycan composition. Moczar et al (1985) have shown that 
hydrocortisone can increase the quantity of sulphated 
glycosaminoglycans by four fold. Thus, in the present 
investigation the effect of glucocorticoids on the composition of 
proteoglycans was investigated in astrocytoma cell lines.
In the present set of experiments the relative proportion of 
each proteoglycan peak was monitored in an attempt to see whether 
the composition of the various glycosaminoglycan groups changed in 
the presence of glucocorticoids. Both dexamethasone and
_5
methylprednisolone, (2.5x10 M), were found to reduce the
proportion of hyaluronic acid present relative to sulphated 
proteoglycans in the glioma cell lines under investigation, while 
a larger quantity of the glycosaminoglycans were associated with 
the cell membrane. This results in the composition of the 
proteoglycans in the malignant cells now resembling closer that of 
normal glial cells as reported by Glimelius et al (1979).
However, there was no apparent correlation between the increase in 
the quantity of cell-associated proteoglycans and a decrease in
the quantity of secreted material. This may be due to the fact 
that the radioactive counts obtained in the pronase extract were 
approximately ten times less than those in the medium extract, and 
such a small increase in the pronase extract may be within the 
statistical limits of the scale used in the former case. It was 
then postulated that the re-expression of density inhibition of 
growth by glucocorticoids as observed in Chapter 2 may occur 
through the above alteration in the proteoglycan composition.
How can alterations in proteoglycan composition relate to the 
physiological behaviour of the cells?
Elevated levels of hyaluronic acid are essential in foetal 
tissues to sustain cell migration, elevated levels of cell 
proliferation and inhibit cell differentiation (Toole, 1981). It 
has been proposed that cell migration may be due to the cell's 
more rounded appearance which may result in weaker binding forces 
to the substrate, as a smaller area of the cell is now in contact 
with the substrate. This alteration in morphological appearance 
of these tissues results from the proteoglycan's ability to absorb 
large quantities of water. Thus, the weaker binding forces would 
increase the ability of these cells to migrate. In contrast, 
heparan sulphate is thought to augment cell adhesion. High 
concentrations of hyaluronic acid have been shown to inhibit 
differentiation of foetal cells, whereas if the concentration of 
this proteoglycan is enzymatically reduced these cells are seen to 
differentiate. A reduction in cell proliferation has also been 
associated with a decrease in the levels of hyaluronic acid.
Thus, the cell's overall physiological behaviour may result from a 
summation of the various physiological characteristics of the 
different proteoglycan groups and not due to the presence of one 
particular group.
It was therefore asked whether a reduction of the quantity of 
hyaluronic acid in malignant cells by glucocorticoids would cause 
the cells to bind more strongly to the substrata. An attempt was 
made to answer this question by using an adhesion assay. The 
preliminary results in the presence of EDTA (which is a Ca^+
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chelator and thus leaves the cell-associated proteoglycans intact) 
suggested, especially for cell line BG84/5, that the presence of 
glucocorticoids did increase the rate of cellular adhesion, but 
only in the first 60 minutes. However, cells which had been 
dissociated with trypsin (which removes surface glycoproteins), 
took longer to adhere to the surface of the capillary tubes 
compared to cells which had been dissociated with EDTA. These 
results suggest that glycoproteins are more important than 
proteoglycans in terms of cell adhesion. The present experiments 
only measures the "degree of adhesiveness" of the cells and not 
the actual force by which the cell binds to the substrata. As the 
concentration of sulphated proteoglycans are increased in the 
presence of glucocorticoids this suggests that cellular adhesion 
may be increased. Heparan sulphate . •. has been documented
in the literature to play an important role in cell adhesion 
(Gallagher et al, 1986), however, this proteoglycan may increase 
the force with which the cell binds to the substrata and not 
influence the initial adhesion itself. In order to answer this 
question an experiment would have to be devised where the actual 
force with which the cell binds to the substrate was investigated.
The extracellular matrix constitutes the normal barrier 
against the passage of cells and small particles from one area 
into another (Liotta et al, 1983; Bosman, 1985). It has been 
widely reported that malignant cells, compared to their normal 
counterparts, possess the ability to degrade proteoglycans present 
in the extracellular matrix (Laug, 1983; Kramer et al, 1981).
This degradation may be due to increased levels of proteinase 
activities such as collagenases, proteoglycanases and plasminogen 
activators. Laug l (1983) have found that proteoglycan 
degradation can proceed either through a plasminogen dependent or 
independent pathway. As the glioma cells under investigation have 
high levels of plasminogen activator activity (Figure 7), it was 
asked whether the presence of glucocorticoids would inhibit the 
degradation of a prelabelled extracellular matrix. Glioma cell 
lines were plated onto a prelabelled extracellular matrix laid 
down by normal endothelial cells, and the release of radioactivity
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into the medium was measured. These experiments were carried out 
in growth medium containing either 10% or 1% Foetal Calf Serum, 
however, no radioactivity was measured except from the spontaneous 
release from the medium itself. Whether the presence of 1% serum 
was sufficient to prevent the degradation of the extracellular 
matrix, or whether these cells lacked the property to degrade the 
matrix requires further clarification.
The discussion up to now has implied that an alteration in 
proteoglycan composition in the presence of glucocorticoids may 
account for the re-expression of density limitation of growth 
observed in Chapter 2. So far however, the experiments do not 
demonstrate a direct correlation. In order to discover whether 
proteoglycans have a direct influence on saturation densities, a 
growth curve was carried out in the presence of exogenous 
proteoglycans. Addition of various exogenous proteoglycans 
(lOyg/ml or 100yg/ml of either dermatan sulphate, chondroitin 
sulphate and hyaluronic acid) were found to have no influence on 
the growth curves of the glioma cell lines under investigation 
(Figure 39). Unfortunately, heparan sulphate, which has been 
implicated in inhibiting cell proliferation, could not be 
commercially obtained within the time limit of these 
investigations. The present findings were similar to those 
reported by Wright et al (1985) where they found that 100yg/ml of 
either chondroitin-4-sulphate, chondroitin-6-sulphate, dermatan 
sulphate or hyaluronic acid had no effect on saturation densities 
on endothelial cells. In contrast, Ohnishi et al (1975) using 
Yoshida ascites hepatoma (AH66) found that 50-100yg/ml of acid 
mucopolysaccharides inhibited cell growth by approximately 84%. 
Whether these results were due to the presence of heparan sulphate 
was not established.
Thus the results in the present investigation imply that 
proteoglycans may be responsible, to a certain extent in 
influencing the physiological behaviour of the cell. They can 
achieve this by influencing either cell shape, proliferation or 
differentiation: this can result in an alteration in both the 
quantity and structure of proteoglycans synthesised by the cell,
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which in turn can alter the composition of both cell-associated 
proteoglycans and those in the extracellular matrix. These 
changes can once again influence cell shape, proliferation and 
differentiation. Thus, an intricate system is set up between 
proteoglycan synthesis and the cell's physiological activity.
It was therefore asked how such a system may work in vivo. A 
possible explanation is that the cell may be able to control its 
physiological behaviour by altering the composition of 
cell-associated proteoglycans and those in the extracellular 
matrix as illustrated in the following example using foetal cells. 
High concentrations of hyaluronic acid are important for immature 
foetal cells to migrate to their site of differentiation. Upon 
reaching the site, in response to some external stimuli, the cells 
reduce the concentration of hyaluronic acid in their immediate 
vicinity, either through enzymatic degradation or by reducing the 
actual amount of hyaluronic acid being released from the cell, 
which then allows the cells to differentiate (Toole, 1981).
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CHAPTER 5
FINAL DISCUSSION
As stated in the general introduction the underlying aim of 
this report was to investigate whether glucocorticoids, exert 
their cytostatic effect by altering the glycoprotein and 
proteoglycan composition associated with malignant glioma cells. 
Glucocorticoids have been widely used to reduce the oedema 
associated with brain tumours but recent evidence suggests that 
these drugs have a direct cytostatic effect on the tumour itself. 
The exact cellular mechanisms by which these effects are exerted 
remains unclear.
As glioma cell lines are comprised of a heterogeneous cell 
population it was important to prevent selection for one 
particular cell type, so the cells under investigation were used 
from frozen stocks for a limited period of three months. This 
resulted in all the experiments being carried out on cells of 
similar passage levels. If cell selection did occur then the 
results produced in vitro may not be representative of what would 
occur in vivo. Alternatively, by carrying out the experiments in 
a limited passage range in both early passage and continuous cell 
lines, any alteration in the concentration of specific proteins 
(as sometimes happens when a cell is passaged for a significant 
length of time in vitro) was prevented. A good example of where 
this is known to happen is with glia fibrillary acidic protein 
(GFAP) which is a specific marker for astrocytes. Cells taken 
from biopsy material were initially found to be GFAP+ve, whereas 
when they were grown for some time in culture they were seen to 
become GFAP-ve (Yates and Stephens, 1987).
Initially the cytostatic effect of glucocorticoids, which has 
been reported by a number of investigators (for example McLean et 
al, 1986), was studied. Dexamethasone and methylprednisolone were 
found in Chapter 2 to reduce the saturation densities of both 
early passage and continuous cell lines in a dose dependent 
manner. This reduction in saturation densities was clearly seen
-99-
in the photographs in Figure 7, where the "piling up" effect was
reduced. However the glucocorticoids were seen to exert a
biphasic response, cell proliferation was augmented at low cell
concentrations in the absence of serum while it was inhibited at
high cell concentrations. The largest cytostatic effect (96%) was
seen in the cell line which reached the highest saturation density
i.e. cell line G-IJKt. A corresponding decrease in labelling
index was observed in the presence of glucocorticoids. Assuming
3
that the uptake of [ H] thymidine was not affected by the presence
of glucocorticoids, these results suggest that the proportion of
cells undergoing proliferation had decreased. These observations
imply that the decrease in saturation density was accompanied by a
decrease in the number of cells proliferating at any period of
time and was not due to cell death. A cytotoxic effect would have
been suggested if no decrease in the labelling index results had
been found in the presence of glucocorticoids. This hypothesis
was confirmed by a clonogenic assay where the glucocorticoids were
seen to have no cytotoxic effect, except at high concentrations 
-4i.e. 2.5x10 M. The latter concentration is much higher than 
would ever be used clinically. However, the glucocorticoids were 
seen to augment cell growth following subculture as observed by 
the increase in the number of colonies formed. In the present 
experiment the colonies formed in the presence of glucocorticoids 
were much more diffuse in appearance than the controls. These 
results are opposite to those found by Guner et al 1977, who 
showed that the size of the colonies in the presence of 
glucocorticoid were more compact in shape than the controls. It 
is not clear why such a difference should occur.
The cytostatic effect of glucocorticoids was found to be 
reversible since 24-48 hours after removal of the glucocorticoids 
the original properties of the cells were seen to be restored. As 
glucocorticoids are known to exert their effect mainly through 
cytoplasmic receptors (Alexis, 1987), it was therefore asked 
whether the largest effect occurred in the cell line which 
possessed the largest number of glucocorticoid receptors. This 
question was investigated with the help of Shelia Colven.
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The various cell lines tested were found to possess 
glucocorticoid receptors but no clear relationship was found to 
exist between receptor number and reduction in saturation density. 
Cell line G-CCM was found to possess ten times the number of 
glucocorticoid receptors than the early passage cell lines, 
however a corresponding decrease in saturation density was not 
observed amongst these cell lines. It would be dangerous, as 
illustrated in the following hypothesis, to conclude that these 
results do not suggest the existence of such a relationship 
without further experimentation. As glucocorticoids readily bind 
to proteins it may be hypothesised that the concentration of 
"free" glucocorticoid (that is the proportion of the drug which 
produces the physiological effect by binding to the glucocorticoid 
receptors) may be too low to saturate all the receptors present in 
the cell lines under investigation. However, if only a fraction 
of all these receptors were occupied and if this number was less 
than the total number of receptors present in the early passage 
cell lines, this would result in any relationship between receptor 
number and reduction in saturation density being masked. Such a 
relationship could be investigated if the total number of 
receptors occupied was theoretically worked out. Knowing the 
partition coefficient, the concentration of "free" drug can be 
worked out for any one drug concentration. Thus, by plotting the 
concentration of "free" drug against reduction in saturation 
density any relationship existing between receptor number and 
saturation density would be obvious.
It may be said that if the glucocorticoids are exerting their 
action by making the properties of malignant cells more like those 
of normal cells, they may be reducing the saturation density of 
the malignant cells to a value comparable to that of their normal 
counterparts. This hypothesis was supported by the finding that 
the largest effect was seen in the cell line which reached the 
highest saturation density. If glucocorticoids were producing a 
standard effect in each cell line, a similar percentage reduction 
in saturation density would have been expected. However, as the 
extent of the reduction seems to be proportional to the saturation
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density, this suggests that the glucocorticoids were reducing the 
saturation density to a certain value. This actual value seems to 
be reproducible within any one cell line, but differs among 
different cell lines. It may be that these differences would not 
be significant if a larger population of malignant cell lines had 
been investigated, or it may be that different types of cells may 
plateau at different values. In order to elucidate these points 
both the saturation and labelling index experiments would have to 
be repeated with a sufficiently large number of different cell 
lines in an attempt to see whether the results are statistically 
different from one another. If the values were all similar then 
it may then be assumed that the glucocorticoid is reducing the 
saturation density to resemble that of their normal, 
differentiated counterparts. Unfortunately, this is a difficult 
concept to investigate as in the majority of cases the parent 
material is not known. One way in which this assumption could be 
investigated would be to use either virally or chemically 
transformed glial cells, this would result in producing both 
malignant and normal cells of similar lineage. However, it is 
questionable whether cells resulting from such a transformation 
are representative of gliomas occurring in vivo.
As many of the side effects of glucocorticoids result from 
their glucocorticoid activity, it was asked whether a similar 
molecule which lacks activity would also possess the above 
cytostatic effect. As the glucococorticoid activity resides in 
the 11-0 orientation, 11-a-epihydrocortisone was tested for 
cytostatic activity. This compound was found to be without 
cytostatic activity, if anything the results suggest that it may 
possess mitogenic activity. Thus, the present results suggest 
that both the cytostatic activity and glucocorticoid activity may 
be associated with the 11-0 orientation.
It may be proposed that the glucocorticoids are acting by 
enhancing cell to cell contact by making the cells larger in size. 
This aspect was not dealt with in this report. It is a simple 
concept to investigate as cell size in the presence or absence of 
glucocorticoids could be investigated using a Coulter counter.
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It was then asked how the above cytostatic effects are 
brought about at the molecular level. As malignant cells are able 
to overcome the normal constraints imposed on them by their 
environment, it was proposed that this behaviour may arise from a 
breakdown in the ability of these cells to communicate with their 
environment. Before this hypothesis can be investigated the 
mechanisms involved in normal growth control need to be 
considered.
An intricate system was seen to exist in section l.A. where 
cell behaviour was influenced by the interaction between the cell 
surface and the extracellular matrix. It was proposed that 
information can be passed from the extracellular matrix through 
proteins, laminins and intermediate filaments to the plasma 
membrane (M Keon et al, 1986), where it is then sent to the 
nucleus through an intricate array of microtubules and filaments. 
The cell may respond to this information by affecting gene 
expression, at either the level of the nucleus (transcription) or 
the cytoplasm (translation) which in turn can influence the 
composition of proteoglycans being synthesised by the cell. 
Equally, the reverse relationship may occur, new gene expression 
could result in alterations in the cytoskeleton, cell shape and 
the extracellular matrix.
Thus, the co-operation of a number of different molecules are 
necessary for the passage of information between the cell and its 
environment.
It may be proposed that, for whatever reason, this method of 
communication may breakdown if the composition of one of the above 
components was altered. This is clearly seen from the following 
experimental evidence in terms of proteoglycans. Proteoglycans, 
in normal rat fibroblasts, are found in close association with 
actin filaments (Hynes, 1981; Gallagher et al, 1986) whereas in 
transformed rat fibroblasts the proteoglycans are found diffusely 
bound throughout the cells. This may suggest a breakdown in the 
relationship between actin and proteoglycans in malignant cells, 
which may lead to a breakdown in both intra- and inter-cellular 
communication.
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If malignant cells arise from a breakdown in communication 
then it may be hypothesised that growth of malignant cells is not 
regulated. This has indeed been postulated but Westermark et al 
(1973) have shown that it is not the case. They have shown that 
malignant cells did respond to density inhibition, but this 
occurred at a much higher cell density than for their 
corresponding normal cells. Thus, it may be hypothesised that in 
malignant cells it is the mechanism which controls the cell 
concentration at which contact inhibition occurs which is at 
fault, and not the actual processes themselves. This would lead 
to the hypothesis that glucocorticoids may be exerting their 
cytostatic effect by "re-setting” the value at which contact 
inhibition occurs. However, the mechanisms through which this is 
achieved are not known.
It has been postulated that the above effects may result 
through an alteration of the composition of carbohydrates 
associated with either the extracellular matrix or the cell. 
Malignant cells have been reported to differ from their normal 
counterparts in terms of glycoprotein and proteoglycan 
composition. These molecules are thought to play an important 
role in cellular communication due to their position on the plasma 
membrane and in the extracellular matrix. Glycoproteins comprise 
80% of all cell carbohydrates and are mainly situated on the 
periphery of the cell membrane. Proteoglycans differ from 
glycoproteins in that they consist of 90-95% carbohydrate by 
weight in the form of many long unbranched glycosaminoglycan 
chains, whereas glycoproteins contain a lower proportion of 
carbohydrate (1-60% by weight) in the form of numerous, relatively 
short (>15 sugar residues), branched oligosaccharide chains which 
often contain terminal sialic acid residues. In spite of their 
relatively small proportion by weight, the surface carbohydrates 
can cover the entire surface of the cell and thus form the first 
point of contact between the cell and its environment. Thus, it 
may be postulated that any alteration in the composition of the 
surface carbohydrates may lead to a breakdown in the communication 
between the cell and its environment.
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The effect of glucocorticoids on the composition of intact 
glycoconjugates in astrocytoma cell lines was investigated with 
the help of Gillian Hunt. Both dexamethasone and 
methylprednisolone were found to alter the composition of intact 
glycoconjugates, however the actual alterations differed between 
the two cell lines under investigation. It has been reported by a 
number of investigators that malignant cells differ from their 
normal counterparts in the extent of sialation of the 
glycoproteins at the cell surface. Malignant cells in general are 
more highly sialated than their normal counterparts, this effect 
is thought to lead to an alteration in the cell's physiological 
activity. It was therefore considered necessary to investigate 
the effect of glucocorticoids on the composition of the 
extracellular glycoconjugates, as it is this material which is
thought to play an important role in passing information from the
of
environment to the inside/\tne cell. The glycoconjugates were 
isolated using gel exclusion chromatography, a quick method by 
which proteins can be separated according to their molecular 
weight. Once again both the cell lines under investigation were 
found to respond differently to glucocorticoids in terms of 
glycoprotein composition. Dexamethasone was found to increase the 
quantity of glycoconjugates present in both the pronase and medium 
fractions in cell line G-CCM and G-IJKt. However, 
methylprednisolone was found to only increase the quantity of 
glycoconjugates in the pronase fraction of cell line G-CCM and in 
the medium fraction of G-IJKt. It was felt that the resolution of 
the latter technique was not sufficient to identify a similar 
reduction in the proportion of the higher molecular weight 
glycoconjugates would be seen as reported by Van Beek et al (1978) 
using neuraminidase, and Freshney et al (1980b) using 
dexamethasone.
Only two cell lines were initially used in the latter 
experiments. These were chosen arbitrarily as the results in 
terms of cytostasis in Chapter 2 showed that the glucocorticoids 
produced a similar effect in all the cell lines under 
investigation, the only difference being the actual extent of the
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reduction in either saturation density or labelling index. Before 
any conclusions can be made in terms of the effect of the 
glucocorticoids on glycoprotein composition, these experiments 
need to be repeated with a wide range of both early passage and 
continuous cell lines. The sensitivity of the above method was 
not regarded as being sufficient to see any slight change in 
glycoprotein composition which may occur. It was therefore 
concluded that a more sensitive technique was required before any 
conclusive results could be made as to whether the glucocorticoids 
may exert their cytostatic effect through altering the 
glycoprotein composition. If when carrying out these experiments 
on a larger population of cells there is still no common 
alteration in the glycoprotein composition, then it may be 
concluded that the glucocorticoids are not exerting their 
cytostatic effect through altering the glycoprotein composition.
The effect of glucocorticoids on the proteoglycan composition 
was then investigated. The proteoglycan composition on the cell 
surface and in the extracellular matrix, as seen in Chapter 4 can 
influence the cell's behaviour. High concentrations of hyaluronic 
acid have been associated with morphologically more rounded, 
undifferentiated cells which have the ability to migrate. In 
contrast high concentrations of heparan sulphate have been 
associated with a much flatter cells which do not possess the 
ability to migrate. It is plausible to suggest that the different 
proteoglycan groups may act synergistically in controlling cell 
behaviour. Thus as discussed in Chapter 4 it may not be the 
absolute quantities but the relative proportion of the 
proteoglycan groups present which are important in determining the 
physiological behaviour of the cell.
The different glycosaminoglycan groups were separated on the 
DE-52 ion-exchange column eluting with a NaCl gradient. As normal 
glial cell lines could not be grown with any success, the results 
obtained in the present investigation were compared with those 
reported by Gallagher et al (1979) for normal glia. The 
proportion of hyaluronic acid to sulphated proteoglycans was found 
to be reduced in the presence of glucocorticoids. The hypothesis
that glucocorticoids enable malignant cells to resemble their 
normal counterparts is supported by work carried out by Gallagher 
et al (1979). They reported that malignant cells possess higher 
quantities of hyaluronic acid than normal glia. Thus, the 
glucocorticoids are reducing the concentration of hyaluronic acid 
which makes the malignant cells resemble more their normal 
counterparts in terms of proteoglycan composition. In addition to 
altering the composition of proteoglycans, the glucocorticoids 
were found to alter the distribution of proteoglycans. The 
presence of both dexamethasone and methylprednisolone was found in 
the present investigation to increase the proportion of 
cell-associated proteoglycans, however there was no corresponding 
decrease in the quantity of proteoglycans released from the cell. 
This discrepancy may have been due to the fact that the number of 
radioactive counts in the trypsin extract was tenfold less than 
the amount secreted into the medium. Thus, the extent of this 
reduction may be within the sensitivity limits of the technique. 
Once again, glucocorticoids are seen to make the malignant cells 
resemble their normal counterparts. Malignant cells are reported 
in the literature (for example by Gallagher et al, 1979) to 
excrete a larger proportion of the synthesised proteoglycans into 
the medium in vitro. The above alterations were considered to be 
sufficient to account for the cytostatic effect of the 
glucocorticoids observed in Chapter 2.
The elevated proportion of hyaluronic acid in the malignant 
cells could account for the ability of these cells to grow on top 
of one another as shown in the photographs in Figure 7. High 
concentrations of hyaluronic acid were essential in foetal tissues 
for migration. The ability for cell migration was correlated in 
Chapter 4 to the cells' more rounded appearance, which resulted in 
a smaller area of their plasma membrane coming into contact with 
the substrate. This hypothesis is correct if the strength with 
which the cell binds to the substrate is proportional to the 
number of binding sites in contact with the substrate. Thus, the 
larger the number of attachment sites, the greater the force with 
which the cells bind to the substrate. The ability of the cell to
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migrate may be a summation between the forces with which the cell 
binds to the substrate and those which stimulates the cell to 
migrate. Therefore, it may be hypothesised that the stronger the 
adhesive force then the less likely the cell is to migrate. The 
decrease in the tendency of malignant astrocytoma cells to migrate 
in the presence of the glucocorticoids is observed by the 
reduction in the "piling-up" effect as illustrated in the 
photographs in Figure 7.
It was asked whether a decrease in the concentration of 
hyaluronic acid brought about by the presence of glucocorticoids, 
would result in the cells adhering more strongly to the substrate. 
An experiment was devised to test this hypothesis. Cells were 
grown in the presence or absence of glucocorticoid, dissociated 
with EDTA in an attempt to prevent the removal of surface 
proteoglycans, and the time taken for them to adhere to a new 
surface was investigated. The results are illustrated in Figure 
37 and show no distinct enhancement in cell adhesion of the glioma 
cell lines in the presence of glucocorticoids. These experiments 
investigate how quickly the cell binds to the capillary tubes but 
not the force with which it binds. As previously mentioned the 
ability of the cell to migrate may not be due to whether the cell 
can adhere to its environment or not, but may depend on the force 
with which it adheres. It would be interesting to devise an 
experiment where the actual binding force in the presence of EDTA 
is investigated and not just the rate of binding. It may be that 
glucocorticoids increase the force with which the cell binds to 
the substrate and do not affect the actual ability of cells to 
adhere.
Malignant behaviour has been described up to now in terms of 
a breakdown in cellular communication between the inside and the 
outside of the cell and between cells. However, it may also be 
alternatively described in terms of the state of cell 
differentiation.
Malignant cells, with the exception of virally transformed 
cells, have not been reported to produce any material which is not
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found at some point in the development of normal cells. As 
previously discussed in Chapter 4 malignant cells resemble foetal 
cells in proteoglycan composition which can account for their 
ability to migrate and their more rounded appearance. Thus, the 
processes occurring are not abnormal but what is different is the 
time in the cell's life cycle at which this is occurring. It can 
be proposed that the malignant cells may only be abnormal in that 
they are expressing properties which are not normally found in 
that stage of a cell's life cycle. One way in which this 
situation may arise is if the total number of cells in any tissue 
is regulated by the "body" through monitoring the number of fully 
differentiated cells present. A reduction in the number of these 
cells would result in immature cells entering the maturation 
pathway until they become fully differentiated cells. This 
transition is a gradual process, thus a block occurring in the 
pathway would result in the presence of undifferentiated cells.
As the transition from undifferentiated to fully differentiated 
cells is a gradual process, the block could theoretically occur at 
any point of this pathway. This would result in different tumour 
lines possessing different quantities of differentiated 
characteristics, which would agree with the heterogeneity found in 
different tumour cells and not in different normal cell lines 
(Yates et al, 1987). The immaturity of malignant cells is clearly 
seen in terms of proteoglycan composition. It may be postulated 
that by inducing the cells to differentiate this would push them 
past this "block". This does not however mean that the cells will 
become more differentiated than fully differentiated cells, but 
means that the immature cells can continue along the maturation 
pathway to the fully differentiated state.
Upon the cells differentiating the composition of the 
proteoglycans would alter to resemble that of normal mature cells 
which is reflected in an alteration in the physiological 
behaviour of the cell. McLean et al (1986) have shown that 
glucocorticoids can induce malignant glioma cells to differentiate 
as seen by the disappearance of P.A. activity and the appearance 
of differentiated characteristics such as glutamine synthetase
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activity. In this investigation, both dexamethasone and 
methylprednisolone were found to abolish P.A. activity. Thus, the 
subsequent alteration in physiological activity may result in the 
more differentiated appearance of the cell. These alterations 
coincide with the results obtained in terms of cytostasis and 
proteoglycan composition.
Due to the cell's immature status, it is important to take 
the state of differentiation into account as the cell's abnormal 
properties need to be considered in terms of whether they are due 
to malignancy or whether they are merely due to an 
undifferentiated state. Glimelius et al (1979) have shown that 
the alteration in proteoglycan composition was not due to the 
malignant cells proliferative ability. The actual state of 
differentiation of the malignant cell needs to be compared with 
normal cells at the same stage in differentiation in order to 
determine whether the abnormal behaviour is due to the cells 
undifferentiated state. Differences in both the composition and 
quantity of proteoglycans have been found between the log and 
stationary phases of the normal cells cycle. Heparan sulphate 
produced by cells during the log phase generally consists of 
simple, unbranched molecules whilst the same glycosaminoglycan 
produced during the stationary phase consists of a longer, more 
highly branched structure. Thus care must be taken when relating 
an alteration in proteoglycan composition to malignancy as it has 
been suggested in the literature that the actual structure of the 
glycosaminoglycans groups may be related to their biological 
activity in relation to the cells physiological activity 
(Gallagher et al, 1986). This suggests that the proteoglycan 
composition (not only the type of proteoglycan produced but also 
its structure) associated with the cell may influence the cell's 
physiological activity.
It is difficult to say whether an alteration in proteoglycan 
composition results in cell differentiation or whether cell 
differentiation then results in an alteration in proteoglycan 
composition. It is felt that the former hypothesis may be correct 
as the results from foetal tissues show that these immature cells
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are not able to differentiate unless the concentration of 
extracellular hyaluronic acid is reduced. It may be hypothesised 
that in malignant tissues it is the mechanism(s) which reduces the 
concentration of hyaluronic acid in the tissue which may be at 
fault as this would give rise to the properties associated with 
malignant cells. A large number of these cells may arise due to a 
"re-setting" of the process which determines at what stage contact 
inhibition occurs or it may arise from the "body's" inability to 
detect these undifferentiated cells.
Thus, the cell's properties in the presence and absence of 
glucocorticoids can be related to the proteoglycan composition. 
This implies that the glucocorticoids may be exerting their effect 
through altering the proteoglycan composition. The effects of 
exogenous proteoglycans were investigated in terms of saturation 
density and labelling index. It may be hypothesised that addition 
of exogenous heparan sulphate, at a concentration which would 
increase its relative proportion to hyaluronic acid, may have 
produced a similar cytostatic effect as that produced by the 
glucocorticoid. Such an experiment would clarify whether the 
alteration in proteoglycan composition is indeed responsible for 
the cytostatic effect of glucocorticoids.
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